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CHAPTER I 
INTRODUCTION 
1 
2 
This investigation examines the effect of two antitumor drugs, all 
trans retinoic acid (RA) and butyric acid (BA), on the metastatic 
properties of murine Bl6a melanoma cells. The Bl6a cell line is the 
murine counterpart to human melanoma which is the most lethal form of 
skin cancer. Accepted forms of chemotherapy have been found to be 
ineffective in controlling metastatic melanoma (McClay and Mastrangelo, 
1988). 
Vitamin A (retinal) and metabolites (such as retinoic acid) are 
necessary for the visual system, normal development and tissue 
differentiation of an organism. Evidence is accumulating for retinoids 
in chemoprevention and therapeutic control of cancer (Lippman et al., 
1988). Butyric acid (and its sodium salt) is a natural four carbon 
fatty acid normally present in lipids. Much less is known about BA than 
RA in the normal development of an organism. However, a role for BA in 
the control of neoplastic formation has been found (Kruh, 1982). 
Retinoic acid and BA warrant investigation for two main reasons. 
First, RA and BA can be less toxic and less mutagenic to the host than 
conventional chemotherapeutic drugs when administered at cytostatic 
concentrations, i.e. the concentration of a drug that inhibits cellular 
proliferation without causing cell death. Second, the effects of RA and 
BA on the individual steps of the metastatic cascade are undefined. 
Most of the deaths due to cancer are a result of the appearance of 
neoplasms in parts of the body removed from the primary lesion. The 
metastatic cascade is a complex series of steps involving: (1) primary 
growth and progression of the primary tumor, (2) intravasation, i.e. the 
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escape of tumor cells into the lymphatics and blood vessels, (3) 
dissemination of cells through the lymphatics and blood vessels, (4) 
arrest of cells within the walls of small vessels, (5) extravasation, 
the escape of tumor cells from small vessels and into surrounding 
tissues, and (5) cell proliferation at the new secondary site. 
Important host tumor cell interactions can take place at any point of 
the cascade. Experimental evidence suggests that only a select few 
tumor cells are capable of completing this sequence of events (Poste et 
al., 1980). 
A tumor cell must invade various tissue barriers, which include the 
extracellular matrices and basement membranes, for metastasis to take 
place. Migration, defined here as the ability of a cell to locomote and 
deform, is an important part of the invasion process. 
The cytoskeleton is a network of proteineous filaments found 
throughout the cytoplasm of all eukaryotic cells. The cytoskeleton 
includes microtubules (25 nm in diameter), intermediate filaments (10-15 
nm in diameter) and microfilaments (5-7 nm in diameter). The 
cytoskeleton has many different functions essential for the normal 
functioning of the cell including cellular migration. However, the 
importance of the cytoskeleton in the metastatic process is unclear. 
Five parameters of the metastatic cascade that I am investigating 
are: (1) determination of the cytostatic and cytotoxic concentrations 
of RA and BA for the Bl6a cell line, (2) quantification of in vitro 
migration, (3) quantification of in vitro invasion, (4) quantification 
of in vivo experimental metastasis, and (5) cytoskeletal morphology. 
The experimental metastasis assay is the inoculation of tumor cells into 
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the murine lateral tail vein followed by extravasation of tumor cells in 
the lungs. This project emphasizes the evaluation of in vitro 
experiments in light of in vivo assays, and stresses the importance of 
testing potential antitumor agents by multiple parameters. This project 
is novel in that it will lead to further understanding of the multistep 
process of metastasis by in vitro methods following RA and BA treatment. 
In this study, evidence for a role for RA and BA in the treatment of 
metastasis was found. In addition, both drugs present interesting model 
systems for evaluating the mechanisms behind tumor cell migration and 
invasion. 
CHAPTER II 
REVIEW OF LITERATURE 
5 
6 
Cancer and Metastasis 
The second leading cause of death in the United States is cancer. 
Most of these deaths are a consequence of metastasis or complications 
as a result of the treatment of the metastasis. Of the million new 
cases of cancer each year, two thirds of the individuals will develop 
and die of metastasis (American Cancer Society Facts and Figures, 
1982). Metastasis is defined as the appearance of neoplasms in parts 
of the body remote from the primary tumor. Metastasis is a complex 
series of events starting with initiation, growth, and progression 
(diversification) of a primary tumor. Some tumor cells have the 
inherant ability to invade local tissues and enter the venous and 
lymphatic vessels (intravasation). Single tumor cells or tumor emboli 
may travel within these vessels to distant sites and then arrest in 
capillaries. Surviving tumor cells may exit the capillaries 
(extravasation) and establish colonies. Fortunately, progress has been 
made in the last two decades towards understanding the metastatic 
process. 
Metastasis and Invasion 
The extracellular matrix is a major barrier to a tumor cell in the 
metastatic cascade. A tumor cell must invade the extracellular matrix 
at multiple points during metastasis. The extracellular matrix is a 
complex meshwork of collagens and elastin embedded with a ground 
substance consisting of glycoproteins (for example: laminin and 
fibronectin) and various proteoglycans. Some of the functions of the 
extracellular matrix include supporting tissues, influencing cell 
attachment, mitogenesis, morphogenesis, cellular differentiation and 
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determining tissue architecture. A specialized portion of the 
extracellular matrix is the basement membrane (the electron microscopic 
term is basal lamina). Tumor cells must cross basement membranes in 
order to invade most organ parenchyma, and to intravasate and 
extravasate. Liotta has proposed a three-step hypothesis to describe 
tumor cell invasion. The tumor cell must first attach to the matrix. 
Subsequently, the tumor cell secretes various proteolytic enzymes which 
locally degrade the matrix. Lastly, the tumor cell must migrate into 
the space created by proteolytic digestion (Liotta et al., 1983). 
Many investigators have chosen to examine the interaction of tumor 
cells with the extracellular matrix as part of a reductionist strategy 
in order to begin to understand the complex nature of the metastatic 
process. 
Invasion Assays 
Various in invasion assays have been used to study the 
mechanisms of invasion (Liotta et al., 1982) as well as evaluating 
various drugs for anti-invasive properties (Welch et al., 1989). These 
methods include: (1) organ culture with such diverse targets of 
invasion as embryonic heart muscle (Mareel et al., 1979), lung tissue 
(Paweletz et al., 1986), kidney (Castro and Cass, 1974), murine 
mesentery (Lee et al., 1988), and brain tissue microspheres (Waller et 
al., 1986), (2) cellular monolayers of fibroblasts (Chew et al., 1988), 
endothelial cells (Waller et al., 1986; Nakajima et al., 1987), and 
endothelial cell-fibroblast gels (Schor et al., 1985), (3) the chick 
chorioallantoic membrane (CAM) (Scher et al., 1976), (4) the human 
amnion basement membrane (HABM) (Liotta et al., 1980; Schleich et al., 
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1981), (5) the lens capsule (Starkey et al., l984a; l984b) and most 
recently (6) reconstituted basement membrane (Terranova et al., 1986; 
Albini et al., 1987). Each of these protocols has their proponents as 
well as detractors. What is required is an vitro assay that is 
repeatable, easy to perform and quantifiable as well as one that 
closely mimics the clinical situation (Poste, 1982). 
Malignant Melanoma 
The most lethal form of skin cancer is malignant melanoma. It is 
estimated that in 1990, twenty-two percent of the patients diagnosed 
with melanoma will die (CA). Melanoma accounts for only 1% of all 
cancer, but the incidence of melanoma continues to rise. The five year 
survival rate of patients presenting a clinically localized disease can 
be estimated from the level of invasion. Those diagnosed with a 
distant metastases have less than a ten percent chance of survival (for 
a review see, Liotta et al., 1987). Human melanoma is refractive to 
most drug therapies. Dacarbazine (DTIC) is viewed as the treatment of 
choice for patients that present with metastasis. The overall response 
(complete and partial) rate has been reported to be 21% with the 
majority of the responses being partial and of short duration. A 
complete response is defined as disappearance of the tumor for five 
years. Phase II clinical trials of multiagent regimens with 
dacarbizine, cisplatin, 1,3-bis-2 chloroethyl 1-nitrosourea, and 
tamoxifen had a overall response rate of 52.5% with 7 complete and 14 
partial responses (McClay and Mastrangelo, 1988). 
Cancer Chemotherapy 
Cancer chemotherapy is currently being reevaluated for several 
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reasons including: (1) drug carcinogenicity to normal tissues 
(Benedict et al., 1979), (2) enhancement of tumor cell diversity 
(McMillian and Hart, 1986), and (3) progression of invasive and 
metastatic capabilities (Nicolson, 1984). Chemotherapeutic drugs have 
been shown to damage normal tissues and allow surviving tumor cells to 
metastasize more easily (Nicolson and Custead, 1985). The damage done 
by antitumor agents to the host may include immunosuppression such as 
reduced natural killer cell activity (Nolibe and Poupon, 1986), or 
vascular injury such as damage done to endothelial cells (Nicolson and 
Custead, 1985). One chemotherapeutic strategy is to use cytostatic 
agents or so called differentiation agents that are less host-toxic and 
less mutagenic than conventional chemotherapy. Cytostatic agents may 
be used as adjuvants between cycles of highly cytotoxic drugs to 
prevent regrowth and tumor cell diverification (Nicolson and Lotan, 
1986). 
Differentiation and Malignancy 
The relationship between differentiation and malignancy has 
received a great deal of attention. Certain common tumors in man, such 
as squamous cell carcinoma of the lung, represent a change in the 
pathway of differentiation. Normal lung epithelium is columnar and 
mucous secreting. The term used for abnormal differentiation is 
transdifferentiation (Wyllie et al., 1981). It also has been observed 
that as a cancer progresses, the neoplasm becomes more dedifferentiated 
(anaplastic) (for review, see Freshney, 1985). A general histological 
progression can be seen in the production of the malignant phenotype. 
Loss of growth control is a hallmark of benign as well as malignant 
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tumors, but local invasion (including degradation of local basement 
membranes) is the hallmark of a malignant twnor. 
The normal cell counterpart to malignant melanoma is the 
melanocyte. Melanocytes are unique cells found in the mucous 
membranes, the choriod of the eye, the piaarachnoid of the nervous 
system, and in basal layer of the epidermis. Melanocytes have a 
phenotype that is distinctive from other cell types. These 
characteristics include (1) dendritic formation, (2) pigmentation due 
to production of melanin in specific organelles (melanosomes) and, (3) 
expression of the specific enzyme tyrosinase. Tyrosinase converts 
tyrosine to 3,4-dihydroxy-phenylalanine (dopa) and dopa to dopaquinone. 
Melanocytes are derived from cells migrating out of the neural crest. 
Neural crest cells give rise to a number of other differentiated cell 
types including neurons and supporting cells of the dorsal root and 
autonomic ganglia and mesenchyme of the head. The question remains at 
what stage or stages of melanocyte differentation are targets for 
malignant transformation. A possible model for understanding malignant 
transformation and progression in human melanoma is benign focal 
proliferation of melanocytes in melanocytic nevi. 
A panel of 25 different human melanomas have been characterized on 
the basis of early, intermediate, or late stages of melanocyte 
differentiation (Houghton et al., 1982). These melanomas were 
classified into three groups (early, intermediate and late stage) based 
on phenotypic characteristics including pigmentation, morphology, 
tyrosinase activity and cell surface antigens. Four different sets of 
melanoma surface antigens were categorized on the basis of reactivity 
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of mouse monoclonal antibodies with fetal, newborn, and adult 
melanocytes. Early stage melanomas were characterized by an epitheloid 
morphology, lack of pigmentation, lack of tyrosinase expression, and 
early marker antigens. Early marker antigens are not expressed by 
fetal, newborn or adult melanocytes. Intermediate melanomas had a 
bipolar shape and expressed antigens also found on the surface of fetal 
or newborn melanocytes. Late stage melanomas had extensive dendritic 
formation, heavy pigmentation, high tyrosinase activity, and expressed 
antigens found on adult melanocytes (Houghton et al., 1982). No 
correlation has been found for human melanoma cell lines between 
melanogenesis and tumor latency, size, or frequency of metastases 
(Aubert et al., 1980). However, various cell surface antigens have 
been linked to melanoma progression. Antigens K.1.2. and HLA-A,B,C 
have been found to be decreased in the course of local and systemic 
melanoma spread, while antigens HLA-DR, A.1.43, and A.10.33 were 
increased in proportion to invasiveness and metastatic properties 
(Brocker et al., 1985). 
Murine Melanoma 
The Bl6 melanoma cell line is a murine counterpart of human 
melanoma. The Bl6 cell line was adapted to tissue culture by Fidler 
(1970) from a transplantable tumor originating spontaneously in the 
C57BL/6J mouse in 1954. The Bl6a (amelanotic) cell line is highly 
invasive and spontaneously metastatic and has been fully characterized 
by K. Honn (Crissman et al., 1983). The phenotype of the Bl6a melanoma 
cell line does not seem to fit into one of the general melanoma 
phenotypes, but instead has dendritic formation without pigmentation. 
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Possible differentiation antigens have been identified in the Bl6 cell 
line. The Met-72 antigen has been correlated to increased metastasis 
in vivo (Kimura and Xiang, 1986). The Norm-1 and Norm-2 antigens have 
been linked to increased proliferation. Antibodies to Norm-1 and 
Norm-2 decrease proliferation and induce changes in morphology of Bl6 
cells (Vollmers et al., 1985). Low serum content in media, high cell 
density or the administration of transforming growth factor beta 
(TGF-beta) decreases Norm-2 antigen presentation (Wieland et al., 
1986). 
Differentiation Agents and Melanoma 
Tumors of ectodermal, neuroectodermal, mesodermal and endodermal 
origins have been shown to undergo some form of differentiation in 
response to various inducers (for review see Freshney, 1985). Melanoma 
is an interesting model system for differentiation. Human melanomas 
have a varied response to inducers in that differentiation can either 
be accompanied by a decrease or increase in tumorgenicity in nude mice 
(Aubert et al., 1980). Tryrosinase activity, changes in proliferation, 
modifications in tumor cell phenotype, as well as alterations in cell 
surface markers, vary from cell line to cell line in response to a 
number of physiological inducers. Several hormones, including 
melanocyte stimulating hormone (MSH) (Fuller and Meyskens, 1981), 
corticotropic hormones (Abramowitz and Chavin, 1978) and prostaglandin 
A1 and E1 (Fuller and Meyskens, 1981; Bregman et al., 1983) have been 
shown to stimulate tyrosinase activity and melanin production in normal 
melanocytes as well as melanoma cell lines. Low metastatic Bl6Fl cells 
were found to be sensitive to MSH or cAMP. Melanocyte stimulating 
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hormone or cAMP induced tyrosinase activity and inhibited proliferation 
in Bl6Fl cells. However, highly metastatic Bl6Fl0 cells were not 
sensitive to MSH or cAMP (Niles et al., 1978). Melanocyte stimulating 
hormone and theophylline (an inducer of cAMP) inhibited proliferation, 
promoted differentiation, and reduced tumorgenicity of murine S91 
melanoma cells (Wick, 1981). Prostaglandin derivitives have been shown 
to inhibit the growth of Bl6a cells (Honn et al., 1981). 
Nonphysiological inducers such as polar solvents can modify the 
phenotype of melanoma cells vitro. An inhibitor of polyamine 
synthesis, 2-difluromethylornithine (DFMO) stimulated melanogenesis and 
inhibit proliferation of S91 cells (Kapyaho and Janne, 1983). DFMO was 
shown to inhibit proliferation of Bl6Fl cells vitro without an 
increase in tyrosinase activity (Sunkara et al., 1983). Polar solvents 
such as dimethyl sulfoxide (DMSO) have been shown to induce growth 
inhibition and to produce changes in morphology of human melanoma cells 
(Huberman et al., 1979) and murine Bl6 cells (Lampugnani et al., 1987). 
Dexamethasone (a glucocorticoid agonist) was shown to inhibit the 
proliferation of six different human melanoma cell lines (Osman et al., 
1985). Even cytotoxic agents, such as the anthracycline antibiotics, 
have been shown to inhibit growth and produce irrevisible morphological 
changes in Bl6Fl cells after 16 hrs of incubation (Raz, 1982). The 
roles of butyric acid and the metabolites of vitamin A, 13 cis and all 
trans-retinoic acid in tumor cell differentiation, will be discussed 
later. 
The effect of differentiation agents on melanomas in vivo has been 
investigated. Drinking ~ater containing 2% DFMO has been shown to 
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decrease the tumor weight of Bl6Fl tumors by 84% in C57BL6 mice 
(Sunkara et al., 1983), and decrease spontaneous metastasis of Bl6a 
cells (Sunkara and Rosenberger, 1987). The mechanism of the inhibition 
of spontaneous metastasis was believed to be in the intravasation step 
of the metastatic cascade, since the administration of DFMO did not 
reduce lung colonization by tail vein inoculation (experimental 
metastasis) (Sunkara and Rosenberger, 1987). Pretreatment of Bl6 
melanoma cells, on the other hand, with differentiation agents has been 
shown to decrease tumorgenicity (Nordenberg et al., 1985), but increase 
experimental metastasis (Bennett et al., 1986; Casali et al., 1988). A 
24 hr incubation of Bl6Fl or Bl6Fl0 cells in medium with a higher pH 
-9 (from 6.9 to 7.2) and containing 10 M MSH was shown to produce an 
increase in tyrosinase activity vitro and experimental metastasis in 
vivo (Bennett et al., 1985). Experimental metastasis was also shown to 
be significantly increased by DMSO pretreatment of Bl6 cells for 4 days 
(Casali et al., 1988). On the other hand, a delay was observed in the 
onset of tumor formation of DMSO pretreated Bl6Fl0 cells (Nordenberg et 
al., 1985). 
The Retinoids: Function in Normal Development 
Vitamin A (retinol) and metabolites are essential for maintainance 
of the visual system (Bridges, 1984), for normal embryonic development, 
for differentiation and maintenance of epithelial tissue (for review 
see Roberts and Sporn, 1984), and for the development and maintenance 
of the immune system (Dennert, 1984). The major sources of vitamin A 
in the diet are certain plant carotenoid pigments, such as B-Carotene, 
and long chain retinyl esters found in animal tissues. B-Carotene and 
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retinyl esters are converted to retinol by the intestinal mucosa 
(Goodman and Blaner, 1984). Many investigators believe that retinoic 
acid is close to the structure of the retinoid that acts within cells 
to control development (Frolik, 1984). Retinoids at low concentrations 
are known teratogens and induce major craniofacial deformities in 
rodent models (Shenefelt, 1972). 
The hypothesis that retinoids may suppress carcinogenesis 
(delaying the preneoplastic progression of carcinogen or 
radiation-treated cells), induce neoplastic differentiation, inhibit 
tumor cell proliferation, and suppress various tumor phenotypic 
properties was not difficult to believe given the role of retinoids in 
normal development. 
Retinoids and Carcinogenesis 
The chemopreventitive nature of the retinoids has been shown to be 
important in inhibiting the promotion phase of chemically induced 
rodent skin, mammary gland, and urinary bladder carcinogenesis (for 
review see Moon and Itri, 1984). A link has been observed between a 
decreased human dietary intake of vitamin A and increased incidence of 
several carcinomas (for review see Moon and Itri, 1984). Retinoids 
have also been used to treat preneoplastic conditions including 
dysplastic nevi (Lippman et al., 1987). Dysplastic nevus is 
characterized by the presence of pigmented flat papules or macules that 
frequently undergo transformation to melanoma. Three patients were 
treated for 10 to 12 weeks with topical all trans-retinoic acid. The 
dysplastic nevus features underwent major changes to benign 
nevocellular nevi (Lippman et al., 1987). 
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Retinoids and Tumor Cell Differentiation 
Retinoids have been shown to have direct effects on proliferation 
and differentiation of tumor cells. Most of the studies have been done 
on tumor cells in vitro, but some in vivo and clinical studies that 
have been performed indicate a possible role of retinoids in the 
treatment of tumors and metastasis. The effect of retinoids on tumor 
cells seems to depend on the cell line being studied. The effect of 
retinoic acid on tumor cell differentiation can be divided into two 
general categories, terminal and reversible differentiation. 
Terminal differentiation occurs in murine embryonal carcinoma 
(Strickland and Mahdavi, 1978; Jetten et al., 1979), human 
promyelocytic leukemia (Breitman et al., 1980), and rat 
rhabdomyosarcoma (Gabbert et al., 1988). An intermediate phenotype was 
induced in retinoic acid-treated F9 teratocarcinoma cells that could 
differentiate further into either visceral or parietal endoderm 
depending on culture conditions (Hogen et al., 1981). Differentiation 
was measured by the induction of plasminogen activator (Strickland and 
Mahdavi, 1978). Retinoic acid-treated human promyelocytic (HL-60) 
cells differentiate into functionally and morphologically mature 
granulocytes (Breitman et al., 1980). Terminal differentiation with 
exposure to retinoic acid was shown to occur with a rat 
rhabdomyosarcoma cell line (BA-HAN-lC). There was an increase in the 
number of terminally differentiated postmitotic myotube-like giant 
cells and an increase in the creatine kinase activity (Gabbert et al., 
1988). 
Reversible differentiation occurs in certain retinoid sensitive 
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tumor cell lines. The effect of retinoids on melanogeneisis of murine 
or human melanoma cells is again dependent on the cell line and is 
reversible upon removal of the retinoid from the growth media. 
Retinoic acid induces an increase in tyrosinase activity and 
melanogenesis in S91 murine melanoma (Lotan and Lotan, 1980), murine 
melanoma Bl6Fl cells (Edward et al., 1988), and Hs939 human melanoma 
cells (Lotan and Lotan, 1981). Retinoic acid has been shown not to 
effect melanogenesis of Bl6Fl0 and Bl6BL6 murine melanoma cells, and to 
inhibit melanogenesis of UCT-Mel2 human melanoma cells (Hoal et al., 
1982). Some tumor cell lines have been reported to undergo 
differentiation with addition of the retinoids. These include human 
neuroblastoma (IA-N-1) (Sidell, 1982), rat adenocarcinoma and 
keratinizing squamous cell carcinoma (Marchak et al., 1981). 
Retinoids and Inhibition of Proliferation 
The ability of retinoids to induce differentiation of tumor cells 
is confined to a few cell lines, while the inhibition of proliferation 
by retinoids is more commonly observed. Inhibition of proliferation in 
either tiisue culture or the soft agar assay is concentration 
dependent, time dependent, independent of cell density, and reversible. 
The natural retinoids with the most potent effects on tumor cell 
proliferation are 13 cis and all trans-retinoic acid (Lotan, 1980). 
The amount of RA induced inhibition varies from having no effect on 
proliferation (<10% inhibition) in some tumor cell lines to inhibiting 
proliferation by greater than 75 percent in other tumor cell lines 
(Lotan and Nicolson, 1977). Two of the tumor cell lines shown to be 
highly sensitive to retinoic acid were the murine melanoma S91 and Bl6 
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cell lines. Differences in sensitivity to retinoic acid were observed 
in clones of the Bl6 cell line. The parental Bl6 line as well as in 
~ selected Bl6Fl and Bl6Fl0n (selected for brain metastasis) cells 
were extremely sensitive, while the in vivo selected Bl6Fl0, Bl6Fl00 
(selected for ovarian metastasis), and the in vitro selected Bl6BL6 
cells were less sensitive to retinoic acid (Lotan and Nicolson, 1979; 
Edward et al., 1988). An important clinical application for the 
assessment of retinoids in treatment of cancer was made using an in 
vitro tumor colony forming assay (Meyskens et al., 1983). This group 
had shown that a correlation existed between a clinical response and 
inhibition of colony formation of human melanoma cells by cytotoxic 
drugs in the soft agar assay (Meyskens et al., 1981). Four of the 
twenty-five human melanomas obtained from fresh biopsies were sensitive 
(reduction of 70% or more) to 13 cis-RA treatment and three of twenty 
were sensitive to 4 hydroxyphenyl-all-trans-retinamide (4-HPR) (a 
synthetic retinoid) treatment (Meyskens et al., 1983). 
The inhibition of proliferation induced by retinoids is believed 
to be linked to a block in the progression of cells through the G1 
phase of the cell cycle (for review see Roberts and Sporn, 1984). Flow 
microflurometric analysis of S91 melanoma cells showed that retinoic 
acid increased the amount of cells in the G1 phase and slowed the rate 
of entry of cells into the S phase of the cell cycle (Lotan et al., 
1981). Niles (1987) has shown that inhibition of proliferation in Gl 
occurs without an inhibition of protein synthesis. 
Retinoids and Changes in Morphology 
Morphological changes and differences in the pattern of protein 
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synthesis have been noted in retinoic acid-sensitive tumor cell lines. 
Some phenotypic changes are seen in terminally differentiated F9 
embryonal carcinoma cells (Linder et al., 1981; Lehtonen et al., 1983). 
Changes in morphology were characterized by progressive flattening and 
were shown to be time dependent taking approximately five days. 
Retinoic acid has been shown to induce the synthesis of type IV 
collagen, laminin, the intermediate protein vimentin, and the 
actin-myosin related protein tropomyosin (Linder et al., 1981). 
Retinoic acid treatment was shown to induce after two days the 
formation of vinculin rich adhesion plaques followed by the appearance 
of actin stress fibers (Lehtonen et al., 1983). The change in the 
distribution of vimentin was profound. Vimentin in untreated cells was 
found around the nucleus, while RA-treated cells had a distinct 
fibrillar pattern throughout the cytoplasm. Another intermediate 
protein, keratin, was found to be induced in many of the 
differentiating F9 cells (Lehtonen et al., 1983). 
Morphological changes induced by retinoic acid have also been 
characterized in a rat osteogenic sarcoma cell line (UMR 106-06) (Ng et 
al., 1985). The phenotypic changes are apparently related to both 
cellular adherence and cell size. Retinoic acid-treated cells were 
larger and more adherant to the substrate. Changes in size and 
adherence were correlated by immunofluorescence and transmission 
electron microscopy to increases in microfilaments (stress fibers) and 
microtubules (Ng et al., 1985). Retinoic acid has also been observed 
to induce in the apparently undifferentiated mononuclear 
rhabdomyosarcoma cells the formation of thick and thin myofilaments 
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(Gabbert et al., 1988). Changes in the tumor phenotype induced by 
retinoic acid in other cell lines have been noted but are not well 
characterized. For example, retinoic acid induced progressive 
flattening in the morphology of three human osteosarcoma and two 
chondrosarcoma cell lines (Thein and Lotan, 1982). However, no 
characterization of the morphological changes were performed in these 
human sarcoma cell lines (Thein and Lotan, 1982). 
Changes in the tumor cell surface have been linked to alterations 
in malignancy and metastasis (Stanford et al., 1986; Gabius et al., 
1987). Retinoic acid induces changes in cell surface glycoproteins of 
a head and neck squamous cell carcinoma (1483) (Lotan et al., 1987a), 
cervical carcinoma (HeLa) (Lotan et al., 1980), and murine S91 melanoma 
cells (Lotan et al., 1983; 1987b). Retinoic acid treatment increases 
the radioactive labelling of high molecular weight (MW>400,000) 
galactoglycoconjugates and sialoglycoconjugates and a 280,000 MW 
sialoglycoconjugate in a well differentiated head and neck squamous 
cell carcinoma cell line. A less well differentiated head and neck 
tumor was not sensitive to retinoic acid (Lotan et al., 1987a). The 
varied effect of retinoic acid on the the head and neck carcinoma cell 
lines was believed to be related to the state of differentiation of the 
tumor, the control of tumor cell proliferation and surface markers. A 
correlation apparently also exists between homotypic aggregation and 
metastasis (Updyke and Nicolson, 1987). Retinoic acid has been shown 
to decrease homotypic aggregation of S91 melanoma cells (Lotan et al., 
1987). A link between the induction by retinoic acid of glycosylation 
of a 160,000 MW sialoglycoconjugate and decreased homotypic aggregation 
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may be important (Lotan et al., 1987). 
Inhibition of proliferation by retinoic acid is not necessary in 
some cases to induce phenotypic changes in tumor cells. All trans-
retinoic acid has been shown to reduce production and activity of type 
IV collagenase in rat mammary adenocarcinoma (13762NF) cells at a 
concentration that did not inhibit proliferation (Nakajima e tal., 
1989). Growth inhibition was also not observed with 13 cis retinoic 
acid in murine squamous carcinoma (KLN205) cells. However, 13 
cis-retinoic acid caused an increase in expression of lectin receptors 
(Couch et al., 1987). The alterations in lectin receptors might have a 
role in the induced decrease seen in experimental metastasis by 
RA-pretreated murine squamous carcinoma (KLN205) cells by increasing 
natural killer cell activity (Couch et al., 1988). 
Retinoids and In Vivo Control of Cancer 
The evidence is strong that retinoids can inhibit proliferation, 
induce differentiation, and change the morphology of many tumor cell 
lines in vitro. Evidence is also accumulating for a role of retinoids 
in the therapeutic control of human tumors and metastasis (for a review 
see Lippman et al., 1985). Retinoids have a role in decreasing tumor 
size and tumorgenicity in animal models (Felix et al., 1975; Drewa and 
Schachtschabel, 1985; Olsson et al., 1985; Halter et al., 1988; McCue 
et al., 1988; Dillehay et al., 1989). There is a link between a 
decrease in proliferation vitro and decrease in tumorgencity in 
vivo. For example, all human squamous-cell (RH-SCL-Lll) and small-cell 
(RH-SCC-LlO) lung carcinoma clones found to be sensitive to RA in the 
soft agar assay were found not to be tumorgenic in nude mice after in 
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vitro pretreatment (Olsson et al., 1985). 13 cis-retinoic acid has 
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been shown enhance T cell protection. Dillehay et al. (1989) treated 
preimmunized mice, athymic mice and euthymic mice with 13 cis-RA. Only 
the euthymic mice had decreased lymphoma tumor growth (Dillehay et al., 
1989). 
The results of pretreatment of tumor cells vitro with RA before 
tail vein inoculation (experimental metastasis) are not as simple. In 
some investigations, RA pretreatment vitro caused a decrease in lung 
colonies (Couch et al., 1988 and Edward et al., 1989), while 
pretreatment of F9 embryonal carcinoma cells with RA and dibutyl cAMP 
caused a change in the pattern of organ metastasis (Terrana et al., 
1987). However, the change in pattern of organ metastasis might have 
been induced by the dibutyl cAMP. 
A role for retinoids (without pretreatment) in the reduction of 
metastasis of a hamster melanoma cell line (HMl-FS) in athymic mice has 
been established by Schleicher et al. (1988). The number of 
spontaneous metastases was shown to be decreased by 13 cis-RA and two 
synthetic retinoids (2 hydroethyl retinamide and N-4(-hydroxyl-phenyl) 
all trans retinamide (4HPR)). One of the synthetic retinoids (4HPR) 
was also shown to decrease the incidence of metastasis (Schleicher et 
al., 1988). 
Retinoids and Clinical Control of Cancer 
Retinoids have been used in the clinic for the treatment of 
neoplastic disease (for review see Lippman et al., 1987). Retinoids 
appear to have value in the treatment of basal cell carcinoma, advanced 
regional or metastatic cutaneous squamous cell carcinoma, melanoma, 
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mycosis fungoides (an uncommon T-cell lymphoproliferative disease), 
leukemia, and squamous cell cancer of the head and neck. Topical all 
trans-RA (tretinoin) was reported to produce 16 complete responses and 
32 partial responses in 49 patients with basal cell carcinoma 
(Schumacher and Stuttgen, 1971; Belisario, 1972; Bollag and Ott, 1975; 
Sankowski et al., 1984). Oral 13 cis-RA was reported to produce a 
complete response in 39 lesions and a partial response in 162 lesions 
(out of 248 lesions in 11 patients having multiple lesion basal 
carcinoma) (Peck et al., 1979). Oral 13 cis-RA produced 1 partial 
response in a patient with basal cell carcinoma (Meyskens et al., 
1982). A synthetic retinoid, oral etretinate, was effective in 
treating basal carcinoma with 3 complete responses 14 partial responses 
and 14 minor responses reported in 40 patients. The reports on 
retinoid treatment in advanced cutaneous squamous cell carcinoma are 
limited to four studies with a total of 14 patients evaluated. Oral 
etretinate produced one complete response and one partial response (out 
of 4 patients) (Grupper and Berretti, 1983). Another synthetic oral 
retinoid, arotinoid, was shown to produce one partial response (out of 
one patient evaluated) (Kingston et al., 1983). Oral 13 cis-retinoic 
acid produced 2 complete responses and 5 partial responses (out of nine 
patients evaluated) (Meyskens et al., 1982; Lippman and Meyskens, 
1987). Successful treatment of mycosis fungoides has been reported 
with systemic 13 cis retinoic acid (Warrell et al., 1983; Molin et al., 
1985; Kessler et al., 1987) and systemic etretinate (Souteyrand et al., 
1981; Zachariae et al., 1981; Claudy and Rouchouse, 1985). The 
clinical data is limited with leukemias, but there is promise for 
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retinoic acid in the treatment of acute promyelocytic leukemia (Flynn 
et al., 1983). Systemic 13-cis RA showed some efficacy in the 
treatment of advanced head and neck cancer with 3 partial responses 
observed out of 19 patients (Meyskens et al., 1982). 
Treatment of patients with topical all trans-retinoic acid or oral 
13 cis-retinoic acid with either cutaneous and metastatic melanoma have 
met with success, but have been limited in scope. Topical all 
trans-retinoic acid used to treat two patients with cutaneous melanoma 
produced a complete regression in one patient and a partial regression 
in the other (Levine and Meyskens, 1980). Partial responses were 
observed in three out of 20 patients that received oral 13 cis-retinoic 
acid in a phase II trial (Meyskens et al., 1982). 
Acute and Chronic Toxicity of Retinoids 
In vivo animal experiments and clinical trials with retinoids have 
been limited by both acute and chronic toxicity (for a review see Kamm 
et al., 1984). Dosage and timings are critical in evaluating potential 
antitumor effects. Major side effects of acute toxicity include 
central nervous system symptoms such as severe headaches, increased 
cerbrospinal fluid pressure, irritablity and dizziness, nausea, 
vomiting, fatigue, weakness, and somnolence. Minor side effects of 
acute toxicity include skin disorders such as inflammation of the lips, 
dryness and swelling of the skin, and dry mucous membranes. Eye 
disorders are also common. They include conjunctival inflammation, 
dryness, diplopia, and blurry vision. Tenderness of the long bones, an 
enlarged liver or spleen and edema are also commonly seen in acute 
toxicity. 
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Major effects of chronic toxicity include abnormalities in 
reproductive function and embryological development, defects in liver 
function and the skeleton. Hypertriglyceridermia is also observed. 
Minor chronic side effects include dry skin and mucous membranes, 
itching inflammation of the lips, hair loss, visual disturbances and 
occipital headaches (Koerner and Voellm, 1975). Synthetic retinoids 
may be critical for possible therapeutic trials. Synthetic retinoids 
tend to have less severe and fewer central nervous system and liver 
side effects (Lippman et al., 1987). Arotinoids, for example, can be 
used at lower concentrations and still have effects vitro simliar to 
retinoic acid (Klaus et al., 1983). 
Butyric Acid 
I have investigated another differentiation agent, butyric acid. 
Butyric acid (and its sodium salt) is a natural four carbon fatty acid 
normally present in lipids and is formed by the hydrolysis of 
ethylbutyrate. Much less research has been done on the role of butyric 
acid in the normal functioning of an organism. Most of what is known 
is based on vitro studies on normal and tumor cell lines. As with 
other differentiation agents, butyric acid has been shown to induce 
differentiation, inhibit proliferation, induce changes in morphology, 
and reduce tumorgenicity of various tumor cell lines (for a review see, 
Kruh, 1982). Nontoxic BA concentrations are at the millimolar level 
(less than 5 mM), though the cytostatic and noncytotoxic concentrations 
vary from cell line to cell line. Thus butyrate levels needed to 
induce functional changes in cells are much more than the 
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concentrations of various retinoids (from 10 to 10 M). 
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~tyrate and Differentiation 
Butyate induces reversible differentiation in many tumor cell 
lines. The first report of differentiation induced by butyrate was in 
murine Friend virus-transformed erythroleukemia cells that had been 
shown to synthesize hemoglobin (Leder et al., 1975). The embryonal 
carcinoma cell lines, as observed with the experiments with retinoic 
acid, presents an interesting model for differentiation. The 
PCC4(RA) 1 cell line that is resistant to differentiation by retinoic 
acid has been shown to be partially differentiated by BA. However, 
further differentiation takes place when retinoic acid and BA are added 
together (McCue et al., 1984). In contrast, BA has been shown to 
inhibit the differentiation of RA-treated F9 embryonal carcinoma cells 
(Levine et al., 1984), and stimulate the differentiation of 6050AJ and 
PCC4azaR embryonal carcinoma cells (McCue et al., 1984). Thus, these 
similiar cell lines may be used in studies to elucidate the action of 
RA and BA at the molecular level. 
As with other differntiating agents, the effect of BA on melanoma 
cells is unique. Tryrosinase production (a classical marker for 
differentiation) is inhibited by BA in murine Bl6Fl0 melanoma cells 
(Malik et al., 1987). However, BA stimulated the activity of other 
enzymes including NADPH cytochrome c reductase (indictive of the 
development of the endoplasmic reticulum) (Nordenberg et al., 1987). 
In a human melanoma (SKMEL-28) cell line, BA has been shown to induce 
marker enzymes such as alkaline phosphatase, y-glutamyl transpeptidase, 
and NADPH cytochrome c reductase(Nordenberg et al., 1987). Thus, BA 
increases protei~ production in ways not previously observed in cells 
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induced to differentiate by other agents. 
Butyrate and Inhibition of Proliferation 
Butyrate induced reversible inhibition of proliferation is 
sometimes accompanied by induction of marker enzymes that are 
indicative of differentiation. Human tumor cell lines that have been 
shown to be sensitive to butyrate induced inhibition of proliferation 
include two colonic carcinomas (SW 480 and Sw 620) (Kim et al., 1980), 
three pancreatic adenocarcinornas (MIA PaCa, PANC-1, and CAPAN-1) 
(Mcintyre and Kirn, 1984), two poorly differentiated ovarian 
adenocarcinomas (PEOl and PE04)(Langdon et al., 1988); one salivary 
adenocarcinoma (HSG) (Azuma et al., 1986), one squamous cell carcinoma 
of the tongue (HNl) (Bijman et al., 1987), and a human melanoma 
(SKMEL-28) (Nordenberg et al., 1987). Inhibition of soft agar 
clonogenicity was also induced by BA (Nordenberg et al., 1987). The 
soft agar assay is believed to be a good indicator for tumorgenicity 
(Meyskens et al., 1983). Arrest of proliferation has been shown to 
occur in the Gl phase of the cell cycle (RA arrests proliferation in 
Gl) (Thorgeirsson et al., 1984). 
Butyric acid inhibits proliferation in cell lines that are not 
sensitive to RA. Retinoic acid did not inhibit proliferation but did 
induce alkaline phosphatase activity in 9-lC rat prostatic 
adenocarcinorna cells. Butyric acid, on the other hand, inhibited 
proliferation at a concentration of 5 rnM or more (Reese et al., 1985). 
Butyrate was also the most effective short chain fatty acid in the 
induction of alkaline phosphastase activity, inhibition of 
proliferation, and increasing the protein content of 9-lC cells (Reese 
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et al., 1985). 
~utyrate and Changes in Morphology 
Changes in proliferation induced by butyrate are usually 
accompanied by dramatic time dependent changes in morphology. The most 
characterized changes in morphology are in virus transformed 
fibroblasts (KNRK) (Altenburg et al., 1976; Ryan and Higgins, 1988) and 
rat hepatoma (72/22) cells (Borenfreund et al., 1980; Ryan et al., 
1987). In virus transformed fibroblasts, butyrate was shown to produce 
the formation of long cytoplasmic processes within 12 to 24 hrs after 
which there was a progressive flattening of cells at 72 hr. 
Ultrastructural and immunofluorescent analysis of the KNRK cells found 
that there was a dramatic increase in the amount of microfilaments and 
microtubules, and an enhanced formation of adhesion plaques (Altenburg 
et al., 1976). The changes in KNRK cells were further characterized by 
gel electrophoresis (Ryan and Higgins, 1987). There was a 2.5 to 3.0 
fold increase in actin, alpha actinin (an actin binding protein), and 
fibronectin. However, the amount of tropomyosin, vimentin, alpha and 
beta tubulin in the KNRK cells was found to be significantly reduced 
(Ryan and Higgins, 1987). The reduction in the amount of alpha and 
beta tubulin conflicts with the results in the experiments of Altenberg 
et al. (1976). The electrophoresis pattern of butyrate-treated KNRK 
cells appear to contain little if any alpha or beta tubulin. This is 
odd noting the elaboration of microtubules in KNRK cells (Altenburg et 
al., 1976). 
Reorganization of the cytoskeleton with inhibition of 
proliferation also occurs in 72/22 cells treated with butyrate 
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(Borenfreund et al., 1980; Ryan et al., 1987). F-actin was observed to 
accumulate at the cellular edges (peripheral band) and in the central 
portion of the cell. The total actin was measured by densitometry of 
electrophoretic patterns and flow cytometry. Total actin was found to 
be increased in butyrate-treated 72/22 cells without an increase in 
mRNA. The structure of the intermediate filaments, which consists of 
both vimentin and keratin, in 72/22 cells, was also changed by 
treatment with butyrate (Borenfreund et al., 1980). Untreated hepatoma 
cells have been shown to have distinct genetically stable, acentric, 
abnormal, juxtanuclear aggregates composed of intermediate filaments 
(Borenfreund et al., 1978). Butyrate treatment induces a progressive 
disintegration of the aggregrates with a resultant normal display of 
filaments (Borenfreund et al., 1980). A flattened morphology is 
typical of BA-treated cells including Bl6Fl0 cells (Nordenberg et al., 
1986), but a further characterization of cytoskeletal changes is 
needed. Most morphological changes produced by butyrate in many tumor 
cell lines are reversible within three days. However, changes 
persisted after 14 months without butyrate in the human salivary 
adenocarcinoma cells (Azuma et al., 1986). 
Butyrate and In Vivo Control of Cancer 
Few reports have investigated the role of butyrate in the in vivo 
or clinical settings. A correlation was shown to exist in the delay of 
tumor appearance, decreased size of tumors and BA-pretreatment of 
Bl6Fl0 cells (Nordenberg et al., 1986). However, a correlation for a 
decrease in tumorgenicity and BA-treatment was not observed in human 
colon cancer cells (Kim et al., 1980). BA-pretreatment has been 
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observed to produce, as with other differentiation agents such as DMSO, 
a concentration and time dependent increase in experimental metastasis 
of low metastatic Lewis lung carcinoma (P-29) cells (Takenaga, 1986). 
Only two studies have reported using butyrate in a therapeutic setting 
(Bourgeade et al., 1979; Novogrodsky et al., 1983). Butyrate and 
interferon were administered (i.p.) on alternate days to Swiss or DBA/2 
mice that received murine sarcoma (180 TG) cells (i.p.). Treatment 
with BA and interferon was found to increase mean survival time and 
final survival rate over untreated or interferon treated mice 
(Bourgeade et al., 1979). 
The effect of butyrate on cells from peripheral blood of five 
human patients with acute leukemia was also examined in vitro 
(Novogrodosky et al., 1983). One patient (a five year old boy) that 
had acute myelogenous leukemia received 2% butyrate (500 ml/kg/24 hrs) 
for ten days. After this time period, it was observed that myeloblasts 
were eliminated from the peripheral blood, the number of mature myeloid 
cells was increased, and the number of bone marrow myeloblasts was 
reduced by 70 to 80%. There were no signs of toxicity in the animal 
study or clinical trial. 
The Synergistic Action of Differentiation Agents 
The use of differentiation agents as adjuvant or in combination 
with cytotoxic drugs or other differentiation agents may be an 
important concept for preventing tumor progression. The notion has met 
with some success vitro. Butyrate, in combination with retinoic 
acid, produced an inhibition of proliferation of human retinoblastorna 
(Y-79) that was synergistic in nature (Kyritis et al., 1984). The 
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addition of PGA1 to media containing both dexamethasone (a synthetic 
glucocorticoid) and all trans-retinoic acid was shown to 
synergistically inhibit the colony forming ability of C8146c human 
melanoma cells (Bregman et al., 1983). A similiar enhanced inhibition 
of colony forming ability was found with the combination of 
dexamethasone, alpha interferon, all trans retinoic acid, and DFMO 
(Bregman and Meyskens, 1986). This in vitro study by Bregman and 
Meyskens (1986) is important since the drug concentrations used in 
vitro were within the limits that are pharmalogically achievable in the 
clinical setting. 
The Seed and Soil Theory in Metastasis 
Much of the experimental ground work of the current theories of 
tumor cell metastasis comes from experiments done on the Bl6 cell line. 
Fidler's 1970 study found that only 0.1% of tumor emboli survive after 
14 days to give rise to lung nodules after tail vein injection 
(experimental metastasis assay). A great deal of information has been 
gleened since this time using the Bl6 cell line that substantiates much 
of the 'seed and soil' 1889 theory of Paget. Paget proposed that 
metastasis was the result of certain tumor cells ("seeds") to find an 
appropriate organ microenvironment ("soil") to develop and grow. Paget 
believed this process was nonrandom and only partially due to 
circulation patterns and mechanical lodgement. Clinical examples of 
metastasis believed not to be due to random events include ocular and 
cutaneous malignant melanoma. The primary sites for these melanomas 
are in the eye and skin, respectively. Ocular melanoma metastasizes 
primarily to the liver, while cutaneous melanoma metastasizes primarily 
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to the brain, liver and bowel. The parent Bl6 melanoma (primary) tumor 
was found to be heterogeneous in regard to metastasis (Poste et al., 
1981). An indication of this was the ability to select for the highly 
metastatic cells by in vivo (Fidler, 1973; Fidler and Nicolson, 1976) 
or vitro methods (Hart, 1979). Metastasis resulted from prexisting 
variant cells within the parental tumor rather than an adaptation to a 
specific site environment (Brunson and Nicolson, 1980; Nicolson and 
Custead, 1982). This is the seed part of the hypothesis. The 'soil' 
experiments included studies that utilized ectopic grafts. Bl6Fl0 
cells metastazied not only to the lung but to subcutaneous lung tissue 
grafts (Hart and Fidler, 1980). 
The Cytoskeleton and Malignancy 
There are three major classes of cytoskeletal filaments found in 
eukaryotic cells: microfilaments, microtubules, and intermediate 
filaments. The cytoskeleton has many different functions essential for 
the normal functioning of the cell including such diverse activities as 
intracellular transport, mitosis, control of cellular proliferation, 
ciliary movement, cellular migration, and maintenance of cell shape. 
Microfilaments are 5-7 nm in thickness and composed of F-actin 
(filamentous actin) which is polymerized from globular monomers 
(G-actin). F-actin and G-actin interact with numerous actin associated 
proteins that regulate the length, distribution, and stability of 
microfilaments. An important probe for analysis of actin filaments is 
the cyclic oligopeptide phallodin. Phalloidin, which is derived from a 
toadstool (Amanita phalloides), binds to actin filaments 
stoichiometrically (Miyamoto et al., 1986). Microtubules are 
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approximately 25 run in diameter. The wall of the microtubule is 
composed of protofilaments consisting of two polypeptides, alpha and 
beta tubulin. Attached to the walls of the microtubules are numerous 
microtubule associated proteins. 
In the discussion of the changes induced in tumor cells by various 
differentiation agents, one of most obvious are phenotypic changes. 
Investigators have used immunofluorescence since 1975 to speculate on 
the role of the cytoskeleton in neoplastic transformation (Brinkley et 
al., 1975; Puck, 1977). Current thought attributes the decrease in 
microtubules observed in transformed cells by Brinkley et al. (1975) 
and Puck (1977) to the shape and spreading of transformed cells that 
obscured the microtubule networks in immunofluorescent studies (DeMey 
et al., 1978; Tucker et al., 1978; Asch et al., 1979). Laboratories 
are now using immunofluorescence and electron microscopy to find 
changes in tumor cell cytoskeleton and are correlating possible 
alterations with biochemical analysis. Immunofluorescence is not 
easily quantifiable given the variable nature of the interactions 
between antibody and cytoskeleton antigen or antigens. 
Malignant transformation has been found to induce many different 
cytoskeletal changes in cell lines. Whether cytoskeletal changes are 
found only in specific cell lines needs further study. Kirsten virus-
transformed rat NRK cells were found to have almost twice as much 
pelletable tubulin compared to NRK cells using a colchicine binding 
assay and a stabilization buffer (Rubin and Warren, 1978). The amount 
of tubulin (without the use of a stabilization buffer) was found by 
. . f 35s h' . b d d . SV 40 incorporation o met ionine not to e ecrease in -
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transformed murine Swiss 3T3 or Rous sarcoma virus-transformed NRK 
cells, but there was a two fold decrease in calmodulin (Chafouleas et 
al., 1981). Calmodulin is a protein present in most eukaryotic cells 
that binds calcium with high affinity and specificity (for a review see 
Means and Dedman, 1980). Calmodulin has a number of functions 
+2 including Ca -dependent regulation of microtubule assembly-diassembly 
(Schiwa et al., 1981), cell cycle regulation (Chafoules et al., 1982), 
and conferring stablity to DNA in tumor cells (Lonn and Lonn, 1986). 
Calmodulin has been shown by immunofluorescence to be closely 
associated with the cytoplasmic microtubule complex (Deery, 1986). 
Beta tubulin has been shown to be composed of different isotypes (for 
review see Sullivan, 1988). A unique tubulin isotype (hB4 ) was found 
by immunofluorescence to be expressed in high levels in tumors of 
epithelial origin as compared to normal tissues. The expression of 
this isotype was not as distinctive with cultured malignant cell lines 
(Walker et al., 1987). This is one example of the concerns in using 
cultured cell lines. 
Microfilaments and Malignancy 
Morphological changes in neoplastic transformation have been 
studied with respect to alterations in microfilaments (Pollack et al., 
1975; Rubin et al., 1978; Tucker et al., 1978). Immunofluroescence and 
phallocidin flourescent studies have noted in some tumor cell lines 
(including the Bl6 cell line) the lack of stress fibers and 
accumulation of structures called F-actin aggregates (Carely et al., 
1981). Aggregates contain not only F-actin but also alpha actinin, 
vinculin, talin and fimbrin but not tropomyosin (Carely et al., 1986). 
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Vinculin, talin and fimbrin are proteins found in adhesion plaques 
(David-Pfeuty and Singer, 1980; Burridge and Connell, 1983; Carely et 
al., 1986). Adhesion plaques and substrate interactions are apparently 
weakened or disrupted in neoplastic transformation (Nigg et al., 1986). 
Vinculin is a target for tyrosine phosphorylation by the src oncogene 
(Sefton et al., 1981). Reorganization of vinculin, actin, and 
alpha-actinin into aggregates was observed in virally transformed cells 
that were encoded for the production of tyrosine kinases. In contrast, 
cells transformed by viruses without tyrosine kinase activity did not 
produce aggregates (Nigg et al., 1986). Rous sarcoma virally 
transformed fibroblasts had less vinculin and talin than normal chick 
fibroblasts (Otto, 1985). Other modifications in adhesion plaques may 
occur in malignant transformation. Rous virus transformed chick 
fibroblasts also showed more than a three fold reduction in the 
acylation of vinculin (Burn and Burger, 1985). Alpha-actinin is 
associated with adhesion plaques and stress fibers (Mangeat and 
Burridge, 1984). Stress fibers are large bundles of microfilaments, 
thought to be a higher level of organization of actin filaments. These 
results are important since, it has been observed in a number of 
transformed fibroblast cell lines, that there was a decrease in the 
levels of one or two major tropomyosins and an increase in the levels 
of one or two minor tropomyosins (Matsumura et al., 1983). These 
experiments were done by biochemical analysis of isolated 
microfilaments (Matsumura et al., 1983). Alpha-actinin and tropomyosin 
isotypes have an apparent function in stabilization of stress fibers. 
Alpha-actinin was colocalized with actin to the leading edge of motile 
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rabbit V2 carcinoma cells, while tropomyosin was not observed in the 
motile leading edge (Jockusch et al., 1983). It is interesting to note 
an increase in a-actinin was observed in butyrate-treated KNRK cells 
with a decrease in tropomyosin (Ryan and Higgins, 1987). An increase 
in migration induced by BA-treatment may be a consequence of an 
increase in alpha-actinin (McGarvey and Persky, 1989). 
Many of the various s involved in tumor cell metastasis are 
related to the cell's ability to deform, to make and break 
intracellular contacts, and to actively migrate. These processes are 
known to be controlled by the components of the cytoskeleton (Raz and 
Ge , 1982). The evaluation of possible differences between the 
cytoskeletons of low and high metastatic cells has been limited by the 
same problems in experiments looking for differences between 
transformed and normal cell cytoskeletons. These problems include the 
the use of immunofluorescence, which is at best only semiquantitative, 
and the use of a limited number of tumor cell lines. Whether changes 
seen in tissue culture are valid in vivo is another question. The use 
of biochemical techniques may be helpful to find if there are any 
actual differences between high and low metastatic cells. 
Immunofluorescent studies have shown that highly metastatic 
variants of the murine K-1735 melanoma and of the UV2237 fibrosarcoma 
have been shown to exhibit distorted actin bundles, a reduction in the 
number of focal contacts, and a reduced organization of vinculin (Raz 
and Ge , 1982). These results were confirmed using various clones 
of the K-1735 cell line (Volk et al., 1984), in the Dunning R3327 rat 
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prostatic adenocarcinoma system (Zachary et al., 1986), and rat 
pancreatic adenocarcinoma (BSp73) variants (Raz et al., 1986). The 
loss of actin organization was shown to be an important part of the 
transition from noninvasive benign human colonic tumors to invasive 
malignant tumors (Friedman et al., 1984). On the other hand, three 
distinct phenotypes were observed in human breast carcinoma cells and 
the cytoskeleton seemed to be more dependent on cell shape (Brinkley et 
al., 1980). In addition, the organization of the cytoskeleton in the 
rat adenocarcinorna cells varied between clones, not with the metastatic 
potential of the clones (Lichtner and Nicolson, 1987). 
Biochemical studies may further define the role of the 
cytoskeleton in metastasis. The cytoskeletal core actin (Triton X 
insoluble) assembly was increased by 35% in highly metastatic clones of 
Bl6Fl0 cells grown in the presence of fetal calf serum. This increase 
was measured by the DNase I inhbition assay and was not seen in the low 
metastatic clones (Holme et al., 1987). Parental and low metastatic 
Bl6 cells also displayed a newly found actin polypeptide (Ax), which 
comprised 30% of the total actin. This peptide, isolated by a number 
of biochemical techniques including the microfilament isolation 
techique of Matsumura et al. (1983) and two dimensional 
electrophoresis, was not found to be expressed in highly metastatic 
Bl6BL6 or Bl6Fl0 cells (Taniguchi et al., 1986). Given the importance 
of actin in motility and cell shape, one can only speculate on the role 
of different actin isotypes or the assembly patterns of actin in 
metastatis. 
The synthesis and expression of intermediate filament types is 
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specific for tissue types (Franke et al., 1978). Melanoma cells 
synthesize intermediate filaments composed only of vimentin (Ramaekers 
et al., 1983). The synthesis of vimentin has been shown to be 
decreased in the rounded configuration, highly metastatic variant of 
the Bl6-Fl0 cell line (Raz and Ben-Ze'ev, 1983). Modifications of cell 
shape are apparently important in metastasis (Stackpole et al., 1985), 
but changes in vimentin synthesis may be only part of the story (Nabi 
and Raz, 1987). On the other hand, cyclohexamide decreased the 
synthesis of vimentin (as well as actin and tubulin) and also decreased 
lung nodule formation (Ben-Ze'ev and Raz, 1985). Is a decrease in 
vimentin associated with a decrease or increase in metastasis? The 
effect of cyclohexamide on metastasis might not be directly due to the 
disorganization or decrease in the synthesis of vimentin, but due to a 
decrease in general protein synthesis (Thorgeirsson et al., 1984). 
Further characterization of the role of the cytoskeleton in 
metastatic spread is needed. Agents that have disruptive effects on 
the cytoskeleton are important tools, but given the wide range of 
functions that the cytoskeleton has in a cell, dissecting a specific 
role for the cytoskeleton in individual steps of the metastatic cascade 
will be a difficult job. The microfilament system appears to have a 
crucial role in lung implantation. Bl6Fl and Bl6Fl0 cells pretreated 
with tertiary amine local anesthetics have decreased lung colonization 
abilties (Nicolson et al., 1986). Tertiary amine local anesthetics 
result in cell rounding and the loss of stress fibers (Nicolson et al., 
1976). However, pretreatment of Bl6 cells with either cytochalasin B 
(an actin depolymerization agent) and colchicine (an antimicrotubule 
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agent) decreased lung colonization with a surprising increase in 
extrapulmonary metastasis (Hart et al., 1980). These three agents have 
been shown to decrease homotypic adhesion and endothelial cell adhesion 
(Hart et al., 1980; Nicolson et al., 1986). Further work is also 
required to find the mechanisms in which cytochalasin B and colchicine 
increased extrapulmonary metastasis. 
Metastasis is a complex series of events that can be investigated 
by holistic and reductionistic experiments. We attempt using in vitro 
models to understand the overall process of metastasis under specific, 
defined conditions that reduce the numbers of variables. The revelance 
of each in vitro model will become known only when 
is understood. 
vivo metastasis 
Chapter III 
PURPOSE 
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This dissertation will examine the affect of two antitumor drugs, 
all trans retinoic acid (RA) and butyric acid (BA), on Bl6a murine 
melanoma cells. The five parameters to be investigated are: (1) 
cytotstatic and cytotoxic concentrations, (2) in vitro migration, (3) 
in vitro invasion, (4) in vivo experimental metastasis (tail vein 
injection), and (5) cytoskeletal morphology. Retinoic acid and BA can 
be less host toxic and less mutagenic than conventional chemotherapy 
when administered at cytostatic concentrations. Both drugs deserve 
investigation because their effect on the individual steps of the 
metastatic cascade is undefined. My hypothesis, which is supported by 
my in vitro preliminary studies and by the literature, is that BA 
inhibits growth yet increases in vitro migration, in vitro invasion, 
and vivo experimental metastasis. In contrast, RA suppresses 
migration, invasion, and experimental metastasis. My study stresses 
the importance of testing the invasive and metastatic effects of 
potential antitumor agents. The net effect of RA and BA on invasion 
and metastasis may be due to their differential action on the 
cytoskeleton. This project may lead to a further understanding of the 
metastatic process. In Chapter IV, I determined the effect of RA and 
BA on the proliferation, migration and cytoskeleton. In Chapter V, I 
determined the effect of RA and BA on adhesion, invasion, and vivo 
experimental metastasis. In Chapter IV, I quantitated the effect of 
migration, invasion, RA and BA on the actin cytoskeleton. 
CHAPTER IV 
THE EFFECTS OF RETINOIC ACID AND BUTYRIC ACID 
ON IN VITRO MIGRATION BY MURINE Bl6a MELANOMA CELLS: 
A QUANTITATIVE SCANNING ELECTRON MICROSCOPIC STUDY 
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ABSTRACT 
Retinoic acid (RA) and butyric acid (BA) were investigated for 
their effect on in vitro migration of highly metastatic murine Bl6a 
melanoma cells. These potential antitumor agents are known to alter 
the cytoskeleton. Our initial studies determined the 72 hr 
cytostatic/cytotoxic concentration of RA (1 X 10- 6 M/>l X 10- 5 M) and 
BA (1.5 mM/2 mM). Cytostasis by RA and BA was confirmed by 
autoradiography and radioisotope incorporation. For the migration 
assays, cells were plated on 3 urn and 5 urn diameter pore polycarbonate 
membranes. Complete media was added containing RA or BA at the time of 
plating. For BA-pretreatment studies, BA was added to cells for 72 hr 
prior to plating cells on the membranes in fresh media + BA. Top and 
bottom surfaces were examined after 72 hr of incubation by scanning 
electron microscopy. Although RA and BA induced cells on the top of 
the membrane to change morphology as shown by phase contrast, 
transmission, and scanning electron microscopy, only BA enhanced the 
migration of cells to allow for passage through the 3 um diameter 
pores. Butyric acid enhanced migration through the 3 um diameter pore 
membranes by 511%. For the 5 um pore membranes, 55% of the plated 
number of untreated early passage cells migrated to the bottom surface 
as compared to 57% for the BA-treated cells and 15% for RA-treated 
cells. However, if cellular proliferation over the 72 hr period was 
factored in, BA-treatment increased migration by 456% and pretreatment 
of cells with BA increased migration by 893%. Without considering 
proliferation, RA inhibited migration by 75% over untreated cells. The 
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decrease in migration observed in RA-treated cells was due to an 
inhibitory effect on cellular migration and decrease in proliferation. 
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INTRODUCTION 
Progress in the treatment of cancer has been hampered by the 
inherant ability of tumor cells to metastasize. Metastasis is a 
complex, multistep process that is poorly understood. Tumor cells must 
invade the extracellular matrix (ECM) at multiple stages during the 
metastatic process. Tumor cell invasion of the ECM has been proposed 
to be a three step process: (1) attachment to endothelial cells and the 
ECM, (2) proteolytic digestion of the ECM, and (3) locomotion (Liotta 
et al., 1983). Although the role of tumor cell locomotion in invasion 
and metastasis has been studied (Werling et al., 1986; Raz and 
Ben-Ze'ev, 1987; Maslow, 1987; Verschueren et al., 1988), the specific 
step of migration needs to be clearly distinguished from the overall 
process of metastasis (Grimstad, 1987, 1988). 
The modified Boyden chamber has been a major instrument to 
quantitate migration (Varani et al., 1978; Nabeshima et al., 1986; 
Fliegel et al., 1985; 1986; Wewer et al., 1987). Membrane invasion 
culture system (MIGS) chambers, (Gehlsen et al., 1984), Transwell 
chambers (Repesh, 1989) and numerous other chambers that are 
modifications of the Boyden chamber have been used to evaluate 
migration and invasion. Early studies on quantitating migration in the 
Boyden chamber (Varani et al., 1978) have now evolved to analyze the 
effect on migration by various chemotactic agents (Orr et al., 1978; 
Lam et al., 1981; Thorgeirsson et al., 1982; Varani et al., 1985), 
haptotaxic agents (McCarthy and Furcht, 1984; McCarthy et al., 1986) 
and drugs (Spiro and Mundy, 1980; Daughaday et al., 1981). Light 
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microscopy (Thorgeirsson et al., 1982), radiolabelling (Repesh, 1989) 
and scanning electron microscopy (Albrecht-Buehler, 1986) have been 
used to evaluate cell locomotion and migration. 
Agents that interfere with either microtubules (e.g. colchicine or 
taxol) or microfilaments (e.g. cytochalasin B) inhibit tumor cell 
migration (Spiro and Mundy, 1980). Raz and Geiger (1982) speculated 
that the role of the cytoskeleton was not only active in migration, but 
also in the tumor cell's ability to deform and make/break intercellular 
contact. Retinoic acid (RA) and butyric acid (BA) inhibit growth and 
induce differentiation of tumor cells (Nordenberg et al., 1986; Roberts 
and Sporn, 1984) as well as affect the cytoskeleton (Lehtonen et al., 
1983; Ng et al., 1985; Borenfreund et al., 1980). 
In my investigation, I quantitated by scanning electron microscopy 
(SEM) the migration of untreated, RA-treated, and BA-treated Bl6a cells 
through porous polycarbonate membranes. I calculated migration rates 
by SEM. The migration rate of Bl6a cells was defined as the number of 
cells adhering to the bottom of a polycarbonate membrane divided by the 
number of cells plated. The number of cells adhering to the bottom of 
the entire membrane was extrapolated from the number of cells counted 
within 50 random fields as observed by SEM. This study demonstrated 
that RA inhibited while BA increased the migration rate of Bl6a cells. 
I have also shown by transmission electron microscopy (TEM) that RA and 
BA induce changes in the cytoskeleton of Bl6a cells. The role of the 
cytoskeleton in tumor cell migration is discussed. 
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MATERIALS AND METHODS 
Cell Culture 
Murine Bl6a (amelanotic) melanoma cells were obtained from the DCT 
Tumor Repository (NCI Frederick Cancer Research Facility, Frederick, 
Maryland). Cells were cultured in Eagle's Minimum Essential Medium 
(MEM) (Gibco, Grand Island, NY) containing Hank's salts and 1-glutamine 
supplemented with sodium pyruvate (110 mg/l) (Sigma, St Louis, MO), 10% 
heat inactivated fetal bovine serum (FBS) (Gibco), 1% penicillin 
G-streptomycin sulfate-amphotericin B (Fungizone) (Gibco), MEM 
non-essential amino acids (10 ml/l) (Gibco), sodium bicarbonate (1.27 
g/l) (Sigma), and Hepes (5.96 g/l) (Sigma). The final pH of the medium 
was 7.3. Cells were cultured in a humidified incubator (37°C in 5% 
co2) and were refed every three days. Cells were subcultured with 
trypsin/EDTA (Sigma) in Hanks Balanced Salt Solution without Ca++ and 
Mg++ (Gibco) during the log phase of growth. All other parameters were 
standard. The experimental metastatic assay (tail vein injection) of 
Poste et al. (1980) was used to verify the lung-colonizing potential of 
the cells in C57BL6 mice. The metastatic potential of the cells was 
confirmed prior to initiating the migration assays and after 
completing all assays. 
In Vitro Growth Curves of RA, BA, Calf Serum, and Colchicine-Treated 
Cells 
Cells were plated in triplicate for each experiment at a 
concentration of 150,000 cells per 35 mm dish (50,000 cells per ml). 
-8 -7 -6 -5 24 h later, RA (OM, 10 M, 10 M, 10 Mand 10 M in complete medium 
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containing 0.1% ethanol+ 10% FBS ), BA+ 10% FBS (0.0mM, O.lmM, 0.2mM, 
0.5mM, lmM, l.5mM and 2mM in phosphate buffered saline), 10% calf serum 
-8 -7 -5 (CS), and colchicine (OM, 10 M, 10 Mand 10 Min complete medium 
containing 0.1% ethanol+ 10% FBS) were added independently. Retinoic 
acid and colchicine were obtained from Sigma, BA from J.T. Baker 
(Phillipsburg, N.J.) and CS from Gibco. Different concentrations of RA 
were prepared under minimal light conditions according to the method of 
Lotan and Nicolson (1979). Retinoic acid was dissolved in 100% ethanol 
-1 -5 
to produce a series of stock solutions from 10 to 10 M, and stored 
f k -60 °c. or up to a wee at Stock solutions were diluted 1:1000 with 
complete medium prior to usage. Two sets of controls were run. One 
control contained complete medium. The second control contained 0.1% 
ethanol (the final ethanol concentration) in complete medium. The FCS 
was exposed to ultraviolet light for 1 h in order to destroy vitamin A 
activity (Ng et al., 1985). The concentration of RA in the control 
medium was therefore considered to be 0 M. The 10- 5M concentration of 
taxol used in the migration assay was the same concentration used in 
the motility assay of Keller and Zimmermann (1986). Viability and cell 
number were determined at 72 h by the trypan blue dye exclusion test 
and the hemacytometer, respectively. The data was reported as the mean 
number of cells + standard deviation. 
Incorporation of 3H Thymidine by BA-treated Cells 
The incorporation of 3H-thymidine was determined by 
autoradiography and beta scintillation counting according to the method 
of Ryan et al. (1987). For autoradiography, untreated and BA-treated 
(1.5 mM) were incubated for 72 h on acid-washed glass slides. One 
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uCi/ml of 3H-thymidine (specific activity 6.7 Ci/mM) was added 24 and 
54 h after the start of incubation. Slides were washed with cold 0.1 M 
thymidine in phosphate buffered saline (PBS) and fixed for 2 min at 
room temperature in freshly prepared 4% paraformaldehyde in PBS 
(pH=7.4). Slides with unlabelled cells were run as a control. Slides 
were washed with PBS, dehydrated in ethanol and air dried. They were 
coated with Kodak NTB2 emulsion, dried overnight in the dark, placed in 
a light tight box and refrigerated for 2, 4, and 6 days. Slides were 
developed in Dl9 developer for 5 min. Each slide was rinsed in 1% 
acetic acid (30-60 sec) and fixed. Finally, slides were rinsed in 
running water and stained with Giemsa (Fisher Diagnostics, Orangeburg, 
NY). Analysis of 3H-thymidine incorporation for autoradiography was 
done by (1) counting the number of labelled and unlabelled cells, and 
(2) measuring the percent area of labelling in cells using a PGT 
digitizer. Background was defined as < 25 grains/window on the PGT 
digitizer at a total magnification of 1550X. 
The total incorporation of 3H-thymidine using beta scintillation 
was determined as follows. Control and growth inhibitory 
concentrations of BA were added in triplicate 24 h after cell plating. 
After 54 h, 1 or 2 uCi/ml of 3H thymidine was added for 18 h. Cells 
++ 
were washed with Hank's Balanced Salt Solution (HBSS) without Ga or 
Mg++ and lifted by trypsin/EDTA. Collected cells were either harvested 
onto glass filter paper or not filtered. Aqueous scintillation fluor 
(Packard Instrument Co., Inc., Downers Grove, IL) was added to the 
filters and to the unfiltered cell suspensions. Counts per minute were 
determined by liquid scintillation spectrophotometry. 
so 
3 !_ncorporation of H-IdUR by RA-treated Cells 
The incorporation of 3H-IdUR was determined by autoradiography and 
beta scintillation as in the above section with the following 
exceptions: (1) for both autoradiography and beta scintillation one 
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uCi/ml of H-5-Iodo- deoxyuridine (Amersham Inc., Arlington Hts., IL) 
(specific activity of 5 Ci/mM) was added at 54 h after the start of 
incubation, (2) the cytostatic concentration of RA was used for both 
autoradiography and beta scintillation, (3) analysis of incorporation 
3 
of H-IdUR by autoradiography was done only by counting labelled and 
unlabelled cells, and (4) cellular suspensions were filtered for beta 
scintillation. 
Migration Assay 
The methodology in this investigation was a modification of the 
migration assay of Varani et al. (1978). I utilized either the 
Transwell chamber system (Costar, Cambridge, MA) or a diffusion chamber 
(Persky and Grganto, 1987). Transwell chambers have a well within a 
well design containing a 3 or 5 um diameter pore polycarbonate membrane 
(10 um in thickness) in the inner well. 
Trial 1 In the first investigation, polycarbonate membranes with 
3 urn pores were utilized. Cells were plated at least in triplicate in 
the upper wells of the Transwell chambers (70,000 cells/well, 50,000 
cells/well and 5,000 cells/well). Cells were allowed to attach to the 
polycarbonate membranes for 24 h prior to treatment with cytostatic 
concentrations of RA, BA, colchicine, or taxol. Cells were then 
incubated for three days without refeeding. Drugs were not replenished 
during the migration assays. Cytostasis was defined as the 
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concentration of drug that inhibited cell growth without measurable 
cell death. The experiment in which cells were treated with or without 
BA (50,000 cells/well) was quantitated by SEM (n=4, 500X). The percent 
migration was determined from the number of cells counted/field times 
50 (the number of fields counted) times 15.36 (50 fields at 500 X is 
equal to 1/15.36 of the total surface area). Colchicine, RA, and 
taxol-treated cells were qualitatively examined. 
Trials 2 - 4 In the second investigation, quantification of 
migration by SEM was done using 5 um diameter pore polycarbonate 
membranes (Nuclepore, Pleasanton, CA) in diffusion chambers or 5 um 
pore Transwell chambers. Migration was evaluated by counting cells on 
the bottom surface of the membranes after 18 (Trial 4) and 72 h (Trials 
2 and 3) of incubation. The number of migratory cells was determined 
by counting cells within 50 fields per membrane, each field at l,700X. 
This magnification was selected in order to properly delineate cell 
boundaries. Percent migration was determined by two different methods. 
The first method was defined as the number of migratory cells counted 
per field times 50 (the number of fields counted) times 177.59 (50 
fields at 1700X is equal to 1/177.56 of the total surface area) divided 
by 50,000 (the number of cells originally plated). For the 18 h time 
period, untreated and BA-treated early passage (less than six passages) 
cells were plated into Transwell chambers (50,000 cells/well). For the 
72 h time period, untreated, BA-treated, BA-pretreated (72 h before 
plating), RA-treated, and calf serum-treated early passage (Trial 2) 
cells were plated into either the Transwell system or a diffusion 
chamber (50,000 cells/well). 
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·The second methodology for determining percent of migration was 
calculated only for untreated and BA-treated cells by incorporating a 
proliferation factor, Pf, for cellular proliferation in 35 mm dishes 
during the 3 day incubation period. The two Pf values were obtained 
with a hemacytometer by counting the number of untreated and BA-treated 
cells after 3 days of incubation. The Pf values were 777,275 and 
177,500 for untreated and BA-treated cells, respectively. This method 
was thus defined as the number of cells per l,700X field times 50 
divided by Pf. 
Trial 3 Quantification of migration was done on later passage 
Bl6a cells (greater than 6 passages) . Untreated, BA-treated, and 
BA-pretreated (72 h before plating) cells were plated into a Transwell 
chamber (n=4, 50,000 cells/well). 
Statistics 
Students' t tests were performed for the results of all 
experiments except for the data from trials two and three of the 
migration assays where Welch's tw (t') unequal variance or 
Bechhofer-Dunnett-Krishnaiah-Armitage equal variance multiple 
comparison tests were done (Wilcox, 1987). 
Scanning Electron Microscopy 
All membranes were prepared according to standard techniques 
except that the membranes were air dryed instead of critical point 
dryed. Briefly, membranes were washed in 0.2M cacodylate buffer, fixed 
in 2% glutaraldehyde, and post fixed in 1% osmium tetroxide. The 
membranes were dehydrated, air dryed, mounted, and sputter coated with 
gold (27 nm coating; Polaron ESlOO Series II sputter coater). 
53 
Membranes were viewed with a JEOL JSM-840A scanning electron 
microscope. 
!!ansmission Electron Microscopy 
A preliminary ultrastructural study was undertaken to provide 
evidence that RA and BA modify the cytoskeleton of Bl6a cells. The 
transmission electron microscopy (TEM) was done according to the method 
of McDonald (1984) and Costar Corporation (personal communication) in 
order to preserve microfilaments. Briefly, a migration assay was run 
with untreated, RA-pretreated, and BA pretreated cells in Transwell 
chambers. All steps were run with membranes still in the Transwell 
chambers. Membranes were fixed after 72 h with 2% glutaraldehyde in 50 
mM cacodylate buffer (pH=7.4) containing 5 mM CaC1 2 for 30 min at 37°C. 
The membranes were rinsed in buffer (3X) for 5 min at 37°C and 
incubated in buffer containing 0.8% K3Fe(CN) 6 for 30 min. The 
membranes were incubated in buffer containing 0.5% Oso4 and 0.8% 
K3Fe(CN) 6 for 30 min, rinsed in buffer, and then rinsed in distilled 
water (3X). The membranes were stained en bloc with 2% uranyl acetate 
(distilled water) for 60 to 120 min, rinsed in distilled water (3X) and 
then dehydrated in grades of ethanol. Membranes were infiltrated into 
resin (Epon-Araldite), cut out of the Transwell inner well, and 
polymerized in blocks at 60°C for several days. Thin sections were 
cut, stained in 1% uranyl acetate (in 70% methanol) and lead citrate, 
and viewed with a Hitachi H-600 transmission electron microscope. 
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RESULTS 
Growth Curves 
In vitro growth curves of BA (Fig. 1), RA (Fig. 2), and 
colchicine-treated (Fig. 3) cells were determined by hemacytometer. 
Cell viability for the six different treatment groups (control medium, 
control medium+ 0.1% ethanol, RA, CS, BA, and colchicine) as 
determined by the trypan blue exclusion test was always greater than 
90%. 
Cells were treated for 72 h with different concentrations of BA 
(Fig. 1). A concentration of 2 mM BA was found to be cytotoxic as 
fewer cells were found after 72 h (130,500 ± 33,600) than were plated 
(150,000). A concentration of 1.5 mM BA was not cytotoxic yet 
inhibited proliferation by 77% + 6% as compared to the controls (0 mM). 
After 72 h of incubation in 1.5 mM BA, viability was comparable to 72 h 
controls (0 mM), i.e., 97.3% ± 1.5% and 98.9% ± 0.3%, respectively. 
There was a range of cytostatic concentrations between 0.5 mM and 1.5 
mM that did not cause cytotoxicity. However, the 'cytostatic' 
concentration of 1.5 mM BA was chosen to be used for all further 
experiments. It was also observed that the lowest concentration of BA 
(0.1 mM) inhibited proliferation by 35%. 
The cytotoxic/cytostatic concentrations for RA were determined to 
be 1 X 10- 5 M/l X 10- 6 M, respectively (Fig. 2). The cytostatic 
-6 -7 
concentration was a range of values between 10 and 10 M. The 1 X 
10-
6 
concentration of RA inhibited proliferation as compared to the 
0.1% ethanol control by 65% and was used for all further cell 
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proliferation and migration experiments. The lowest concentration 
tested (1 X 10- 8 M) inhibited proliferation by 50%. The dishes that 
contained 1 X 10-4 M concentration of RA were found to have more viable 
-7 4 
cells than 1 X 10 M. Since crystals of RA were found in the 1 X 10-
M concentration medium, I believe that this concentration produced a 
supersaturated condition such that the RA was not able to completely 
dissolve in ethanol. The addition of 0.1% ethanol did not affect 
proliferation (p<0.05) (Table 1). Proliferation was significantly 
inhibited (p<0.001) by 59.1% when 10% CS was substituted for 10% fetal 
calf serum (Table 1). 
Figure 3 is the growth curve of colchicine-treated cells. The 
cytostatic concentration was determined to be 5 X 10- 7 M. 
3H-Thymidine Incorporation in BA-treated Cells 
Inhibition of 3H-thymidine incorporation by BA was determined by 
autoradiography and beta scintillation counting. In the experiments 
using autoradiography, two different 3H-thymidine incubation times, 18 
h and 48 h, were used. Two separate experiments were done in which the 
cells were labelled for 18 h, starting 54 h after cell plating. 
Unlabelled and labelled cells were counted from twelve different fields 
(average of 125 cells counted/field, 200X) from three different slides 
(two slides from the first 18 h protocol, one from the second 18 h 
protocol). Autoradiography revealed that after 18 h 59.1% (SEM 9.3) 
of the untreated cells had incorporated the 3H-thymidine, while only 
32.9% (SEM = 0.6%) of the BA-treated cells had incorporated the label. 
The percent inhibition of 3H-thymidine incorporation was calculated to 
be 42.0% (SEM = 7.1%) (p<0.001). Figure 4a and 4b illustrate two 
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autoradiographs of BA-treated cells that were (Fig. 4A) or were not 
treated with 3H-thymidine for 18 hr. Three of nine cells in Fig. 4A 
were interpreted to be labelled. 
Two autoradiography methods (A and B) were used for counting cells 
1 b 11 d · h 3 h ·d· f 48 h that were a e e wit H-t ymi ine or . For both methods, cells 
were labelled 24 h after plating. For method A, the absolute number of 
labelled and unlabelled cells was counted. After 48 h of incubation, 
96% of the untreated cells were labelled, while 58.5% of the BA-treated 
cells were labelled (data not shown). The percent inhibition of 
incorporation of 3H thymidine was calculated to be 39%. For method B, 
the amount of labelling was calculated on a PGT digitizer from the 
2 percent of a set area containing the label (739.8 um, 689X). A total 
of 53 cells were digitized for each group, i.e., untreated and 
BA-treated cells. A minimum of 10 random fields were investigated for 
each group. The area labelled in untreated and BA-treated cells was 
calculated to be 6.6% (S.D= 3.2) and 3.2% (S.D.=3.7), respectively. 
The percent areas were significantly different (p>0.0001). 
Lastly, 3H-thymidine incorporation for untreated and BA-treated 
cells was measured after an 18 h incubation period by beta 
scintillation. The average percent inhibition of 3H-thymidine 
incorporation was 80% (p<0.001) (Table 2). 
3 
H-IdUR Incorporation in RA-treated Cells 
Inhibition of 3H-IdUR incorporation by RA was determined by 
autoradiography and beta scintillation counting. For the 
autoradiography, unlabelled and labelled cells were counted from 21 
(untreated) or 24 (RA-treated) different fields (200X) from three 
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different slides. Autoradiography revealed that 64.5% (SEM=l.6) of the 
untreated cells were labelled after 18 h incubation with 3H-IdUR, while 
only 29.8% (SEM=l.5) of the RA-treated cells had incorporated the 
label. The percent inhibition of 3tt-IdUR was calculated to be 53%. 
3 For the beta scintillation, the percent inhibition of H-IdUR 
incorporation was 72% (p<0.0001) (Table 3). 
Migration Assay 
The initial experiments using 3 um diameter pore polycarbonate 
membranes led to further analysis and quantification of migration with 
5 um diameter pore membranes. Light microscopy showed untreated cells 
grown on plastic to be heterogeneous in morphology (round to flat) as 
well as diverse in cell size. In contrast, BA-treated cells were a 
homogeneous population of large, flattened cells. 
The morphology of untreated cells (Figs. 5 and 6), RA-treated 
(Fig. 7), BA-treated (Fig. 8), colchicine-treated (Fig. 9) and 
taxol-treated (Fig. 10) cells was also evaluated by SEM on both 3 and 5 
um diameter pore polycarbonate membranes. In all cases, cells on the 
top surface of the polycarbonate membranes had morphology similar to 
comparable treated cells grown on plastic. Butyric acid (Fig. 8), 
colchicine (Fig. 9), and taxol (Fig. 10) treatment induced a flattened 
morphology as compared to untreated cells whether the cells were grown 
on plastic or on polycarbonate membranes. Colchicine and taxol-treated 
Bl6a cells on top of the membrane were not as flattened in shape as 
BA-treated cells. The majority of colchicine (Fig. 9) and taxol 
treated cells (Fig. 10) were covered with blebs. Retinoic acid induced 
a spindle-shaped morphology. The major observation was that many more 
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BA-treated cells migrated through 3 um pore membranes than untreated, 
RA, colchicine, or taxol-treated cells. The experiment in which cells 
were treated with or without BA (50,000 cells/well) was quantitated 
using SEM. The increase in the percent migration induced by BA over 
untreated controls was calculated to be 511% (Trial l, Table 4). If 
migration rates were formulated to incorporate proliferation during a 
three day incubation period (Fig. 1), BA enhanced migration by 2300%. 
Migration through the membrane for untreated (Fig. 5), RA treated, 
colchicine (Fig. 9) or taxol (Fig. 10) was < 2% of the original plated 
number. Cell plating density, which ranged from 5,000 to 75,000 cells 
per well, did not have an effect on the migration of untreated and 
BA-treated cells through the 3 um pore polycarbonate membrane (data not 
shown). 
Later experiments quantitated by SEM the migration of untreated 
and treated cells through 5 um pore diameter membranes after 18 (Trial 
4, Table 4) and 72 hrs (Trials 2 and 3, Table 4) of incubation. Both 
diffusion chambers and Transwell chambers were used. Table 4 
illustrates that Transwell chambers were used for Trials 3, 4, and PBA, 
RA, CS treatments of Trial 2. Diffusion chambers were used for the 
other parameters of Trial 2. 
Trial 2. Using early passage cells (passage less than six), an 
average of 3.11 control cells/field (SEM=l.22) and 3.23 BA-treated 
cells/field (SEM=l.13) were observed on the bottom of the membrane 
(Table 4). The number of cells per field initially suggest no 
significant difference in migration between untreated and BA-treated 
cells. However, these numbers do not take into account the partial 
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cytostasis induced by BA. If migration rates were formulated to 
incorporate cellular proliferation (Fig. 1) during a three day 
incubation period, BA-treatment enhanced migration by 456% over 
controls (p< 0.05) (Table 5). The migration of BA-treated cells using 
10% FCS was 192% greater than untreated cells using 10% calf serum (p< 
0.05) (Trial 2, Table 4). A further enhancement of migration was 
induced by BA if cells were pretreated for 72 h with BA before plating. 
Pretreatment increased migration over non-pretreated BA-treated cells 
by 196% (p<0.05) and similarly increased migration over untreated cells 
by 203% (p<0.05) (Trial 2, Table 4). If 72 h migration rates were 
formulated to incorporate proliferation, the rate for the BA pretreated 
cells was 893% (p< 0.05) greater than untreated cells (Table 5). There 
was no significant difference in migration in the 18 h incubation 
period between untreated and BA-treated cells (Trial 4, Table 4). In 
contrast, the migration of RA-treated cells during the 72 h incubation 
period was decreased by 75% (p<0.05) as compared to untreated cells. 
(Trial 2, Table 4). If 72 h migration rates were formulated to 
incorporate proliferation, the rate for the RA-treated cells was not 
significantly different from the untreated cells (Table 5). There was 
no significant difference in migration rates between 10% CS-treated 
cells and 10% FCS-treated (CO) cells. 
Trial 3. Migration was quantified using later passage Bl6a cells. 
The methodology above was used to quantitate migration of untreated, 
BA-treated, and PEA-treated cells (n=4). The percent migration of 
untreated cells was calculated to be 3.72% of the plated number. 
Again, I found that BA or PBA increased migration by 438% and 919%, 
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respectively, over the untreated controls (p<0.05, p<0.05). If 72 h 
migration rates were formulated to incorporate proliferation, the rate 
for the BA-treated late passage cells was 1900% (p<0.05) greater and 
the rate for the BA-pretreated late passage cells was 4000% (p<0.05) 
greater than untreated late passage cells (Table 5). 
Transmission Electron Microscopy. 
The analysis of the cytoskeleton of untreated, RA treated and 
BA-treated Bl6a cells was a qualitative TEM study. Analysis of 
untreated Bl6a cells found two distinct cytoskeletal phenotypes. Cells 
that were not visibly attached to the substrate displayed few 
microtubules and intermediate filaments. Microfilaments were visible 
only along cell margins. Cells that were attached to the substrate 
displayed a disorganized microtubule and intermediate filament system. 
Microfilaments were found in the cortical areas of the cytoplasm (Fig. 
10). In contrast to untreated cells, RA and BA treatment altered the 
structure of the cytoskeleton. Retinoic acid-treated cells displayed 
parallel arrays of microtubules and intermediate filaments (Fig. 11). 
Less cortical microfilaments were seen with wider focal adhesion 
contacts than in untreated cells. Butyric acid-treated cells also 
displayed parallel arrays of microtubules and intermediate filaments 
oriented along the longitudinal axis of the cells. An extensive 
cortical microfilament network was seen (Fig. 12). This preliminary 
ultrastructural study supports the evidence presented in the literature 
that RA and BA alter the structure of the cytoskeleton. 
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DISCUSSION 
In this investigation, BA enhanced while RA decreased the 
migration of Bl6a cells through 3 and 5 um diameter pores. Migration 
of untreated and RA-treated cells through 3 um pore membranes was 
negligible (< 2% of cells plated). In contrast to untreated cells, 
treatment with BA resulted in a 511% increase in migration through 3 um 
diameter pores. The 3 um diameter pore is near the minimum 1-2 um pore 
size that allows passage of Bl6 cells (Tullberg and Burger, 1985), 
although there are more 3 um diameter pores per membrane than in 5 um 
or 8 um diameter pore membranes (Costar Co., personal communication). 
Untreated early passage (<6 passages) cells migrated significantly 
through 5 um diameter pores (55.1%). The effect of BA on the percent 
change of migration through 5 um pores was not as pronounced as through 
3 um diameter pores (104% vs 511% migration, respectively). On the 
other hand, RA-treated cells migrated through 5 um pores at 14.0%, 
i.e., 75% less than untreated cells. 
It was important to determine the cytotoxic/cytostatic 
concentrations of RA and BA since they vary from cell line to cell line 
(Reese et al., 1985; Kyritsis et al., 1984; Lotan and Nicolson, 1979). 
The use of non-cytotoxic drug concentrations in in migration 
assays is important since cytotoxicity will mask enhancement or 
inhibition of migration (Mareel and DeMets, 1984). I used 
hemacytometer counts to demonstrate that RA and BA decreased 
proliferation during the three day incubation period. I used 
autoradiography and beta scintillation counting to show that RA and BA 
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also inhibited the incorporation of 3H-thymidine and 3H-IdUR. Both RA 
and BA have been shown to inhibit proliferation in various tumor cell 
lines in the Gl phase of the cell cycle (Roberts and Sporn, 1984; 
Thorgeirsson et al., 1984). 
In my study, phase microscopy and SEM revealed morphological 
changes in RA and BA-treated cells. How these changes are related to 
migration is not known. The untreated cell population on top of 3 and 
5 um pore membranes is heterogeneous (Figs. 4 and Sa). There are, 
however, more flattened cells on top of 3 um pore membranes than 5 um 
pore membranes. Concomitantly, bottom surfaces of 5 um pore membranes 
are dominated by flattened cells. I concluded that increasing the pore 
size from 3 to 5 um allowed more flattened cells to migrate to the 
bottom surface. Rounded-up cells, i.e., mitotic cells, do not migrate. 
It is therefore not surprising that incubation with BA, which enhances 
cell flattening, increases cell migration. The morphology of 
RA-treated cells differs from either untreated or BA-treated cells. 
The RA-treated cell population consisted of spindle to flattened shaped 
cells. 
Various methods have been used to quantify motility (Volk et al., 
1984; Keller and Zimmermann, 1986), deformabilty (Ochalek et al., 1988) 
and to correlate these properties to metastatic potential. Methods 
used to quantify motility include time lapse photography (Keller and 
Zimmermann, 1986) and the phagokinetic assay (Volk et al., 1984). Data 
from the above experiments have in some cases been found to be in 
direct conflict with data from migration assays (Spiro and Mundy, 
1980). Our experimental protocol emphasizes that migration 
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incorporates both active cellular deformabilty and motility 
(locomotion) (Daughaday et al., 1981). Migration is therefore defined 
as the net summation of cellular deformability and motility. 
Microtubule (MT) inhibitors, e.g., colchicine, and microfilament (MF) 
disrupting agents, e.g., cytochalasin B, inhibited the migration of 
tumor cells in a micropore filter system (Spiro and Mundy, 1980) even 
though cell motility was enhanced (Keller and Zimmermann, 1986). The 
decreased migration seen with microtubule inhibitors may be due to 
reduced cellular deformabil (Ochalek et al., 1988). Retinoic acid 
is not a microtubule inhibitor, so the decrease in migration of 
RA-treated cells may be due to affecting motility rather than 
deformability. In contrast, since the percent increase in migration of 
early passage BA-treated cells through the 3 um diameter pore membrane 
is greater than through the 5 um pore membrane, BA may be affecting 
deformability rather than motility. 
Retinoic acid and BA are being investigated as potential 
antitumor-antimetastatic agents. Studies on various cell lines 
(Roberts and Sporn, 1984; Thorgeirsson et al., 1984; Ryan et al., 
1987), including the Bl6 melanoma cell line (Lotan and Nicolson, 1979; 
Nordenberg et al., 1986) have stressed the effect of RA and BA on 
growth inhibition and differentiation. The change in morphology in 
these cell lines has been linked to a change in the cytoskeleton 
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et al., 1976; 
Borenfreund et al., 1980). 
The role of the cytoskeleton in migration has been demonstrated by 
rnicrotubule inhibitors (e.g., colchicine, vinblastine) and 
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microfilament inhibitors (e.g., cytochalasin B) (Spiro and Mundy 1980). 
These inhibitors reduce migration. Both RA and BA have been shown in 
various tumor cell lines to increase the formation of microfilaments 
and vinculin plaques, and to reorganize vimentin intermediate filaments 
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et al., 1976; 
Borenfreund et al., 1980). I also observed by TEM an increase in 
microtubule and microfilament organization in Bl6a cells. Retinoic 
acid and BA induced changes in the cytoskeleton appear to be similar, 
although the surface morphology and shape of RA or BA-treated cells 
differ as examined by phase contrast microscopy and SEM. Subtle 
changes in the cytoskeleton may induce migration of BA-treated cells 
while inhibiting the migration of RA-treated cells. Butyric acid may 
have a role in increasing the amount of acetylated a-tubulin (Grant et 
al., 1987) thus contributing to the stabilization of microtubules 
(Piperno et al., 1987). 
The role of cellular migration in invasion and metastasis needs 
further investigation. The Transwell system has merit for both 
migration and invasion assays. Various investigators have studied 
invasion by using porous polycarbonate membranes coated with a 
reconstituted basement membrane (Matrigel) (Albini et al., 1987; 
Hendrix et al., 1987; Repesh, 1989). An increase in migration of tumor 
cells in vitro has been linked to enhanced invasion in (Grimstad, 
1987; Verschueren et al., 1988). However, enhanced in vitro migration 
of tumor cells may not necessarily lead to increased metastasis. 
Grimstad (1988) found that hypermotile selected fibrosarcoma cells were 
less metastatic than the original parent population. Mohler et al. 
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(1988) found, in contrast, a positive correlation between metastatic 
potential of Dunning R-3327 rat prostatic adenocarcinoma cells and 
motility. Invasive cells that form specialized pseudopodia have been 
interpreted by Kramer et al. (1986) to form adhesion contacts with the 
matrix. I observed that migratory cells (e.g., Fig. Sb) also form 
pseudopodia when passing through 5 um diameter pores. In addition, I 
have observed by TEM focal adhesion contacts (not illustrated). 
Cell motility has been linked to various parts of the cell cycle 
in 3T3 fibroblasts (Thurston and Palcic, 1987). Thurston and Palcic 
(1987) found a peak in the rate of cell movement in G2 and a 
significant increase in the average rate of movement as cells transit 
from Gl to S phase. The significance of their data, which was obtained 
on 3T3 cells, as applied to a tumor cell system is not known. Since RA 
and BA block entry into the S phase of the cell cycle (Roberts and 
Sporn, 1984; Thorgeirsson et al., 1984), Thurston and Palcic's data may 
not be applicable. Thurston and Palcic (1987) also found a weak 
correlation between the rate of cell motility and the rate of cell 
proliferation. It is extremely important to emphasize that a decrease 
in proliferation is not sufficient to explain an increase in migration 
of BA-treated cells. A 5 X 10 5 M concentration of RA inhibits both 
proliferation and migration. Calf serum (CS) does not have as many of 
the growth factors that are in fetal calf serum. Calf serum was found 
to inhibit cell proliferation by 59.1% as compared to 10% FCS (Table 
1). However, the migration of CS-treated cells was not significantly 
decreased from the untreated and BA-treated cells. The migration of 
calf serum-treated cells, however, is significantly greater than the 
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RA-treated cells (P<0.05). Another method of evaluating the migration 
data is the use of a proliferation factor. If the proliferation factor 
is applied to migration rates of RA-treated cells, there is no 
significant decrease in migration. Therefore, I conclude that the 
decrease in migration produced by RA was due to both an inhibitory 
effect on cell migration and a decrease in proliferation. A purely 
speculative explanation for the anti-migratory effect of RA is that 
changes in glycoproteins found on the cell surface may influence 
migration (Lotan et al., 1987 a,b; Couch et al., 1987, 1988). 
The migration rates for untreated and BA-treated early passage 
cells were similar (Table 4). However, if the decrease of cellular 
proliferation by BA is included in defining migration, the enhancement 
of migration by BA is significant (Table 5). Hendrix et al. (1985) 
have stated that cells which invaded the amnion had similar 
proliferation rates as cells which did not invade. The observation 
that migration by preincubated BA-treated cells was significantly 
different from untreated and BA-treated cells suggests that further 
changes occur in the phenotype of these cells after 3 days. 
Tumor cell migration has been investigated vitro using short 
time periods (4-18 h) (Varani et al., 1985; Nabeshima et al., 1986; 
Grimstad, 1988). It is questionable whether four hours is long enough 
to quantitate migration in this or any other assay. Perhaps such a 
short period does not adequately reflect the vivo condition. I 
noted that there was no significant difference between the migration of 
untreated and BA-treated cells at 18 h (even if 18 h proliferation data 
were used in the calculations, data not shown). Cells treated for 72 h 
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with BA before plating show a significant increase in migration 
(greater than both the untreated and BA-treated cells) in a three day 
assay (Tables 4 and 5). It would be of interest to pretreat cells with 
BA or RA for 72 h prior to an 18 h migration assay. This project would 
make unnecessary the use of a proliferation factor in comparing 
migration rates. 
In summary, RA and BA warranted investigation for two main 
reasons. First, these two drugs can be less host toxic and less 
rnutagenic than conventional chemotherapeutic drugs when administered at 
cytostatic concentrations. Second, the effects of RA and BA on the 
individual steps of the metastatic cascade are only beginning to be 
known. 
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Figures 1-3. 
Dose response curves as measured by hemacytometer for BA, RA, and 
colchicine-treated Bl6a cells. Cells were plated (50,000 cells/ml, 3 
ml total) in culture dishes. Various concentrations of BA, RA, and 
colchicine were added after 24 hrs. Cell number was determined 96 hrs 
after plating. Dotted line indicates number of cells plated. 
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Figure 4. 
Two autoradiographs of BA-treated cells that were (Fig. 4A) or were not 
. 4B) treated with \1 thymidine for 18 hr. The number of 
over all nuclei were counted by two independent investigators. For 
4A, the mean + SE of the number of grains over the nuclei of the 
six cells that "appeared" unlabelled was 10 ± 0.7 grains. The three 
nuclei that "appeared" contained> 40 grains per nuclei. For Fig. 48, 
an average of 13.3 + 1.1 were counted for the 10 nuclei. By 
comparing Fig 4A to 48, three of the nine cells in Fig. 4A were 
interpreted to be labelled cells (arrows). 
A 
B 
• 
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Figure 5. 
Scanning micrograph of untreated cell on the top surface of a 3 um pore 
polycarbonate membrane after 72 hrs of incubation. (Bar = 10 um) 
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Figures 6-8. 
Scanning micrographs of untreated (Fig. 5), RA-treated (Fig. 6), and 
BA pretreated (Fig. 7) cells on the top ("a") and bottom ("b") 
of 5 um diameter pore polycarbonate membranes after 72 hrs of 
incubation. Note the pseudopod coming out of a pore in Figures 5 and 6. 
(arrow). (Bar 10 um) 
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Figure 9 -10. 
Scanning micrographs of colchicine and taxol-treated cells on the top 
surface of 5 um diameter pore polycarbonate membranes after 72 hrs of 
incubation. (Bar = 10 um) 
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Figure 11-13. 
Transmission micrographs of untreated (Fig. 11), RA-treated (Fig. 12), 
and BA-treated cells (Fig. 13). The untreated cell (Fig. 11) displays 
a disorganized microtubule and intermediate filament system with 
microfilaments in the cortical area of the cytoplasm. The RA-treated 
cell (Fig. 12) shows an organized microtubule and intermediate filament 
system with less cortical actin than untreated cells. The BA-treated 
cell (Fig. 13) displays an extensive system of parallel microtubules 
and a large amount of cortical actin. Microtubules (black arrow), 
intermediate filaments (open arrow), and microfilaments (arrow head) 
are present in all three cell types (Bar= 0.2 um). 
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TABLE 1. 
The means of the untreated and 0.1% ethanol groups were not 
significantly different (p > 0.05). The means of the hemacytometer 
counts for 10% FCS-treated cells and 10% CS-treated cells were 
significantly different (p < 0.001). 
Mean 
St. Dev. 
N 
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NUMBER OF CELLS AFTER 72 HOURS OF INCUBATION 
AS DETERMINED BY HEMACYTOMETER 
UNTREATED 
4.8 x 105 
4.3 x 104 
4 
0.1% ETHANOL 
4.5 x 10 5 
6. 8 x 104 
3 
10% FCS 
4.3 x 105 
4.2 x 104 
3 
10% cs 
1.8 x 105 
2.1 x 104 
3 
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TABLE 2. 
The 3tt-thymidine incorporation by untreated and BA-treated cells after 
18hr incubation was measured. Cells were lifted with trypsin/EDTA and 
the cell suspension was either unfiltered or filtered with a cell 
harvester. The percent inhibition by BA of 3tt-thymidine incorporation 
was 67% for unfiltered cell suspensions and 93% for filtered 
suspensions. The average percent inhibition was 80%. 
Mean 
St Dev 
N 
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INCORPORATION OF 3H-THYMIDINE 
CPM AS DETERMINED BY BETA SCINTILLATION 
UNFILTERED CON UNFILTERED BA FILTERED CON FILTERED BA 
1 uCi/ul 
6.3 x 105 
2.7 x 104 
3 
2.0 x 105 
7.6 x 104 
3 
2 uCi/ul 
1.5 x 106 
1.4 x 105 
3 
1.0 x 105 
2.7 x 104 
3 
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TABLE 3. 
The 3H-IdUR incorporation by untreated and RA-treated cells after 18 hr 
incubation was measured. Cells were lifted with trypsin/EDTA and the 
cell suspension was filtered with a cell harvester. The percent 
inhibition of 3H-IdUR incorporation by RA was 72%. 
Mean 
St Dev 
N 
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INCORPORATION OF 3H-IdUR 
CPM AS DETERMINED BY BETA SCINTILLATION 
FILTERED CONTROL 
1. 9 x 104 
2.4 x 103 
3 
FILTERED RA 
5.2 x 103 
1.0 x 103 
6 
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TABLE 4. 
The migration of Bl6a cells through 3 urn and 5 um diameter pore 
polycarbonate membranes. There was a significant difference in the 
migration through a 3 um diameter pore membrane between untreated and 
BA-treated cells (p < 0.013) (Trial 1). In contrast, there was no 
significant difference between untreated and BA-treated early passage 
cells (Trial 2), but there was a significant difference between 
untreated and BA-treated late passage cells after 72 h incubation 
(Trial 3). Interestingly, there was a significant increase in 
migration of BA-pretreated early passage cells as compared to control 
and BA-treated cells (p < 0.05, p < 0.05, respectively, Trial 2). 
There was also a significant decrease in migration of RA-treated cells 
as compared to control and calf serum-treated cells (p < 0.05, p < 
0.05, respectively). Lastly, there no was a significant difference 
between untreated and BA-treated cells after 18 h incubation. This 
table includes percent migration and percent change in migration. The 
percent change in migration of untreated cells was considered to be 
100%. 
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TRIAL TIME 
#1 72 hr 
72hr 
EARLY PASSAGE 
#2 72hr 
72 hr 
72 hr 
72 hr 
72 hr 
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#3 72hr 
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MEAN! 
OF~J:~!~ 
i.± SE) 
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1.93 ± 0.23 
1.07 ± 0.21 
1.16 ± 0.30 
% MIGRATION 
1.26 
6.42 
55.13 
57.26 
74.69 
14.00 
29.78 
3.72 
16.31 
35.68 
18.97 
20.56 
~n!M~f& SIGNlfJCANCE 
INMIG~ILON lfYf1 
+41 l 0.013 
+4 .. 
+203 0.05 
-75 005 
-54 N.s:•• 
338 0 05 
819 005 
8 N.s:•• 
• The 1700x magnification was used to delineate cell boundaries. Care was taken not to overlap between cells. 
• • Refer to proliferation table, Table V. 
••• NS . 'f' 
.. = not s1gm 1cant. 
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TABLE 5. 
The migration rate of control, BA-treated, BA-pretreated and RA-treated 
cells after 72 hr incubation with a proliferation factor incorporated 
into the migration rate (data obtained from trials 2 and 3, Table IV). 
Note that early an late passage cells were used for BA experiments 
while only early passage cells were used for the RA experiments. The 
migration value was defined as the number of the cells per field times 
50 divided by the final hemacytometer cell population after 72 hr 
incubation (Fig. 1). There was a significant increase in migration of 
BA-treated and BA-pretreated cells as compared to control cells (p < 
0.05, p < 0.05, respectively). Retinoic acid treatment did not 
significantly change migration rates. 
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MIGRATION VALUES 
(INCLUDING THE PROLIFERATION RATE) 
CONTROL (CO) BUTYRATE (BA) PRE-BUTYRATE (PBA) 
N 5 6 5 
MEAN 1. 99 x 10-4 9.08 x 10- 4 17. 8 x 10- 4 
(EARLY PASSAGE) 
ST DEV 1. 26 x 10- 4 4.95 x 10- 4 1. 27 x 10- 4 
STEM 0.56 x 10- 4 0.20 x 10- 4 0.06 x 10- 4 
% MIG. 456* 893>'< 
N 4 4 4 
MEAN 1. 36 x 10-5 2.58 x 10- 4 5.44 x 10- 4 
(LATE PASSAGE) 
ST DEV 0.51 x 10- 5 0. 96 x 10- 4 1. 28 x 10- 4 
STEM 0.26 x 10-5 0.48 x 10-4 0.64 x 10- 4 
% MIG. 1897* 4000>'< 
CONTROL (CO) RETINOIC ACID (RA) 
N 5 5 
MEAN 1. 99 x 10- 4 2.36 x 10- 4 
ST DEV 1. 26 x 10-4 1. 27 x 10- 4 
STEM 0.56 x 10-4 0.45 x 10- 4 
% MIG 118 
* SIGNIFICANTLY DIFFERENT FROM THE CONTROL (P < 0.05) 
CHAPTER V 
THE EFFECT OF BUTYRIC ACID AND RETINOIC ACID 
ON INVASION AND EXPERIMENTAL METASTASIS 
OF MURINE MELANOMA CELLS 
90 
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ABSTRACT 
The effect of butyric acid (BA) and all trans-retinoic acid (RA) 
on murine melanoma cells was investigated in vitro and in The in 
vitro assays included 3H-IdUR incorporation, adhesion, migration and 
invasion experiments. Butyric acid decreased 3H-IdUR cellular 
incorporation within 24 hrs and increased adhesion as measured by 
trypsin release of 3H IdUR labelled cells from either polycarbonate 
(p.c.) or Matrigel-coated p.c. membranes. Migration and invasion rates 
after 72 hrs were quantified by scanning electron microscopy (SEM). 
The invasion barrier consisted of Matrigel coated p.c. membranes. 
Butyric acid significantly enhanced migration and invasion of Bl6a 
cells, while RA significantly decreased migration and invasion Bl6a 
and K-1735 cells. Subcutaneous administration of either BA or RA 
pellets significantly decreased the number of lung nodules in the 
experimental metastatic assay. The experimental metastatic assay is 
defined as a tail vein inoculation protocol followed by subsequent lung 
evaluation. 
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INTRODUCTION 
The role of differentiating agents in the treatment of neoplasms 
and metastases is becoming increasingly important. Since 
differentiating agents may be less host-toxic and less mutagenic than 
chemotherapy, they may be used between rounds of chemotherapy to help 
prevent regrowth and diversification of remaining tumor cells (Nicolson 
and Custead, 1985). One such agent, 13-cis-RA (topically applied) has 
produced partial responses in patients with melanoma (Lippman et al., 
1987). 
In pretreatment of tumor cells with differentiation agents 
such as BA (Takenaga, 1986), dimethyl sulfoxide (DMSO) (Takenaga, 
1984), and N-methylformamide (NMF) (Tofilon et al., 1986) has increased 
in experimental metastasis. In addition, in vitro pretreatment 
with both RA and dibutyl cyclic AMP together has changed the pattern of 
organ metastasis of F9 embryonal carcinoma cells (Terrana et al., 
1986). 
Few studies have investigated the in vivo effect of 
differentiation agents on metastasis without drug pretreatment. 
Experimental evidence indicates that both the route and timing of the 
administration of differentiation agents is critical. 
N-methylformamide, when given prior to tail vein injection of tumor 
cells, increased experimental metastases, while NMF given after tail 
vein injection decreased experimental metastases (Tofilon et al., 
1986). Dietary retinoids given to athymic mice decreased the number of 
spontaneous metastases produced by untreated hamster melanoma HMI-FS 
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cells (Scheicher et al., 1988). 
A positive correlation has been shown between the in vitro 
recombinant basement membrane (RBM) invasion assay and vivo 
metastasis (Albini et al., 1987; Repesh, 1989). The RBM model consists 
of a porous Transwell p.c. membrane (Costar Co., Cambridge, MA) that is 
coated with a reconstituted basement membrane (Matrigel, Collaborative 
Res., Bedford, MA). Matrigel is derived from the murine 
Engelbreth-Holm-Swarm (EHS) sarcoma cell line and consists of laminin, 
collagen type IV, heparan sulfate proteoglycan and entactin (Kleinman 
et al., 1986). During invasion, tumor cells locally degrade the 
Matrigel and migrate through the porous p.c. membrane. The cells can 
then be quantified on the underside of the p.c. membrane by light 
microscopy (Albini et al., 1987; Hendrix et al., 1989), radioactive 
labelling (Repesh, 1989) or scanning electron microscopy. 
The RBM model has been used to test the effect of various drugs on 
the invasion process. Drugs tested include cytoskeletal agents such as 
Colchicine (Welch et al., 1989) and estramustine (Wang and Stearns, 
1988). The two drugs chosen for this study, RA and BA, effect the 
cytoskeleton in some tumor cell lines (Ng et al., 1985; Lehtonen et 
al., 1983; Altenburg et al., 1976; Ryan and Higgins, 1988). I have 
previously reported the effect of these two agents on the migration of 
murine Bl6a cells (McGarvey and Persky, 1989. The short term effects 
of BA on the invasion process in the human amnion basement membrane 
(HABM) assay have been reported (Thorgeirsson et al., 1984). 
Pretreatment for 24 hrs with BA enhanced the invasion of M5076 sarcoma 
cells (Thorgeirsson et al., 1984). Likewise, pretreatment of murine 
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Bl6Fl0 melanoma cells for 24 hrs with RA increased invasion through the 
amnion. However, pretreatment with RA for 48 to 72 hrs decreased 
invasion (Wood et al., 1985)). Retinoic acid has been shown to inhibit 
invasion of tumor cells in the RBM assay without effecting cellular 
proliferation (Nakajima et al., 1989). 
In my study, both in vitro and in vivo protocols were used to 
study invasion and metastasis. For the in vitro migration and invasion 
studies, Bl6a and K-1735 melanoma cells were treated with BA or RA for 
three to six days. For the in vivo study, syngeneic female C57BL6 mice 
were primed with all trans-RA or BA by subcutaneous implantation of 
drug pellets one day prior to tail vein injection of Bl6a cells. 
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MATERIALS AND METHODS 
Cell Culture: Murine Bl6a and K-1735 melanoma cells were obtained 
from the DCT Tumor Repository, NCI-Frederick Cancer Research Facility 
(Frederick, MD). Murine NIH-3T3 cells were obtained from American Type 
Tissue Collection (Rockville, MD). Cells were cultured in Eagle's 
Minimum Medium (MEM) (Gibco, Grand Island, NY) containing Hank's salts 
and L-glutamine supplemented with sodium pyruvate (110 mg/ml) (Sigma, 
St. Louis, MO), 10% heat inactivated fetal bovine serum (FCS) (Gibco) 
or 10% NuSerum (Collaborative Res., Cambridge, MA), 1% penicillin 
G-streptomycin- amphotericin B (Fungizone) (Gibco), MEM non-essential 
amino acids (Gibco) (10 ml/l), sodium bicarbonate (1.27 g/l) (Sigma), 
and Hepes (5.96 g/l) (Sigma) (final pH 7.3). Cells were cultured in a 
humidified incubator (37°C, 5% co2 ) and were refed every three days. 
Cells were subcultured with trypsin/EDTA (Sigma) during log phase 
growth. 
Bl6a cells were also obtained from metastatic lung nodules or 
subcutaneous tumors according to the following protocol. The cells, 
originally obtained from the repository, were grown to preconfluence in 
T-75 flasks, trypsinized, and suspended in PBS without Ca++ and Mg++ 
Four female C57BL6 mice received an injection of 0.2 ml of PBS-tumor 
cell suspension (500,000 cells/ml) either in a subcutaneous site or in 
the lateral tail vein. Mice were killed after 21 days. Subcutaneous 
or lung tumors were removed and minced in MEM containing FCS. After 24 
hours of incubation, unattached cells and debris were removed from the 
tissue culture-treated dishes. The adherent subcutaneous or lung 
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nodule-derived cells were passaged twice in 
experiments without further passage. 
Though a range of cytostatic concentrations of butyric acid (J.T. 
Baker, Phillipsburg, NJ) and retinoic acid (Sigma) was observed 
-6 (McGarvey and Persky, 1989), a concentration of 1.5 mM BA and 1 X 10 
M RA were used in all 3H-IdUR incorporation, migration and invasion 
assays. 
Incorporation of 3H-Iododeoxyuridine: Untreated and BA-treated 
cells were incubated with 1 uCi/ml 3H-Iododeoxyuridine ( 3H-IdUR) 
(Amersham Inc., Arlington Hts., IL) for 24, 48 and 72 hrs. Butyric 
acid was simultaneously added with the 3H-IdUR to the cells. Cells 
were lifted with trypsin/EDTA, filtered, and the bound radioactivity 
was determined as counts per minute (CPM) with a beta scintillation 
counter. The mean (n=4) and standard error of the mean (SE) were 
determined for each time point. 
Adhesion Assay: Untreated and BA-treated Bl6a cells were labelled 
with 1 uCi/ml of 3H-IdUR for 24 hrs. Labelled cells were plated onto 
uncoated or Matrigel-coated p.c. membranes and incubated for 72 hrs. 
The cell supensions above and below the membrane were collected 
individually following incubation with trypsin/EDTA and filtered. The 
membranes were collected, solubilized (Soluene 350, Packard Inc., 
Downers Grove, IL), and liquid scintillation fluor added. Counts per 
minute for each of the three fractions were determined by beta 
scintillation counting. The mean (n=8) and SE of each fraction were 
calculated. Students' t tests compared the means of the unt~eated 
BA-treated cells. An average of 0.05 counts per minute per cell were 
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plated onto the uncoated and Matrigel-coated membranes. 
Key: The key for identification of the migration and invasion 
experiments follow an X-Y-Z format whereby X is the drug, Y is the 
treatment, and Z is the cell source. X may be C (control, i.e. 
untreated), BA or RA. Y may be PT (pretreatment), NP (no pretreatment) 
or NT (no treatment). Z may be LN (lung nodule derived), SC 
(subcutaneously-derived), EP (early passage, less than six vitro 
passages), LP (late passage, greater than six in vitro passages), or K 
(K-1735 cells). 
Migration Assay: The methodology was a modification of the 
migration assay of Varani et al. (1978). Our modifications of this 
procedure have been reported in detail (McGarvey and Perksy, 1989). 
Three different migration experiments were performed on Bl6a cells 
(Figure #2). Experiment #l compared the migration of untreated lung 
nodule-derived (C-NT-LN), untreated subcutaneously-derived (C-NT-SC) 
and BA-pretreated lung nodule derived (BA-PT-LN) Bl6a cells. 
Experiment #2 compared the migration of untreated (C-NT-LN), RA-treated 
(RA-NP-LN), and RA-pretreated (RA-PT-LN) lung nodule-derived cells. 
Experiment #3 compared the migration of untreated subcutaneously-
derived (C-NT-SC) and RA-pretreated subcutaneously-derived (RA-PT-SC) 
cells. Each experiment was done at least in triplicate. In each 
experiment, 5 X 104 cells in appropriate media (MEM+FCS with or without 
BA or RA) were plated in the Transwell insert (inner well). The 
matching outer wells similarly contained MEM + FCS with or without BA 
or RA, but no cells. Drug pretreatment indicated that the cells were 
incubated in RA or BA for 72 hrs before the migration assay in T75 
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flasks, and for a further 72 hr incubation period during the migration 
assay. Non-pre-treated cells were incubated with BA or RA only during 
the time of the migration assay. At the conclusion of the migration 
assay, membranes were processed for SEM. Cells that migrated to the 
bottom of the membrane were quantified by counting cells in 50 random 
fields at 500X. A Students' t test was performed on the results of 
experiment 3. For all other migration experiments, Welch's tw (t') 
unequal variance or Bechhofer-Dunnett-Krishnaiah-Armitage equal 
variance multiple comparison tests were performed (Wilcox, 1987). 
Invasion Assay: The invasion assay consisted of a Transwell 
chamber with an 8 um diameter pore p.c. membrane coated with Matrigel. 
Matrigel was diluted 1:20 (71 ug of protein/well) and added to 
Transwell inserts kept on ice (Repesh, 1989). After overnight 
dehydration, Matrigel was rehydrated for two hrs with serum free MEM. 
The MEM was removed, and cells were added to the top wells of the 
Transwell insert (50,000 cells/well). In some experiments, cells were 
preincubated with RA or BA for 72 hr prior to being plated on the 
Matrigel. At the time of plating, RA or BA was added to the top and 
bottom wells. Two sets of controls were done, one containing medium 
alone the other containing medium with 0.1% ethanol (the carrier for 
RA). After 72 hrs, membranes were processed for SEM. 
Invasive cells were quantified as described in the migration assay 
with the noticeable exception that for selected experiments, the entire 
bottom surface of the membrane was scored for invasive cells rather 
than 50 fields at 500 X. Each experiment was performed at least in 
triplicate. Six different invasion experiments were done (see Fig. 3). 
99 
Experiment #l compared the invasion rates of untreated early passage (< 
6 passages) (C-NT-EP), untreated late passage (>6 passages) (C-NT-LP), 
BA-treated late passage (BA-NP-LP), and BA-pretreated late passage 
(BA-PT-LP) Bl6a cells. Experiment #2 compared the invasion rates of 
untreated (C-NT-SC), BA-treated (BA-NP-SC) and BA-pretreated (BA-PT-SC) 
subcutaneously-derived Bl6a cells. Experiment #3 compared the invasion 
rates of untreated subcutaneously-derived (C-NT-SC) (plated at 50,000 
or 25,000 cells/well), untreated lung nodule-derived (C-NT-LN) (plated 
at 50,000 cells/well), BA-treated lung nodule-derived (BA-NP-LN) and 
BA-pretreated lung nodule derived (BA-PT-LN) Bl6a cells (plated at 
50,000 cells/ml). Experiment #4 compared the invasion rates of 
untreated lung nodule-derived (C-NT-LN), RA-treated lung nodule-derived 
(RA-NP-LN) and RA-pretreated lung nodule-derived (RA-PT-LN) Bl6a cells. 
Experiment #5 compared the invasion rates of untreated (C-NT K) and 
RA-pretreated (RA-PT-K) K-1735 cells. Experiment #6 compared the 
invasion rates of untreated (C-NT-LN) and BA-pretreated (BA-PT-LN) lung 
nodule derived cells in the presence of NIH-3T3 cell conditioned medium 
for 24 and 48 hrs. The conditioned medium was obtained by incubating 
preconfluent NIH-3T3 cells for 24 hrs in serum-free medium containing 
1% bovine serum albumin and 0.005% ascorbic acid (Albini et al., 1986). 
This conditioned medium was added to the outer well. After 24 hrs, 
cells were refed with fresh media with or without BA. Fresh 
conditioned medium was also added to the outer well. A students' t 
test was performed on the results of experiment five. For all other 
invasion experiments, Welch's tw (t') unequal variance or 
Bechhofer-Dunnett-Krishnaiah -Armitage equal variance multiple 
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comparison tests were performed. 
The In Vivo Assay: The day before tumor cell injection via 
lateral tail vein methodology, each mouse was inplanted subcutaneously 
with a pellet containing 5 mg of all trans-RA, BA, or placebo 
(Innovative Res., Toledo, OH). Pellets release the drugs by zero order 
kinetics. A 5 mg pellet over 20 days releases 250 ug/day (10 ug/hr) of 
RA or BA. In addition, a steady state for each drug is reached after 
two to four hours (S. Shafie, personal communication). Lung 
nodule-derived and subcutaneous-derived Bl6a cells were suspended in 
PBS in a 1:1 ratio. The concentration of cells was a~usted to 500,000 
cell/ml. Cell viability before tail vein injections was always greater 
than 90% as determined by the trypan blue exclusion method. A 0.2 ml 
cell suspension was injected into the lateral tail vein of 46 day old 
female C57BL6 mice (Harlem Sprague Dawley, Indianapolis, IN). The mice 
were divided into 25 controls and 50 experimental. Fifteen (5 control, 
5 RA-treated, and 5 BA-treated) mice received tail vein injections per 
day in order to maximize the proficiency of the injection protocol. 
Cell viability was also determined to be greater than 90% in the cell 
suspension not injected into the mice. Thus the subcutaneous pellet 
implantation and tail vein injection protocols were spread over five 
days. Mice were killed after 21 days. Lungs were fixed in Bouin's 
fixative and the metastatic nodules were counted with a stereo 
dissecting microscope at 6.4 X. Gross examination of the 
thoracic-abdominal viscera and body walls was performed. Mann-Whitney 
U nonparametric test was performed to determine statistical 
significance (Wilcox, 1987). 
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RESULTS 
Butyric acid reduced the incorporation of 3H-IdUR in Bl6a cells 
within the first 24 hrs of drug incubation. The percent inhibition of 
3H-IdUR incorporation by BA as compared to the control was 79%, 64% and 
71% at 24, 48 and 72 hrs, respectively (Fig. 1). There is a dramatic 
increase in cpm from 24 to 48 hrs followed by a leveling off 
thereafter. 
Adhesion Assay: Butyric acid increased significantly the adhesion 
of 3H-IdUR labelled Bl6a cells, which were incubated for 72 hr, to both 
uncoated and Matrigel-coated p.c. membranes (45%, p<.01; 66%, p<.0001, 
respectively). After fifteen minutes of incubation in a trypsin/EDTA 
solution, 43.3% (±6.3%) and 76.8% (±2.9%) of BA-treated cells were 
still bound to the uncoated and Matrigel-coated membranes, 
respectively, as compared to 23.9% (±3.0%) and 30.2% (±4.6%) for 
untreated cells. 
Migration Assay: Figure 2 illustrates the mean + SE of the three 
migration experiments. For each experiment, percent migration of the 
untreated (control) cells was adjusted to 100%. Percent migration is 
defined as the number of cells plated on top of the p.c. membrane 
divided by the number of cells calculated to be on the bottom membrane 
surface multiplied by 100. 
In the first experiment, 1.08±0.18 lung nodule-derived untreated 
cells were counted per field on the bottom of the p.c. membrane 
(percent migration 1.7%). In contrast, 4.35±0.79 subcutaneously-
derived untreated cells were counted per field (percent migration 
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6.7%). Subcutaneously-derived untreated cells had an increased 
migration rate (403%, p<0.05) compared to lung nodule-derived untreated 
cells. The migration rate of lung nodule-derived cells was increased 
by pretreatment with BA (667%, p<0.05). The number of BA-pretreated 
cells counted per field was 7.21±0.86 (percent migration was 11.1%). 
If the migration rates were formulated to include cellular 
proliferation during the 72 hr incubation (Chapter IV, Fig. 1), 
BA-pretreatment further enhanced migration (2900% increase, p<0.05). 
In the second experiment, 1.13±0.25 lung nodule-derived untreated 
cells were counted per field (percent migration 1.7%). RA-treatment 
(0.59±0.14; percent migration 0.9%) or RA-pretreatment (2.24±0.48; 
percent migration 3.4%) did not significantly effect the migration rate 
of lung-nodule derived cells. The percent migration values of 
untreated lung nodule-derived cells were similiar for experiments 1 and 
2. If the migration rates were formulated to include cellular 
proliferation during the 72 hr incubation (Chapter IV, Fig. 2), 
RA-treatment and RA-pretreatment enhanced migration (246% increase, 
p<0.05; 934% increase, p<0.05, respectively). 
In contrast to the migration data of lung nodule-derived cells of 
Exp. 2, RA-pretreatment of subcutaneously-derived cells did decrease 
migration (62% decrease, p<0.001) (Exp. 3). For the 
subcutaneously-derived cells, 4.48+0.38 untreated cells (percent 
migration 6.7%) and 1.67~0.22 RA-pretreated cells (percent migration 
2.6%) were counted per field. If the migration rates were formulated 
to include cellular proliferation during the 72 hr incubation·(Chapter 
IV, . 2), then RA-pretreatment did not significantly enhance 
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migration. The rationale for using or not using a proliferation factor 
to determine migration rates is found in the Discussion. It is 
noteworthy that the percent migration values of subcutaneously-derived 
untreated cells for Exps. 1 and 3 were similiar. 
Invasion Assay: For each of the six invasion experiments, the 
percent invasion of untreated cells was adjusted to 100% (Fig. 3). The 
untreated cells were derived from three different sources, i.e. from 
stock received from the tumor depository (Exps. 1 and 5), from 
subcutaneous passage (Exp. 2), and from tail vein passage (Exps. 
3,4,6). The invasion rates were dependant on the derivation of the 
cells. 
Invasion experiments 1-3 demonstrate that (1) BA increases 
invasion and (2) lung nodule derived cells are more invasive than 
subcutaneously derived cells. 
In the first invasion experiment, there was no significant 
difference amoung the invasion of untreated late passage (0.13±0.12 
cells, percent invasion 0.20%), untreated early passage (0.22±0.02 
cells per field, percent invasion 0.34%), and BA-treated late passage 
(0.29±0.05 cells, percent invasion 0.45%) Bl6a cells. There was, 
however, a significant increase in the invasion rate (490%) of 
BA-pretreated late passage cells as compared to both early and late 
passage untreated cells (p<0.05, p<0.05, respectively). An average of 
0.64±0.10 BA-pretreated late passage cells were counted per field 
(percent invasion 0.98%). If the invasion rates were formulated to 
include cellu~ar proliferation during the 72 hr incubation (Chapter IV, 
Fig. 1), BA-treatment and BA-pretreatment further enhanced invasion 
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(940% increase, p<0.05; 2100% increase, p<0.05). 
In the second experiment, the invasion rate of BA-treated and 
BA-pretreated subcutaneously-derived cells was significantly increased 
(p<0.05 and p<0.05, respectively) as compared to untreated 
subcutaneously-derived cells. Since there were few untreated 
subcutaneous-derived cells on the bottom of the membrane, cells on the 
entire bottom surface of the membrane were counted. An average of 30.7 
untreated cells were counted per membrane; percent invasion 0.12%. On 
the other hand, an average of 1.81±0.37 BA-treated and 10.15+0.60 
BA-pretreated cells were counted per field. Percent invasion for 
BA-treated and BA-pretreated cells was 2.8% and 15.4%, respectively. 
If the invasion rates were formulated to include cellular proliferation 
during the 72 hr incubation (Chapter IV, Fig. 1), BA-treatment and 
BA-pretreatment further enhanced invasion (17600% increase, p<0.05; 
110000% increase, p<0.05). 
In the third invasion experiment, there was no significant 
difference in the invasion rate of subcutaneously-derived untreated 
cells plated at either 25,000 cells or 50,000 cells/well. An average 
of only 4.7 and 5.7 cells were counted on each of the triplicate 
membranes. Percent invasion for 25,000 and 50,000 cells was 0.02% and 
0.04%, respectively. All experiments except this one plated 50,000 
cells/well. There was, however, a significant increase in the invasion 
of lung nodule-derived untreated cells (p<0.05, 0.73±0.10 cells per 
field, percent invasion 1.1%). Butyric acid treatment or pretreatment 
increased the invasion rate of lung nodule-derived cells (238%, p<0.05 
and 673%, p<0.05, respectively). An average of 1.74+0.36 BA-treated 
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cells (percent invasion 2.67%) and an average of 4.91+0.02 
BA-pretreated cells (percent invasion 7.5%) were counted per field. If 
the invasion rates were formulated to include cellular proliferation 
during the 72 hr incubation (Chapter IV, Fig. 1), BA-treatment and 
BA-pretreatment further enhanced invasion (1051% increase, p<0.05; 
2936% increase, p<0.05, respectively). 
Experiments four and five illustrate the effect of RA on two cell 
lines that have different invasive potential. The percent invasion of 
untreated Bl6a cells (Fig. 3, Exp. 4) and of untreated K-1735 cells 
(Fig. 3, Exp. 5) was 0.13% and 23.6%, respectively. For Exp. 4, there 
was an average of 33.6 untreated, 15.2 RA-treated, 43.8 RA-pretreated 
cells counted per membrane. The percent invasion was 0.13%, 0.06%, and 
0.18%, respectively. Thus, invasion was inhibited 54% by RA-treatment 
(p<0.05), but not by RA-pretreatment. If the invasion rates were 
formulated to include cellular proliferation during the 72 hr 
incubation (Chapter IV, Fig. 2), RA-treatment and RA-pretreatment 
enhanced invasion (295% increase, p<0.05; 853% increase, p<0.05). For 
Exp. 5, an average of 1.33±0.38 untreated and 0.38+0.07 RA-pretreated 
K-1735 cells were counted per field at 1700X (instead of the usual 
500X). This higher magnification was selected to properly deliniate 
cell boundaries due to the number of invasive cells. The percent 
invasion per 50,000 cells plated was 23.6% and 6.7%, respectively. 
There was a 72% decrease in invasion of RA-pretreated cells (p<0.001). 
If the invasion rates were formulated to include cellular proliferation 
during the 72 hr incubation (Chapter IV, Fig. 2), RA-pretreatment 
enhanced invasion (132% increase, p<0.05). 
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The sixth experiment determined the affect of conditioned medium 
on lung nodule-derived Bl6a cell invasion. Conditioned medium was 
placed in the bottom well and the invasion assay was reduced from the 
standaand 2.02±0.29 BA-pretreated cells were counted per field. 
Percent invasion was 0.60% and 3.10%, respectively. For 48 hrs, 
1.70±0.09 untreated and 6.15±0.29 BA-pretreated cells were counted per 
field. Percent invasion was 2.6% and 9.4%, repectively. Thus, 
experiment #6 has two key points. First, conditioned medium enhanced 
invasion. The percent invasion of untreated lung nodule derived cells 
after 48 hrs in the conditioned medium (Fig. 3, Exp. 6) was 233% 
greater than for lung nodule-derived cells after 72 hrs without 
conditioned medium (Fig. 3, Exp. 3). Second, BA-pretreatment 
significantly increased invasion in 24 hrs by 518% and in 48 hrs by 
362% as compared to untreated cells of the same incubation period. 
In Vivo Assay: Both RA or BA, which were administered by 
subcutaneous pellet, reduced experimental metastasis (p<0.05 and 
p<0.05, respectively) according to the Mann-Whitney U test (Fig. 4). 
Butyric acid decreased the number of lung nodules as compared to the 
placebo pellet by 91.4% (mean decrease) or 99% (median decrease). 
Retinoic acid decreased the number of lung nodules as compared to the 
placebo pellet by 80% (mean decrease) or 84% (median decrease). 
Furthermore, two mice were completely tumor-free in the RA-treated 
group and nine mice were tumor-free in the BA-treated group. Gross 
examination of the thoracic-abdominal viscera and body walls revealed 
that all metastatic foci were confined to the lungs. Figure 6 
illustrates lungs from untreated, RA, and BA-treated animals. 
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DISCUSSION 
The experimental metastatic assay contains different steps 
associated with the formation of lung tumors (Fidler, 1970). These 
include blood borne transport, extravasation and tumor growth. One or 
more steps of the assay can be effected by BA and RA. I used 3H-IdUR 
incorporation, adhesion, migration and reconstituted basement membrane 
(RBM) assays as reductionist tools to understand the metastatic 
process. 
-6 I have shown that 1 X 10 M RA and 1.5 mM BA produce cytostasis 
without cytotoxicity in the Bl6a cell line (McGarvey and Persky, 1989). 
I have also emphasized the importance of using the cytostatic 
concentration of potential anti-invasive drugs in in vitro studies 
(McGarvey and Persky, 1989). Retinoids, which include all 
trans-retinoic acid, induce tumor cell differentiation, inhibit tumor 
cell growth (Gl phase of the cell cycle), suppress tumor cell 
phenotypic properties, and stimulate the host immune response (for a 
review see Roberts and Sporn, 1984). Butyric acid similiarly induces 
differentiation and inhibits proliferation (Gl phase of the cell cycle) 
of tumor and nontumor cells (Kruh, 1982). 
In my study, BA decreased 3H-IdUR incorporation within the first 
24 hours of incubation. Despite this reduction in proliferation, the 
invasion rate increased with longer exposure to BA (Fig. 3, Exps. 1-3). 
Drug concentrations necessary to inhibit in vitro invasion may be 
similiar or lower than that needed to inhibit proliferation in vitro. 
For example, RA reduced invasion of rat mammary adenocarcinoma 13762NF 
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cells in vitro without inhibiting proliferation (Nakajima et al., 
1989). 
A shortened time period for the invasion assay would be 
advantageous to distinguish drug induced inhibition of proliferation 
from drug induced inhibition of invasion. Therefore, I used 
conditioned medium to increase invasion. There was an increase in 
invasion of untreated and BA-pretreated lung nodule-derived cells in 48 
hrs using conditioned medium (Fig. 3, Exp. #6) as compared to 72 hrs 
without conditioned medium (Fig. 3, Exp. #3). A further enhancement of 
the migration and invasion rate by BA was observed if the 72 hr 
proliferation data (Fig. l, Chapter IV) were included in determining 
these rates (Table 1 and 2). 
Retinoic acid decreased the migration and invasion rates of Bl6a 
and Kl735 cells. These findings support the experiments of Nakajima et 
al. (1989). However, if a proliferation factor was used to calculate 
migration and invasion rates, then RA enhanced both migration and 
invasion. The usefulness of a proliferation factor in calculating 
migration and invasion rates can be questioned in light of my results 
obtained from calf serum treated cells. For example, the migration of 
RA-treated Bl6a cells was significantly decreased compared to untreated 
and calf serum treated Bl6a cells. Both RA and calf serum 
significantly decreased proliferation as compared to untreated cells 
(McGarvey and Persky, 1989). The concern of using a factor to 
"correct" for cellular proliferation in the migration experiments is 
also applicable to the invasion experiments. Therefore, whether RA 
decreases or increases migration or invasion of murine melanoma cells 
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would be answered by shortening the duration of the assay so that 
proliferation would not be a factor. 
In this in vivo study, it is possible that once the tumor cells 
invaded the lung paranchyma the growth of the lung colonies was 
inhibited by the continuous exposure to BA or RA. This would enhance 
the ability of host defenses to eradicate or reduce the tumors. 
Retinoids administered by i.p. injection or orally have been shown to 
reduce the size of xenotransplanted subcutaneous human mammary 
carcinoma (MDA-MB-231) (Halter et al., 1988)), murine embryonal 
carcinoma (McCue et al., 1988) and murine Bl6Fl0 melanoma (Drewa and 
Schachtschabel, 1985). However, the precise role of growth inhibition 
in experimental metastasis is unknown. Only recently has inhibition of 
primary tumor growth been separated from the reduction of spontaneous 
metastasis by retinoids in a hamster melanoma-athymic mouse model 
(Scheicher et al., 1988). 
Tumor cell adhesion vitro is important in theories of cellular 
invasion (Liotta et al., 1983). I have shown that BA pretreatment 
increases heterotypic adhesion between Bl6a cells and p.c. membranes as 
well as Matrigel coated p.c. membranes. This increase in adhesion 
correlates with increased in vitro invasion of BA-treated Bl6a cells. 
In contrast to the increased cellular adhesion to Matrigel induced by 
BA, a decrease in the number of laminin receptors has been reported in 
the BA-treated human pancreatic carcinoma cell line (PANC-1) (Bryant et 
al., 1986). Matrigel contains collagen type IV, heparin sulfate 
proteoglycans and entactin as well as laminin. Therefore, it is 
possible that a decrease in binding to one element of a basement 
llO 
membrane does not imply a decrease in binding to all components. 
Tumor cell adhesion in vivo is central to the 'seed and soil' 
hypothesis of Paget (1889). Decreased adhesion has been correlated 
with both increased and decreased experimental metastasis (Takanaga, 
1984; Takanaga, 1986; Raz and Ben-Ze'ev, 1983; Werling et al., 1986). 
Butyric acid has been shown to increase homotypic and heterotypic 
adhesion of Lewis lung carcinoma (P-29) cells and pretreated cells have 
been shown to have increased experimental metastasis (Takanaga, 1986). 
In contrast to the increase in heterotypic adhesion induced by BA, 
RA has been shown to decrease the adhesion of a Bl6Fl variant to 
elements of the basement membrane (laminin, entactin and collagen type 
IV) and collagenous stroma (collagen type I) (Edward et al., 1989). 
This decrease in adhesion may be one of the factors that decreased 
vitro invasion and experimental metastasis in my study. The same 
reasoning may apply to the results observed in in vitro invasion assays 
(Fazely et al., 1988; Fazely et al., 1985; Nakajima et al., 1989) and 
experimental metastasis assays (Edward et al., 1989; Couch et al., 
1987). 
The role of proteolytic enzymes in the degradation of the 
extracellular matrix by tumor cells in invasion has been correlated 
with the in vivo metastatic potential of many tumor cell lines 
including the Bl6 melanoma cell line (Wang et al., 1980; Sloane et al., 
1982; Liotta et al., 1980). Both BA and RA have been shown to modulate 
the activity and production of degradative enzymes. Increased invasion 
of M5076 sarcoma cells in the HABM assay by butyric acid has been 
correlated with increased type IV collagenase activity (Thorgeirsson et 
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al., 1984). The increase in collagenase type IV activity supports my 
observation that BA-treatment enhances invasion. On the other hand, RA 
has been shown to decrease the degradation of the collageneous capsule 
surrounding subcutaneous murine tumors (Takahashi et al., 1985), and to 
decrease both type IV collagenase and the invasion of 13762NF cells in 
the RBM assay (Nakajima et al., 1989). The reported decrease in type 
IV collagenase by RA-treatment likewise supports my finding that RA 
treatment decreased the invasion of Bl6a and K-1735 cells in the 
Matrigel assay. 
There appears to be a correlation between increased migration and 
increased invasion. The K-1735 cells used in this study are highly 
invasive and highly migratory (Silberman et al., 1990). There are, 
however, exceptions to the theory that highly migratory cells are 
highly invasive. For example, subcutaneously derived cells were 
significantly more migratory than lung nodule derived cells. This may 
be due to the heterogeneous nature of the subcutaneously-derived cells. 
On the other hand, lung nodule-derived cells invaded the Matrigel in 
significantly greater numbers than subcutaneously-derived cells. This 
is expected since the lung nodule-derived cells represent a special 
subpopulation that are invasive in vivo. Selection for invasive or 
migratory cells has already been reported. For example, repeated 
passage of invasive cells in the RBM assay produced more invasive cells 
(Wang and Stearns, 1988; Hendrix et al., 1989). Likewise, cells 
obtained from repeated serial passages through the human amnion have 
produced more experimental metastases (Persky and Chmielewski, 1987) 
and spontaneous metastases (Tullberg et al., 1989). In contrast, 
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hypermotile c~lls from repeated passage through microporous membranes 
decreased the number of experimental and spontaneous metastases 
(Grimstad, 1988). It is possible that selection of either the 
migratory or the invasive phenotype may select a subpopulation that is 
not as competent at completing another step of the metastatic cascade. 
The cells used in the in vitro assays were derived from multiple. 
sources (the tumor depository, subcutaneous tumors and lung nodules) 
and had different migration and invasion rates. Therefore, each 
migration and invasion experiment must be independently evaluated. The 
use of cells from different sources, different passage numbers or 
different cell lines should not cloud the main in vitro concept that BA 
increases migration and invasion and that RA decreases migration and 
invasion. An important observation in the migration and invasion 
assays is that retinoic acid has a greater effect on highly invasive 
(K-1735 cells) or highly migratory cells (subcutaneously derived Bl6a 
cells) whereas butyric acid has a greater effect on the migration and 
invasion of low invasive cells (McGarvey and Persky, 1989). However, 
if the decrease in proliferation induced by RA and BA is included in 
the invasion rates, RA and BA enhanced invasion. In addition, 
increasing the in vitro invasion rate by either using lung 
nodule-derived cells or conditioned medium did not obliterate the 
overall effect of BA on increasing vitro invasion. 
I believe that drug administration by pellet prior to tumor cell 
injection primed the animal. Administration by subcutaneous pellet 
allowed for constant drug exposure during the entire experiment, unlike 
i.p., i.v. or dietary intake. Blood serum levels of mice that received 
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a 5 mg pellet of RA have been shown to contain 5 X 10- 8 M RA (Mariotti 
et al., 1987). Tissue concentrations of RA were not reported in this 
study. However, administration of all trans-RA by intravenous 
injection found that tissue concentrations were higher than blood serum 
levels (Wang et al., 1980). Pellets containing higher concentrations 
resulted in toxicity to the mice (Mariotti et al., 1987). I have not 
determined the murine serum levels of BA in this study. However, the 
animals in these experiments did not show signs of BA toxicity. The BA 
concentration was based on information provided by Dr. S. Shafie from 
Innovative Research Inc. (personal communication). To my knowledge, no 
information is available on blood serum or tissue concentrations of BA 
by pellet administration. 
Although BA and RA have a myriad of effects on the multiple steps 
of the metastatic cascade, both drugs significantly reduced in vivo 
experimental metastasis in our study. Further combined vitro and in 
investigations with these drugs and other differentiation agents 
are warranted. 
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Figure 1: 3 Counts per minute (CPM) of H-IdUR labelled cells 
plotted at 24, 48, and 72 hrs. as the mean (n=4) + standard error 
of the mean. 
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Figure 2: The percent migration of Bl6a cells. Three separate 
experiments were done. For details see "Migration Assay" in the 
results section. Each bar is the percent migration ~ standard 
error of the mean. An asterisk (*) represents a value that is 
significantly different from the controls. 
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Figure 3: The percent invasion of Bl6a cells. Four different 
experiments were performed. For details see "Invasion Assay" in 
the results section. Each bar is the percent invasion ± 
standard error of the mean. An asterisk (*) represents a value 
that is significantly different from the controls. In experiment 
#3, the percent invasion of lung nodule-treated cells was 
significantly different from the percent invasion of the 
subcutaneously-derived cells plated at either 25,000 or 50,000 
cells/well. 
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Figure 4: The percent invasion of Bl6a and K-1735 cells. Two 
differrent experiments were performed. For details see "Invasion 
Assay" in the results section. Each bar is the percent invasion 
+ standard error of the mean. An asterisk (*) represents a value 
that is significantly different from the controls. The double 
asterisk (**) in experiment #6 represents a value that is 
significantly different from the controls at 24 hrs. 
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Figure 5: The in vivo experimental data. Subcutaneous pellets 
containing either a placebo, BA, or RA were implanted into C57BL6 
mice one day prior to injection via tail vein with Bl6a cells. 
Mice were killed 21 days after tumor cell injection. An average 
of 102.7±49.4 (mean± S.D.), 8.8±14.4, and 20.3±15.8 lung nodules 
were counted per the placebo, BA, and RA-treated groups, 
respectively. The median scores were also determined for each 
group. 
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Figure 6. A photograph of lungs from control (placebo) 
treated animals. The lungs in Figs. 6, 7 and 8 were printed 
at different magnifications. 
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Figure 7. A photograph of lungs from BA-treated animals. 
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Figure 8. A photograph of lungs from RA-treated animals. 
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TABLE 1. 
The migration rate of untreated, BA-treated, BA-pretreated, RA-treated 
and RA-pretreated cells after 72 hr incubation with a proliferation 
factor incorporated into the migration rate. The migration value was 
defined as the number of the cells per field times 50 divided by the 
final hemacytometer cell population (Fig. 1 and Fig. 2, Chapter IV). 
There was a significant increase in migration of BA-treated and 
BA-pretreated cells as compared to untreated Bl6a cells (p<0.05, 
p<0.05, respectively). There was a significant increase in migration 
of lung nodule-derived RA-treated and RA-pretreated cells as compared 
to untreated Bl6a cells (p<0.05, p<0.05, respectively). 
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MIGRATION VALUES 
(INCLUDING THE PROLIFERATION RATE) 
MIGRATION EXPERIMENT 1 
LUNG NODULE CELLS SUBCUTANEOUS CELLS 
N 4 4 
MEAN 6.93 x 10-5 28.0 x 10- 5 
SD 1. 62 x 10- 5 7.30 x 10- 5 
SEM 3.60 x 10- 5 3.60 x 10- 5 
* % MIG 404 
MIGRATION EXPERIMENT 2 
LUNG NODULE CELLS RETINOIC ACID 
N 3 3 
MEAN 0. 72 x 10- 4 1. 77 x 10- 4 
SD 0.28 x 10- 4 0. 72 x 10- 4 
SEM 0.16 x 10- 4 0.41 x 10-4 
* % MIG 246 
MIGRATION EXPERIMENT 3 
SUBCUTANEOUS CELLS PRE-RETINOIC ACID 
N 3 6 
MEAN 2.86 x 10" 4 5.01 x 10 4 
SD 0.44 x 10" 4 1.67 x 10- 4 
SEM 0.25 x 10- 4 0.68 x 10- 4 
% MIG 175 
* 
PRE-BUTYRATE 
3 
203 x 10- 5 
42 x 10- 5 
24 x 10- 5 
* 2929 
PRE-RETINOIC ACID 
6 
6.73 x 10- 4 
3.53 x 10- 4 
1.44 x 10-4 
* 934 
- indicates a significant difference at p < 0.05. 
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TABLE 2. 
The invasion rate of untreated, BA-treated and BA-pretreated cells 
after 72 hr incubation with a proliferation factor incorporated into 
the invasion rate. The invasion value was defined as the number of the 
cells per field times 50 divided by the final hemacytometer cell 
population (Fig. 1, Chapter IV). There was a significant increase in 
invasion of BA-treated and BA-pretreated cells as compared to untreated 
Bl6a cells (p<0.05, p<0.05, respectively). 
N 
MEAN 0.86 
SD 0.49 
SEM 0.22 
% INV 
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INVASION VALUES 
(INCLUDING THE PROLIFERATION RATE) 
5 6 
x 10- 5 8.07 x 10- 5 
x 10- 5 3.56 x 10- 5 
x 10- 5 1.45 x 10- 5 
* 938 
INVASION EXPERIMENT 2 
SUBCUTANEOUS CELLS BUTYRATE 
N 4 4 
MEAN 3.98 x 10- 5 700 x 10- 5 
SD 1.09 x 10- 5 330 x 10- 5 
SEM 0.54 x 10 5 165 x 10 5 
* %INV 17588 
INVASION EXPERIMENT 3 
LUNG NODULE CELLS BUTYRATE 
N 4 4 
MEAN 4. 70 x 10- 5 49.4 x 10- 5 
SD 1.26 x 10- 5 14.5 x 10- 5 
SEM 0.63 x 10- 5 7.20 x 10- 5 
* %INV 1051 
* - indicates a significant difference at p < 0.05. 
5 
17.9 x 10- 5 
6.30 x 10- 5 
2.80 x 10- 5 
* 2081 
PRE-BUTYRATE 
4 
4350 x 10- 5 
320 x 10- 5 
160 x 10- 5 
* 109296 
PRE-BUTYRATE 
4 
138 x 10- 5 
21.1 x 10- 5 
10.5 x 10- 5 
* 2936 
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TABLE 3. 
The invasion rate of untreated, RA-treated and RA-pretreated cells 
after 72 hr incubation with a proliferation factor incorporated into 
the invasion rate. The invasion value was defined as the number of the 
cells per field times 50 divided by the final hemacytometer cell 
population (Fig. 2, Chapter IV). There was a significant increase in 
invasion of lung nodule-derived RA-treated and RA-pretreated cells as 
compared to untreated Bl6a cells (p<0.05, p<0.05, respectively). There 
was a significant increase in invasion of RA-pretreated Kl735 cells as 
compared to untreated Kl735 cells (p<0.05). 
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INVASION VALUES 
(INCLUDING THE PROLIFERATION RATE) 
INVASION EXPERIMENT 4 
LUNG NODULE CELLS 
N 5 
MEAN 3.1 x 10- 5 
SD 0.81 x 10- 5 
SEM 0.08 x 10- 5 
%INV 
INVASION EXPERIMENT 5 
UNTREATED - K1735 CELLS 
N 
MEAN 
SD 
SEM 
% INV 
* 
4 
34 x 10- 4 
1.6 x 10- 4 
0.3 x 10- 4 
RETINOIC ACID 
6 
9.0 x 10- 5 
2.4 x 10- 5 
1.0 x 10- 5 
* 295 
PRE-RETINOIC ACID 
4 
26.1 x 10- 5 
8.0 x 10- 5 
4.0 x 10- 5 
··k 
853 
PRA - Kl735 CELLS 
4 
45 x 10- 4 
3.0 x 10- 4 
1.0 x 10- 4 
... k 
132 
- indicates a significant difference at p < 0.05. 
CHAPTER VI 
QUANTIFICATION OF F-ACTIN IN 
MIGRATORY AND INVASIVE 
MURINE Bl6a MELANOMA CELLS 
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ABSTRACT 
Butyric acid (BA) and retinoic acid (RA) affect the cytoskeleton 
(McGarvey and Persky, 1989). In this study, F-actin of migratory, 
nonmigratory, invasive and noninvasive murine Bl6a melanoma cells was 
digitized and quantified by image analysis. Cells were untreated or 
pretreated for three days with BA or RA before being plated onto 
uncoated (the migration assay) or Matrigel-coated (the invasion assay) 
polycarbonate membranes. Butyric acid or RA was added to the 
pretreated cells at the time of plating onto the membranes. After 72 
hrs of incubation, cells were fixed, permeablized and stained with 
Bodipy phallacidin for F-actin, and examined by fluorescent microscopy. 
The F-actin was divided into two categories, nonfilamentous and 
filamentous actin. Untreated migratory cells had less filamentous 
F-actin than BA-pretreated migratory cells (78% decrease, p<0.05) and 
RA-pretreated migratory cells (65% decrease, p<0.05). BA-pretreated 
invasive cells had less nonfilamentous F-actin than RA-pretreated 
invasive cells (9% decrease, p<0.05). Migratory untreated cells had 
less filamentous actin than invasive untreated cells (26.1% decrease, 
p<0.05). Invasive and migratory cells were capable of bundling actin. 
Few actin cables were found in noninvasive untreated cells, while actin 
cables were numerous in nonmigratory untreated cells. In addition, 
large bundles of actin were predominate in nonmigratory and noninvasive 
cells, regardless of whether the cells were drug treated or not. The 
F-actin phenotype is dependent on drug treatment, substrate 
interactions, migration and invasion. 
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INTRODUCTION 
The cytoskeleton has many different properties essential for 
normal functioning including maintenance of cell shape, cellular 
adhesion and cellular migration. The cytoskeleton has been divided 
into three different classes based on the size and composition of the 
proteinaceous filaments present in the cytoplasm. They are 
microfilaments, intermediate filaments and microtubules. 
Microfilaments are essential for cell motility and have been shown 
by fluorescent and transmission electron microscopic (TEM) techniques 
to be present in the leading edge of motile cells (Lewis et al., 1982; 
Jockusch et al., 1983). They are composed of F-actin, myosin, filamin, 
tropomyosin, and alpha-actinin. The organization of F-actin has been 
inversely correlated with motility (Lewis et al., 1982; Herman et al., 
1981). Diffuse actin fluorescence in HeLa cells has been observed in 
the areas of motile cytoplasm such as leading lamellae and ruffling 
membrane (Herman et al., 1981). Large bundles of microfilaments, 
called stress fibers, are lacking in rapidly moving embryonic chick 
cells, human skin fibroblasts (Lewis et al., 1982), and murine K-1735 
melanoma cells (Raz and Geiger, 1982). In addition, motility is 
inhibited by microfilament disrupting agents such as cytochalasin B 
(Keller and Zimmermann, 1986). 
Microtubules affect cellular migration. Microtubule 
depolymerizing agents colchicine and vinblastine stimulate random 
motility (Keller and Zimmermann, 1986) while inhibiting deformability 
and chemotaxis (Spiro and Mundy, 1980). Immunolabeling has shown that 
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microtubules stabilize contacts for stress fiber assembly (Rinnerthaler 
et al., 1988). 
Changes in tumor cell morphology, migration rate and invasion rate 
have been observed in response to BA and RA (McGarvey and Persky, 
1989a; McGarvey et al., 1990). An increase or appearance of stress 
fibers occured in RA-treated F9 teratocarcinoma (Lehtonen et al., 
1983), RA-treated rat osteoblastic sarcoma cells (Ng et al., 1985), 
BA-treated virus transformed (KNRK) fibroblasts (Altenburg et al., 
1976), and BA-treated rat hepatoma cells (Borenfruend et al., 1980). 
In order for metastasis to occur, tumor cells must invade tissue 
boundaries and basement membranes at multiple points. Invasion is a 
three step process that includes: (1) cellular adhesion to a substrate, 
(2) proteolytic digestion of the substrate, and (3) migration of the 
cell into the space created by proteolytic digestion (Liotta et al., 
1983). Few reports have investigated the role of actin microfilaments 
in tumor cell migration or invasion. Psuedopodal extension has been 
observed in migratory and invasive cells (Kramer et al., 1986; McGarvey 
and Persky, 1989b). Actin filaments of low metastatic human melanoma 
variants (A375P) become disorganized after invasion through the human 
amnion basement membrane (Hendrix and Seftor, 1986); however, the cells 
that had successfully invaded the amnion were enzymatically detached 
and then plated onto glass slides. Thus, actin analysis was performed 
on cells that had invaded and attached to a different substrate than 
originally used. 
In our study, the actin cytoskeleton of untreated, BA-treated and 
RA treated Bl6a cells was visualized by fluorescence and quantified by 
140 
computer image process and analysis. Cells on the top and bottom of 
uncoated and Matrigel-coated polycarbonate (p.c.) membranes were 
visualized directly by fluorescent microscopy and transmission electron 
microscopy (TEM). 
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MATERIALS AND METHODS 
Cell Culture: Murine Bl6a (amelanotic) melanoma cells were 
obtained from the DCT Tumor Repository (NCI Frederick Cancer Research 
Facility, Frederick, Maryland). Cells were cultured in Eagle's Minimum 
Essential Medium (MEM) (Gibco, Grand Island, NY) containing Hank's 
salts and L-glutamine supplemented with sodium pyruvate (110 mg/l) 
(Sigma, St. Louis, MO), 10% Nu-Serum (Collaborative Research, Bedford, 
MA), 1% penicillin G-streptomycin sulfate amphotericin B (Fungizone) 
(Gibco), MEM non-essential amino acids (10 ml/l) (Gibco), sodium 
bicarbonate (1.27 g/l) (Sigma), and Hepes (5.96 g/l) (Sigma) (final pH 
of the medium was 7.3). Cells were cultured in a humidified incubator 
(37°C in 5% co2) and were refed every three days. Cells were removed 
from flasks with trypsin/EDTA (Sigma) during log phase growth. Cells 
were injected into 46 day old female C57BL6 mice (Jackson Laboratories, 
Bar Harbor, ME) either subcutaneously or by lateral tail vein. 
Subcutaneously-derived Bl6a cells were used in the migration assay. 
Lung nodule-derived Bl6a cells were used in the invasion assay. The 
derivation of these cells is detailed elsewhere (McGarvey et al., 
1990). The cytostatic concentrations of butyric acid (J.T. Baker, 
Phillipsburg, NJ) and all trans-retinoic acid (Sigma) were chosen from 
a range of concentrations that were previously shown to be cytostatic 
(McGarvey and Persky, 1989). The cytostatic concentrations of BA and 
RA used in all migration and invasion assays were 1.5 mM and 1 X 10- 6 
M, respectively. 
Migration Assays were performed as described 
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in two previous studies (McGarvey and Persky, 1989; McGarvey et al., 
1990). Briefly, Bl6a cells were untreated or pretreated with BA or RA 
for three days. In both the migration and invasion experiments, 5 X 
104 or 1 X 103 cells in appropriate media (MEM + NuSerum with or 
without BA or RA) were plated in each Transwell insert (inner well) 
(Costar Inc., Cambridge, MA). The matching outer wells contained MEM + 
NuSerum with or without BA or RA, but without cells. The 1 X 103 cell 
concentration was chosen in order to be able to quantitate the actin of 
individual nonmigratory and noninvasive cells. Polycarbonate (p.c.) 
membranes in the migration experiment contained 5 um diameter pores 
(7.9% of the membrane is represented by pores) and were uncoated. The 
p.c. membranes in the invasion experiment contained 8 um diameter pores 
(5.0% of the membrane is represented by pores) and were coated with 
Matrigel (Collaborative Research, Bedford, MA). The Matrigel was 
diluted 1:20 in media prior to application to the Transwell inserts in 
the cold (71 ug protein per 6.5 mm diameter membrane). The duration of 
the migration and invasion assays was 72 hrs. 
Fluorescent Staining: Bodipy phallacidin (Molecular Probes Inc., 
Eugene, OR) staining of F-actin was performed as described by Barak et 
al. (1980). In brief, cells on uncoated p.c or Matrigel coated p.c. 
membranes were rinsed 2x with PBS, fixed with 2% paraforaldehyde in 
PBS, rinsed with PBS, permeablized with 0.5% Triton X, rinsed in PBS, 
stained with Bodipy phallacidin, and rinsed again with PBS. Matrigel 
and cells on top of the p.c. membrane were removed with a cotton swab 
from some of the p.c. membranes in order to remove background staining 
(cells on top of the membrane); this removal procedure was performed in 
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order to permit accurate analysis of the fluorescence of the migratory 
or invasive cells that were located on the bottom of the p.c. membrane. 
Photography and Image Analysis: Cells were photographed with a 
Leitz Orthoplan microscope utilizing an epifluorescent light source and 
a number I2 filter block. The fluorescent image was recorded on Kodak 
Tri-X film at 400 ASA. Exposure time for each negative was determined 
automatically by the camera system within the films minimum and maximum 
density. Minimum density is defined as that point where exposure time 
and light intensity make a first recording on the film. Maximum 
density is defined as that point where increasing either time or 
intensity fails to further enhance the density of the image on the 
film. Increasing exposure time or light intensity past the maximum 
density point causes the entire negative to turn progressively black 
(Practical Densitometry, Kodak Publication No. E-59, 1985). Because 
the intensity of the fluorescence varies with exposure time for the 
Tri-X film and because film development varies from film strip to film 
strip, it was necessary to standardize each negative for quantitative 
image analysis. The morphological depiction (i.e. micrograph) of 
F-actin was achieved by the optimal exposure for each negative. Thus, 
because each fluorescent micrograph represents the ideal photograph, it 
is not possible to compare the actin from one photomicrograph to the 
next. In short, the fluorescent micrographs are qualitative and 
nonstandardized (uncorrected) while the image analysis data are 
quantitative and standardized (corrected). 
For the image analysis, each 35 mm negative was subsequently 
digitized using a Javelin MOS solid state high resolution television 
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camera interfaced through a Colorado Video Inc. digitizer that was 
connected to a Princeton Gamma-Tech image analyzer. A total of 90 
migratory (30 control, 30 BA-pretreated, and 30 RA-pretreated) and 90 
invasive (30 control, 30 BA-pretreated, and 30 RA-pretreated) cells 
were individually digitized (400 x 512 pixels). A total of 90 
nonmigratory (30 control, 30 BA-pretreated, and 30 RA-pretreated) and 
90 noninvasive (30 control, 30 BA-pretreated, and 30 RA-pretreated) 
cells were individually digitized (400 X 512 pixels). For each 
digitized image, the 256 grey levels were arbitrarily divided into 7 
grey levels: 0-87, 88-112, 113-132, 133 157, 158-174, 175-184 and 
185-256. Each grey levels was assigned a color. The extracellular 
background for each negative was standardized by using the intensity 
control on the Colorado video digitizer until the extracellular 
background was always within the 175-184 grey level range. Several 
attempts were usually required to standardize the background. This 
standardization procedure is an "internal standard protocol" and is a 
recommended procedure for the PGT image analysis work (personal 
communication; Princeton Gammma-Tech; Peter Quigley, Product Manager; 
George Helmstetter, Senior Service Specialist (609-924-7310)). After 
this standardization procedure for each negative, no data was observed 
in the 185-256 grey levels. Thus only 6 grey levels remained in the 
final digitized image. The percent area for each of these 6 grey level 
was determined for each negative. This initial percent area included 
both cellular and extracellular data. The grey level group that was 
extracellular was removed (grey levels 175-184) and new percent areas 
were calculated based only on cellular grey levels. Five grey level 
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groups thus represented the cell. Fluorescent intensity was 
arbitrarily divided into five final grey levels defined as: (1) 
greatest intensity of stained actin aggregates or actin cables 
(designated actin 3, grey level 0-87); (2) intermediate intensity of 
stained actin aggregates or actin cables (designated actin 2, grey 
level 88-112); (3) least intense stained actin cables, diffuse actin, 
or actin aggregates (designated actin 1, grey levels 113-132); (4) 
diffuse actin (grey levels 133-157; no actin cables or aggregates); and 
cellular background (grey levels 158-174; nonfluorescent nonactin 
cytosol). The intensely stained actin cables appear to be due to an 
increase in the number of cables rather than the size of the cables. 
Figures 1 and 2 illustrate the image analysis protocol. 
Measurement of Cell Area: The area of each migratory or invasive 
cell (180 total) was measured by a Videoplan system (Carl Zeiss Inc.) 
and analyzed with a measuring histogram software program. The five 
final grey level groups were converted"into area by multiplying the 
area (um2) of each cell by the percent area of the actin (um2/um2) in 
each cell. 
Statistics: The percent of actin and cell areas of the three grey 
levels of migratory BA-pretreated cells were individually compared to 
the percent of actin and areas of untreated or RA-pretreated cells 
using the either the Welch's tw (t') test unequal variance or the 
Bechhofer-Dunnett-Krishnaiah-Armitage muliple comparison test (Wilcox, 
1987). Both percent of actin and cell area of the three cellular grey 
levels of migratory RA-pretreated cells were individually compared with 
the percent actin and areas of untreated cells using the either the 
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Welch's tw (t') test unequal variance or the Bechhofer-Dunnett-
-Krishnaiah-Armitage multiple comparison test (Wilcox, 1987). The 
percent actin and areas of migratory cells were compared separately 
from invasive cells. Percent actin from similiarly treated migratory 
and invasive cells were also compared. For example, the nonfilamentous 
actin was compared between untreated migratory and invasive cells. The 
percent actin of the three grey levels of nonmigratory untreated, 
BA-pretreated and RA-pretreated cells were individually compared with 
the matching percent actin of the three grey levels of similarly 
treated migratory cells. The percent actin grey levels of invasive and 
noninvasive cells were similarly evaluated. 
A significance level of p<0.05 was defined as significant for all 
experiments. 
Transmission Electron Microscopy: Transmission electron 
microscopy was performed as described in a previous study (McGarvey and 
Persky, 1989b). Briefly, membranes were fixed for 30 min at 37°C with 
2% glutaraldehyde in 50 mM cacodylate buffer (pH 7.4), rinsed in buffer 
(3X) for 5 min at 37°C and incubated for 30 min in buffer containing 
0.8% K3Fe(CN) 6 . Membranes were then incubated for 30 min in buffer 
containing 0.5% Os04 and 0.8% K3Fe(CN) 6 , rinsed in buffer, rinsed in 
distilled water (3X), stained en bloc with 2% uranyl acetate (dH20) for 
60 to 120 min, rinsed in distilled (3X) and dehydrated in ethanol. 
Membranes were infiltrated into resin (Epon-Araldite), cut out of the 
Transwell insert, and polymerized. Thin sections were cut, stained in 
1% uranyl acetate (in 70% methanol) and lead citrate, and viewed with a 
Hitachi H-600 microscope at 75 kV accelerating voltage. 
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RESULTS 
The data from the results of the image analysis were simplified as 
follows. The percent area of background, diffuse actin, and actin 1 
were combined into a major group designated nonfilamentous actin. 
Likewise, the area of background, diffuse actin, and actin 1 were 
combined. 
Quantification of F-actin in Migratory Cells (Table 1): 
BA-pretreated cells have less nonfilamentous actin than untreated cells 
(19.2% decrease, p<0.05). BA-pretreated cells have less nonfilamentous 
actin than RA-pretreated cells (13.3% decrease, p<0.05). Untreated 
cells have less actin 2 than RA-pretreated cells (42% decrease, p<0.05) 
and BA-pretreated cells (64% decrease, p<0.05). Untreated cells also 
have less actin 3 than RA-pretreated cells (66% decrease, p<0.05) and 
BA-pretreated cells (83% decrease, p<0.05). 
Quantification of the Total Area and of Actin in Migratory 
Cells: BA-pretreated cells had more total area than untreated cells 
(189% increase, p<0.05). There was no significant change in area with 
RA-pretreatment (Fig. 3). BA-pretreated cells had more nonfilamentous 
actin and filamentous actin (actin 2 and 3) in area than untreated 
cells (158% increase, p<0.05; 601% increase, p<0.05; and 701% increase, 
p<0.05, respectively) (Table 2). There was an increase in the area of 
actin 2 and actin 3 of RA-pretreated cells compared to untreated cells 
(188% increase, p<0.05,; and 272% increase, p<0.05, respectively) 
(Table 2). 
Fluorescence, Migration Assay: At a plating concentration of 5 X 
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4 10 cells, cell processes usually overlapped on top of the uncoated 
p.c. membrane (Fig. 4A, C, and E). Few F-actin filaments were observed 
on top of the membrane in untreated or drug-treated cells (Fig. 4A, C, 
and E). Individual cells were seen on the bottom of the p.c. membrane. 
F-actin aggregates and stress fibers were evident in untreated 
migratory cells (Fig. 4B). An organized pattern of F-actin filaments 
predominates throughout BA-pretreated cells. No F-actin aggregates 
were seen (Fig. 4D). Parallel F-actin filaments and F-actin aggregates 
were observed in RA-pretreated cells (Fig. 4F). 
Quantification of Actin in Invasive Cells (Table 1): There was no 
significantly difference in nonfilamentous actin, actin 2 and 3 of 
untreated cells compared to BA-pretreated cells and RA-pretreated 
cells. However, there was a significant increase in nonfilamentous 
actin in RA-pretreated cells compared to BA-pretreated cells (110% 
increase, p<0.05). In addition, there was a significant decrease in 
actin 2 in RA-pretreated cells compared to BA-pretreated cells (56% 
decrease, p<0.05). 
Quantification of the in Invasive 
Cells: BA-pretreated cells had a significantly larger total area than 
untreated cells (160% increase, p<0.05). There was no significant 
difference in total area between untreated and RA-pretreated cells 
(Fig. 5). BA-pretreated cells had a larger area of nonfilamentous 
actin, actin 2 than untreated cells (131% increase, p<0.05; and 231% 
increase, p<0.05, respectively) (Table 2). There was a significant 
decrease in the area of actin 2 and 3 of RA-pretreated cells compared 
to untreated cells (51% decrease, p<0.05; and 34% decrease, p<0.05, 
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respectively). (Table 2). 
Fluorescence, Invasion Assay: At a plating concentration of 5 X 
104 cells, individual cells on top of Matrigel-coated p.c. membranes 
can not be delineated. Diffuse or filamentous actin observed at 
different focal points renders high magnification difficult (Fig. 6A, G 
and E). Untreated cells on top of the membrane have diffuse actin at 
the cell borders (Fig. 6A). RA-pretreated and BA-pretreated cell 
processes contain F-actin filaments (Fig. 6C and E). An untreated 
invasive cell on the bottom of the p.c. membrane has parallel F-actin 
filaments and F-actin aggregates (Fig. 6B). A dense pattern of F-actin 
is observed in BA-pretreated invasive cells (Fig. 60). Stress fibers 
are observed in RA-pretreated cells (Fig. 6F). Both BA-pretreated and 
RA-pretreated invasive cells apppear to lack F-actin aggregates, but 
diffuse staining actin is observed (Fig. 6A and F). 
Stress fibers are not apparent in a BA-pretreated invasive cell 
(Fig. 1). Two pores of the polycarbonate membrane are surrounded with 
diffuse actin. A ring of organized actin surrounds one of the two 
pores. F-actin microspikes can be observed within the leading edge of 
the cell ending at the cell border. A trailing tail can also be seen 
(Fig. 1). 
Gomparision of F-Actin between Migratory and Invasive Cells: 
There was an increase in actin 2 in untreated invasive cells compared 
to untreated migratory cells (151%, p<0.05). There was an increase in 
actin 2 and 3 in RA-pretreated migratory cells compared to 
RA-pretreated invasive cells (169%, p<0.05; 214% p<0.05). There was 
more actin 3 in BA-pretreated migratory cells than in BA-pretreated 
150 
invasive cells (258% increase, p<0.05). 
Quantification of Actin in Nonmigratory and Noninvasive Cells 
(Table 3): There was more nonfilamentous actin in RA-pretreated 
nonmigratory cells than BA-pretreated nonmigratory cells (135% 
increase, p<0.05). There was less actin 2 in nonmigratory 
RA-pretreated cells than untreated nonmigratory cells (29% decrease, 
p<0.05). Nonmigratory BA-pretreated cells had more actin 3 than 
untreated or RA-pretreated cells (182% increase, p<0.05; 249% increase, 
p<0.05, respectively). There was more actin 3 in BA-pretreated 
noninvasive cells than untreated noninvasive cells (167% increase, 
p<0.05). 
Comparison of F-Actin between Nonmigratory and Migratory Cells 
(Tables 1 and 3): Migratory untreated cells had more nonfilamentous 
actin than untreated nonmigratory cells (147% increase, p<0.05). There 
was more actin 2 and 3 in untreated nonmigratory cells compared to 
untreated migratory cells (425% increase, p<0.05; 850% increase, 
p<0.05, respectively). There was more nonfilamentous actin in 
migratory BA-pretreated cells than nonmigratory BA-pretreated cells 
(137% increase, p<0.05). Nonmigratory BA-pretreated cells contained 
more actin 3 than migratory BA-pretreated cells (266% increase, 
p<0.05). There was more actin 2 and 3 in RA-pretreated nonmigratory 
cells compared to RA-pretreated cells (174% increase, p<0.05; 211% 
increase, p<0.05, respectively). 
Comparison of F-Actin between Noninvasive and Invasive 
(Tables 1 and 3): Untreated invasive cells had more nonfilamentous 
actin than untreated noninvasive cells (125% increase, p<0.05). There 
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was more actin 2 and 3 in untreated noninvasive cells compared to 
untreated invasive cells (237% increase, p<0.05; 342% increase, p<0.05, 
respectively). BA-pretreated invasive cells had more nonfilamentous 
actin than BA-pretreated noninvasive cells (127% increase, p<0.05). 
Noninvasive BA-pretreated cells contained more actin 2 and 3 than 
invasive BA-pretreated cells (153% increase, p<0.05; 381% increase, 
p<0.05). RA-pretreated invasive cells had more nonfilamentous actin 
than RA-pretreated noninvasive cells (137% increase, p<0.05). There 
was more actin 2 and 3 in RA-pretreated noninvasive cells than 
RA-pretreated invasive cells (314% increase, p<0.05; 664% increase, 
p<0.05, respectively). 
Fluorescence, Nonmigratory and Noninvasive Individual 
cells were observed on top of uncoated (Fig. 7A, C, and E) and 
Matrigel-coated (Fig. 7B, D, and F) p.c. membranes at a plating 
concentration of 1 X 103 cells. Prominent stress fibers are seen in 
untreated nonmigratory cells (Fig. 7A). In contrast, few stress fibers 
were visualize in untreated noninvasive cells (Fig. 7B). Organized 
stress fibers can be observed in the drug-treated cells on top of 
either substrate (Fig. 7C, D, E, and F) However, RA pretreated 
nonmigratory cells contain paranuclear actin staining not observed in 
RA-pretreated noninvasive cells (Fig. 7E and F) 
Transmission Electron Microscopy of Migratory and Invasive Cells: 
This investigation observed the cytoskeleton of migratory and invasive 
cells above, below and within the pores of the polycarbonate membrane 
(Figs. 8-10). Higher magnification of the cytoplasm within the pore of 
migratory or invasive cells reveals microtubules and cortical actin. 
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The microtubules are parallel to the apparent movement of the cell 
(Figs. 8-9). Cortical actin is most often observed adjacent to the 
Matrigel, the p.c. membrane, and at cell margins in noninvasive and 
invasive BA-pretreated cells (Fig. 10). 
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DISCUSSION 
This report quantitatively compared the actin cytoskeleton of 
untreated and drug-treated cells that had or had not migrated or 
invaded in a three dimensional assay. There were two major goals of 
this study. The first purpose was to quantitate nonfilamentous and 
filamentous actin between noninvasive and invasive cells as well as 
between nonmigratory and migratory cells. The second purpose was to 
describe morphologically F-actin when modulated by drug treatment, 
substrate, and the processes of migration and invasion. 
Past reports have compared cells on two dimensional substrates 
such as glass or plastic. Serniqualitative analysis of irnrnunolabelled 
or phalloidin labelled cytoskeletons has been limited to studies of 
motility or chemotaxis (Volk et al., 1984; Anderson et al., 1982). 
Flow cytofluorimetry has been used to compare total F-actin 
fluorescence between chemotactically active and nonactive 
polyrnorphonuclear neutrophils (PMNs) (Howard and Meyer, 1984) and has 
shown an increase in total actin in BA-treated hepatoma cells (Ryan et 
al., 1987). The ability to quantitate F-actin by fluorescence is based 
on the unique stoichiometric binding of F-actin to phallacidin (1:2) 
(Miyamoto et al., 1986). 
Both area of actin and percent of actin within cells were computed 
in this study. The area of actin data showed that BA-pretreated 
migratory and invasive cells were larger in size and had more 
nonfilamentous actin and actin 2 than untreated migratory and.invasive 
cells. In contrast, the percent of actin demonstrated differences in 
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actin groups that were not based on cell size. 
Cell shape, degree of confluency, and cell spreading affect 
cytoskeleton visualization (DeMey et al., 1978; Wolin and Kucherlapati, 
1979). In my study, individual cells on top of uncoated or 
Matrigel-coated p.c. membranes could not be delineated when the cell 
4 plating density was 5 X 10 , and thus actin fluorescence was quantified 
at the lower density (1X103). 
Substrate interactions are important in the morphology of actin 
filaments. The actin cytoskeleton appears nondistinct in untreated or 
4 treated cells plated at 5 X 10 cells on top of uncoated p.c. 
membranes. This was in contrast to the morphology of the F-actin 
cytoskeleton of cells plated at 5 X 104 cells on top of Matrigel-coated 
p.c. membranes. The actin fluorescence of untreated cells on top of 
Matrigel appeared similiar to the actin morphology of epithelial cells 
in situ where F-actin fluorecence is largely confined to cell periphery 
(Friedman et al., 1984) (Fig. 6A). In addition, the actin cytoskeleton 
was still diffuse in untreated cells plated at a concentration of 1 X 
103 cells (Fig. 7B). Extensive actin filaments, on the other hand, 
were observed in BA or RA-treated cells on top of the Matrigel at 
either plating concentration (Fig. 6C and E, Fig. 7D and F). 
Restoration of stress fibers and adhesion plaques has been reported in 
some transformed cells when grown on fibronectin (Ali et al., 1977; 
Willingham et al., 1977). Glass or plastic substrates allow for the 
formation of stress fibers which are generally absent from most cells 
in situ (Burridge et al., 1987). Nuclear F-actin aggregates or 
peripheral stress fibers observed in glass grown untreated Bl6a cells 
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(Persky and McGarvey, 1990) were not observed in migratory or invasive 
untreated Bl6a cells. Therefore, F-actin expression appeared to be 
dependent on both the cell substrate and cell activity. Thus, the 
value of comparing noninvasive and invasive cells can be questioned, 
since noninvasive cells were on a Matrigel substrate and the invasive 
cells were attached to an uncoated p.c. membrane. 
The actin morphology of the BA-treated cell in Figure 2A appears 
to typical of migratory cells (Lewis et al., 1982; Rinnerthaler et al., 
1988). Prominent stress fibers were not present. Instead, diffuse 
actin was prominent with microspikes bundles at the leading edge and a 
retracting tail. This morphology was similiar to that observed for 
migratory fibroblasts (Lewis et al., 1982; Rinnerthaler et al., 1988). 
On the other hand, nonmigratory fibroblasts have prominent stress 
fibers (Lewis et al., 1982). Large stress fibers seem to have a 
structural role rather than a migratory role. I observed an increase 
actin 3 in all nonmigratory and noninvasive cells compared to migratory 
and invasive cells. The most striking increase in stress fibers was 
seen in untreated nonmigratory cells compared to migratory untreated 
cells (Fig. 7A). 
Transmission electron microscopy of untreated and drug treated 
cells demonstrated parallel bundles of microtubules and intermediate 
filaments were observed by TEM in the pseudopods that were within the 
pores of the p.c. membrane. Microtubules, intermediate filaments, and 
cortical actin bundles are known to be involved in migration and 
invasion. Anti-microtubule agents such as colchicine·inhibit-
deformability (Daughaday et al., 1981). Both deformability and 
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motility are necessary for migration through a porous membrane. 
Chemotactic activation of PMNs has been shown to increase the average 
length of microtubules parallel to the direction of cell migration 
without affecting the number of microtubules per cell (Anderson et al., 
1982). 
Changes in the cytoskeleton may affect the organization, 
distribution, and amount of actin or tubulin protein. Ryan and Higgins 
(1988) found by biochemical analysis that total actin (globular and 
filamentous actin) represented only 5.45% of total cellular protein in 
transformed fibroblasts and 18.05% of total cellular protein in 
BA-treated transformed fibroblasts. I compartmentalized the F-actin 
fluorescence according to fluorescent intensity and showed that 
cortical actin is prominent in BA-pretreated noninvasive and invasive 
cells (Fig. 10). Obviously, the percents of F-actin presented here 
represented the compression of a three dimensional structure into two 
dimensions. This compression is seen in Fig. 6D by the overlapping of 
actin structures. Confocal microscopy would allow for optical 
sectioning through the cell and can accurately quantify actin at 
varying cell heights. An increase in actin close to the substrate, as 
viewed with confocal microscopy, has been reported to be indicative of 
highly migratory cells (Hay, 1985). 
Fluorescent microscopy (Figs. 4 and 6) and image analysis data 
show that migratory and invasive Bl6a cells organize actin into cables. 
The organization of actin is most prominent in invasive untreated, 
migratory RA pretreated and migratory/invasive BA-pretreated cells. 
The ability of a cell to organize actin into a structural component of 
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the cytoskeleton or into a intergral part of the migratory process may 
predict the migratory/invasive nature of the cell. My invasion data 
are in contrast to the findings of Hendrix and Seftor (1986), although 
the differences may be attributed to the protocols used. Hendrix and 
Seftor studied actin filaments after the invasive cells were detached 
from the amnion and then allowed to attachment to a glass substrate. 
They used a different cell line and they utilized the human amnion 
rather than Matrigel as the invasive barrier. Their study was 
significant in that the morphology of actin in low metastatic cells 
that were invasive for the amnion appeared similar to the morphology of 
high metastatic cells that were noninvasive for the amnion. 
Motile fibroblasts possess diffuse actin (Lewis et al., 1982). 
Interferon treatment of transformed cells restores or increases the 
number of the stress fibers as well as inhibits tumor cell motility on 
glass (Pfeffer et al., 1980; Bourgeade et al., 1981). Thus, migratory 
and invasive cells would be expected to contain only diffuse F-actin. 
However, migratory and invasive cells contained varying amounts of 
filamentous actin. Migratory and invasive BA-pretreated cells contain 
a complex organization of actin filaments compared to migratory and 
invasive untreated cells. There was a significant increase in actin 
organization of migratory RA-pretreated Bl6a cells as compared to 
migratory untreated cells. The increase in F-actin organization would 
be indicative of a nonmigratory phenotype. In contrast to the 
migration data, I did not observe an increase in F-actin organization 
in RA-pretreated invasive cells as compared to untreated invasive 
cells. In addition, it would be expected that BA-pretreated cells 
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would be less invasive and migratory than untreated cells, but the 
converse has been shown (McGarvey and Persky, 1989; McGarvey et al., 
1990). Therefore, the function of filamentous actin with respect to 
motility, migration, and invasion still has to be elucidated. 
A shift in the pool of actin from G-actin (globular actin) to 
F-actin (filamentous actin) has been reported in chemotactically 
activitated neutrophils (Howard and Meyer, 1984). My study was limited 
in that I could not determine if there was a shift in the pool of G to 
F-actin, or measure total actin. It has been noted that BA-treatment 
of transformed KNRK cells increases the amount and organization of 
F-actin. However, BA-treatment of tranformed KNRK cells does not 
completely restore actin to the pattern observed in untransformed KNK 
cells (Ryan and Higgins, 1988). My study only quantitated the 
organization of F-actin. Both total actin and F-actin organization are 
probably important for motility. 
An important question in my study is whether F-actin subgroups are 
selected by migratory and invasive cells. The increase in certain 
F-actin subgroups in invasive untreated cells compared to untreated 
migratory cells could indicate that a certain F-actin phenotype is 
necessary for invasion. In addition to the selective pressure of 
invasion on F-actin subgroups, F-actin subgroups are modified by drug 
treatment. In addition, drug treatment may affect a selected 
cytoskeletal phenotype before or after the migratory and invasive 
process. 
The image analysis system is based on fluroescent intesity of the 
F-actin, not on the organization of the actin. Thus, image analysis 
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does not distinguish between intensely stained F-actin aggregates and 
cables that were observed in migratory and invasive untreated cells. 
Only F-actin cables were observed in BA-pretreated cells. Therefore, 
there were more changes that took place with drug treatment than could 
be quantitated by image analysis. These differences may be important 
to the enhanced migratory and invasive rates induced by BA. 
Other cytoskeletal components may function in conjunction with 
F-actin to regulate migration and invasion. Butyric acid or RA may up 
or down regulate the production of other cytoskeletal proteins or 
effect their interaction with F-actin. Regulation of actin 
polymerization, including gelation, bundling, capping, severing and 
stabilizing of actin filaments, is a known function of numerous 
actin-binding proteins (Weeds, 1982). It is possible that each 
actin-binding protein is necessary in cell motility, but little is 
known about most of these proteins. One gel-bundling protein, 
alpha-actinin, has been localized to both stress fibers and to the 
leading lamellae of motile V2 carcinoma cells (Jockusch et al., 1983). 
Other actin-binding proteins, such as tropomyosin and myosin that have 
a role in muscle tissue contractility, are not found in the motile 
leading edge (Jockusch et al., 1983). Ryan and Higgins (1987) found 
that BA-treated transformed fibroblasts (KNRK) had a three fold 
increase in total cellular actin, detergent resistant actin, and 
alpha-actinin. Linder et al. (1981) observed an increase in synthesis 
of tropomyosin in RA-treated F9 teratocarcinoma cells. An increase in 
alpha-actinin or tropomyosin may play a role in migration of Bl6a 
cells. Further study must be done on the role of actin binding 
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proteins, and the modulation of migration by BA or RA treatment. 
In conclusion, this study reports on F-actin in nonmigratory, 
migratory, noninvasive, and invasive cells. The isolation of migratory 
and invasive cells in the Transwell chamber may allow for future 
quantitation of changes in the cytoskeleton by biochemical analysis or 
sensitive radioimmunoassays (Bernal et al., 1983; Ball et al., 1986). 
Further work utilizing confocal microscopy, monoclonal antibodies and 
biochemical techniques may help evaluate the mechanisms involved in 
cell migration and invasion. 
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Figure 1 - 2. 
Fluorescent micrographs (lA and 2A), the digitized (lB and 2B) and the 
color enhanced images (lC and 2C) of two invasive cells. Figures lC 
and 2C illustrate the extracellular background (deep grey), 
nonfilamentous background (black), least intense filamentous actin 
(grey), and most intense filamentous actin (white). See the Material 
and Methods for further detail. 
162 
163 
Key to Fig. 3 
2 Clear bar - Mean± S . E . area (um ) of untreated (control) cells. 
2 Top right to bottom left hatch bar - Mean+ S.E. area (um ) of 
RA-pretreated cells . 
Top left to bottom right hatch bar -
BA-pretreated cells. 
2 Mean+ S.E. area (um ) of 
Asterisk (*) - Defines a value that is significantly different 
(p<0.05) from untreated cells. 
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Figure 3. 
Total area of untreated, RA-pretreated and BA-pretreated migratory 
cells. 
AREA OF MIGRATORY CELLS 
.4000 
3800 
3800 
3.400 
3200 
3000 
2800 
2600 
2<100 
a 2200 
r 
e 
2000 
a illOO 
i600 
S.400 
i200 
sooo 
BOO 
600 
<100 
200 
* 
166 
Figure 4. 
Flourescent micrographs of cells on the top (A,C,E) and bottom (B,D,F) 
of uncoated p.c. membrane. Labels A and B are for untreated cells, c 
and D are for BA-pretreated cells, and E and F are for RA-pretreated 
cells. Bar = 20 um. 
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Key to Fig. 5 
2 Clear bar - Mean± S.E. area (um ) of untreated (control) cells. 
2 Top right to bottom left hatch bar - Mean+ S.E. area (um ) of 
RA-pretreated cells. 
Top left to bottom right hatch bar -
BA-pretreated cells. 
2 Mean + S.E. area (um ) of 
Asterisk (*) - Defines a value that is significantly different 
(p<0.05) from untreated cells. 
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Figure 5. 
Total area of untreated, RA-pretreated and BA-pretreated invasion 
cells. 
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Figure 6. 
Flourescent micrographs of cells on the top (A,C,E) and bottom (B,D,F) 
of Matrigel-coated p.c. membranes. Labels A and B are for untreated 
cells, C and D are for BA-pretreated cells, and E and Fare for 
RA-pretreated cells. Bar= 20 um. 
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Figure 7. 
Fluorescent micrographs of cells on top of uncoated (A,C,E) and 
Matrigel-coated (B,D,F) p.c. membranes. Labels A, B are for untreated 
cells, labels C, D are for BA-pretreated cells, and labels E and Fare 
for RA-pretreated cells. Bar= 20 um. 
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Figures 8A and B. 
Transmission electron micrographs of a migratory untreated cell within 
a pore of the p.c. membrane (p.c.). Cortical actin (a) and 
microtubules (arrow) are found in the cytoplasm within a pore. Fig. 
37A, Bar = 2 um. Fig. 38B, Bar = 1 um. 
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Figures 9A and B. 
Transmission electron micrographs of untreated cells on the top, within 
and on the bottom of a Matrigel (m) coated p.c. membrane (p.c). 
Cortical actin (a) and microtubules (arrows) are found in the cytoplasm 
within the pore. Fig. 9A and B, Bar= 1 um. 
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Figure 10. 
Transmission electron micrograph of BA-pretreated cells on top of 
Matrigel (m) and on the bottom of a p.c. membrane (p.c.). Cortical 
actin (arrows) is found in both non-invasive and invasive cells. Bar 
2 um. 
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TABLE 1. 
The percent of the form of F-actin in untreated, BA-pretreated, and 
RA-pretreated migratory and invasive cells. For details see the 
Results. 
N 
co 
.--t 
FORM OF ACTIN (%) 
TREATMENT I CONDITION N.F. L.l.F. 
X±S.E. X±S.E. 
UNTREATED/MIGRATORY 92.6±1.0 5.7± 0.9 
BA-TREATED /MIGRATORY 74.8 ± 2.8* 16.0 ± 1.9* 
RA-TREATED /MIGRATORY 86.3 ± 1.8** 9.8 ± 1.1* 
UNTREATED /INVASIVE 88. 6±1.8 8.6±1.5 
BA-TREATED /INVASIVE 83.1±1.6 13.2± 1.4 
RA-TREATED/INVASIVE 91.7 ± 1.3** 5.8 ± 0.9** 
N.F. - Nonfilamentous actin 
L.l.F. - Least intense filamentous actin (Actin 2) 
M.l.F. - Most intense filamentous actin (Actin 3) 
* Significant p < 0.05 level, untreated vs. drug-treated cells. 
** Significant p < 0.05 level, BA-treated vs. RA-treated cells. 
M.I.F. 
X±S.E. 
1.6 ± 0.3 
9.3±1.3* 
4.7 ± 0.9* 
2.4±0.6 
3.6± 0.7 
2.2 ± 0.4 
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TABLE 2. 
The area (um2 ) of the form of F-actin in untreated, BA-pretreated, and 
RA-pretreated migratory and invasive cells. For details see the 
Results. 
""" ro 
..-i 
AREA OF F-ACTIN 
TREATMENT /CONDITION N.F. L.l.F. 
X±S.E. X±S.E. 
UNTREATED/MIGRATORY 2013.0±179.5 110.3±19.3 
BA-TREATED/MIGRATORY 3172.0 ± 299.8* 662.4 ± 109.3* 
RA-TREATED/MIGRATORY 1900.0 ± 182.6** 207.3 ± 28.9* 
UNTREATED /INVASIVE 1790.0 ± 214.8 218.3 ± 42.70 
BA-TREATED/INVASIVE 2650.0 ± 273.7* 505.3 ± 72.2* 
RA-TREATED/INVASIVE 1673.0 ± 121.9** 107.4 ± 16.7* 
N.F. - Nonfilamentous actin 
L.l.F. - Least intense filamentous actin (Actin 2) 
M.I.F. - Most intense filamentous actin (Actin 3) 
* Significant p < 0.05 level, untreated vs. drug-treated cells. 
**Significant p < 0.05 level, BA-treated vs. RA-treated cells. 
M.I.F. 
X±S.E. 
35.4 ± 9.9 
248.1±41.0* 
96.6 ± 22.8* 
49.5± 12.4 
142.5 ± 34.0 
32.6 ± 5.9* 
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TABLE 3. 
The percent of the form of F-actin in untreated, BA-pretreated, and 
RA-pretreated nonmigratory and noninvasive cells. For details see the 
Results. 
l.O 
co 
r-1 
FORM OF ACTIN (%) 
TREATMENT /CONDITION N.F. L.I.F. 
X±S.E. X± S.E. 
UNTREATED/NONMIGRATORY 62.8±3.4 24.2± 2.3 
BA-TREATED /NONMIGRATORY 54.5±3.2 20.7± 1.4 
RA-TREATED/NONMIGRATORY 73.5 ± 2.5** 17.1±1.5* 
UNTREATED/NONINVASIVE 70.9 ± 2.4 20.4± 2.2 
BA-TREATED /NONINVASIVE 65.3 ± 2.8 20.2± 1.9 
RA-TREATED/NONINVASIVE 67.0± 2.7 18.2±1.1 
N.F. - Nonfilamentous actin 
L.I.F. - Least intense filamentous actin (Actin 2) 
M.I.F. - Most intense filamentous actin (Actin 3) 
* Significant p < 0.05 level, untreated vs. drug-treated cells. 
** Significant p < 0.05 level, BA-treated vs. RA-treated cells. 
M.I.F. 
X±S.E. 
13.6±1.8 
24.7± 2.6* 
9.9 ± 1.4** 
8.2±1.0 
13.7 ± 1.4* 
14.6 ± 2.3 
CHAPTER VII 
GENERAL DISCUSSION 
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I have studied the affect of two antitumor agents, butyric acid 
(BA) and all trans-retinoic acid (RA), on the proliferation, adhesion, 
migration, invasion, cytoskeleton, and experimental metastasis of 
murine Bl6a melanoma cells. Clinical application of BA and RA is 
increasing despite limited knowledge on how these agents perturb 
cellular migration and invasion. I have discussed within in chapters 
IV, V and VI some of the mechanisms behind the the affect of BA and RA 
on tumor cells. The mechanism of action of BA and RA at the molecular 
level needs further study. 
Phenotypic Drift and Metastasis 
Phenotypic diversity and tumor cell progression are important 
parts of the metastatic process. Tumor cell progression is defined as 
the evolution of tumor cells through a combination of genetic 
instability and host selection. Progression produces tumor cells with 
enhanced autonomy, survival and growth characteristics. The ultimate 
success of chemotherapy depends on the ability to eliminate rare, 
highly metastatic cell subpopulations. Elimination of the majority of 
tumor cells by cytotoxic drugs can create a new group of subclones that 
are drug resistant and phenotypically unstable. Long term cultures 
with BA-treated cells have not shown typical signs of drug resistance 
such as failure to inhibit proliferation. In fact, these cultures have 
shown further phenotypic changes including enhanced cell spreading. A 
substantial increase in the invasion or migration rates was noted if 
the inhibition of proliferation induced by BA was factored into these 
rates. In addition, I have shown in the migration and invasion assays, 
have shown that increasing the time of BA incubation further enhances 
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migration and invasion. This was not the case in the invasion assay 
with RA-treated and RA-pretreated cells. The limited effect of RA on 
the invasion of Bl6a cells may be due to the low invasive capability of 
Bl6a cells, since RA-pretreatment of K-1735 cells (a highly invasive 
cell line) reduced invasion. Radical changes in morphology, eg. cell 
size were not observed with RA-treatment. The amount of actin in 
nonmigratory and invasive RA-pretreated cells was significantly less 
than nonmigratory and invasive untreated cells, respectively. How this 
information may be related to the decrease in migration and invasion by 
RA-pretreated cells is open to speculation. Two factors seem to 
operate to control movement in cells. These are the F-actin to G-actin 
ratio (an increase in F-actin is indictative of an increase in 
migration) and the organization of F-actin (higher forms of 
organization are indicative of a decrease in migration). Both factors 
seem to operate with RA-pretreated cells. Nonmigratory RA pretreated 
cells have more total F-actin and increased organization of F-actin 
than migratory cells. The questions that remain are whether there is a 
decrease in total actin (globular and filamentous) or if there are 
changes in actin binding proteins that regulate actin polymerization. 
The genetic instability of metastatic tumor cells has been 
reported vitro and in vivo. I have observed that the migration rate 
of untreated Bl6a cells decreased with increasing passage of cells in 
culture (McGarvey and Persky, 1989b). I have also observed that no 
extrapulmonary metastasis occurred with tail vein injection of a 
mixture of lung nodule-derived and subcutaneously-derived Bl6a cells 
(McGarvey et al., 1990). In contrast, Honn et al. (1981) have reported 
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liver and spleen metastases from tail vein injection of Bl6a cells. 
There may a link between decreased migration in the Transwell system 
and a decrease in extrapulmonary metastasis. Decreased migration of 
subcutaneously-derived cells compared to early passage cells may be 
linked to decreased deformability of the cells through the lung 
capillaries. Subtle changes in genome probably account for these 
changes. 
Phenotypic drift of the Bl6 melanoma cell line has been observed 
(Poste et al., 1981; Stackpole, 1983). There was interlesional 
heterogeneity in the early stages of growth in experimental metastatic 
assays followed by intralesional heterogeneity (Poste et al., 1981). 
Before 25 days, cells are homogeneous within lesions. Progressive 
growth of the nodules gave rise to clones with differing metastatic 
capability (Poste et al., 1981). Stackpole (1983) has reported that 
the Bl6 melanoma cell line was not stable in culture or in serial 
subcutaneous passage (over 30 monthly generations). During this time, 
metastatic activity of the original tumor, which was intially slight, 
was lost by generation 10 and was restored by generation 18. Four 
different phenotypes were observed. Some lines produced both 
spontaneous and experimental metastases, some lines produced 
spontaneous metastases only, some lines produced experimental colonies 
only, while other lines produced neither spontaneous nor experimental 
metastases. Phenotypic drift is not exclusive to the Bl6 cell line 
(for review see Welch and Tomasovic, 1985). Other tumor cell lines 
reported to drift with respect to metastatic rate are the murine Kl735 
melanoma ~Talmadge et al., 1984) and clones of the 13762NF mamamary 
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adenocarcinoma (Welch et al., 1984). Schirrmacher (1980) has reported 
that the ESb lymphoma cell line has extremely high rates of drift to 
nonmetastatic behavior. Therefore, care must be taken in evaluating 
both in vitro and in vivo using metastatic tumor cells. Because of 
phenotypic drift, I performed tail vein and subcutaneous injections 
before and after all in vitro studies in order to verify that the cells 
were tumorigenic and metastatic. 
Cellular Migration 
The fundamental question in cellular migration is "what is the 
driving force behind cellular motility?" Clearly actin has a major 
role, while myosin probably does not. Certain forms of actin 
especially actin 3, are indicative of nonmigratory untreated or drug 
treated Bl6a cells. The actin morphology of BA-pretreated cells appear 
to be an example of a nonmigratory cell, but BA-pretreated cells are 
highly migratory. I have shown that BA modifies the organization of 
diffuse actin and actin bundles. This modification probably occurs 
through controlling the expression of actin binding proteins such as 
alpha actinin (Ryan and Higgins, 1987). Answers to how BA affects 
actin need to be solved at the molecular level. 
Actin bundles can change cell shape and regulate cell movement. I 
have shown in Chapter VI that the process of migration and invasion can 
change the morphology and amount of total F-actin, but only a 
combination of factors (substrate interactions and drug treatment) can 
account for the actin morphology observed in invasive and migratory 
cells. The interaction between drug treatment and the migratory 
process is important. For example, there was no significant difference 
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in total F-actin between untreated and BA-treated nonmigratory cells, 
but there was significantly more total F-actin in BA-treated cells than 
untreated migratory cells. However, the effect of drug interactions 
with the migratory or invasive processes on the F-actin does not tell 
the whole story. There were differences in actin morphology and total 
F-actin between untreated migratory and invasive cells. In addition, 
the affect of substrate interactions with drug treatment on F-actin 
morphology was observed in comparing noninvasive untreated and drug 
treated cells. Transformed motile cells, transformed nonmotile cells, 
and untransformed motile cells are interesting model systems to examine 
the mechanisms behind cellular motility. Drugs that affect cellular 
movement expand the model systems. The role of differentiating agents, 
such as DMSO and DMF, on motility would be interesting to investigate 
since they are known to change the morphology of tumor cells 
(Lampugnani et al., 1987; Dexter et al., 1974). 
The Transwell system allows for the isolation of unique 
subpopulations of cells (nonmigratory/migratory and 
noninvasive/invasive) for further analysis. One question that was not 
addressed in my experiments was whether there was a quantifiable change 
in the nonactin cytoskeleton by BA or RA. There is, apparently, a role 
for microtubules as shown by TEM in the migration of untreated and drug 
treated cells through the pores, but quantification was not posssible. 
It is clear that the morphology of actin filaments is distinctive in 
subpopulations of untreated Bl6a cells. The actin morphology of 
migratory and invasive untreated cells is different from nonmigratory 
and noninvasive untreated cells and is not just a result of substrate 
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interactions. 
Substrate interactions do have an effect on morphology, motility 
and metastasis of tumor cells (Nabi et al., 1990). In my study, there 
are differences in the actin morphology of nonmigratory and noninvasive 
untreated cells. The majority of F-actin filaments of noninvasive 
cells is confined to diffuse actin. In contrast, actin filaments (not 
diffuse actin) dominate the cytoplasm of untreated cells grown on 
uncoated polycarbonate membranes. The noninvasive and nonmigratory 
cells were similiar in that the majority of the cells grew in clusters. 
Migration and cell shape are related to metastasis? For example, 
an increase in motility and lung colonization was found in Bl6Fl 
melanoma cells that were grown as spheroids on a nonadhesive substrate 
(Poly(HEMA)) (Raz and Ben-Ze'ev, 1983; Nabi et al., 1990). Bl6Fl cells 
that were grown on Poly(HEMA) and allowed to reattach to tissue culture 
treated plastic were found to have increased spreading characteristics 
compared to cells that were grown only on the tissue culture treated 
plastic. Increased spreading was correlated to increased motility 
(Nabi et al., 1990). This is interesting to note since I have noted 
increased spreading and migratory capability of BA-treated Bl6a cells 
(McGarvey and Persky, 1989). The molecular events that increased 
motility in Poly (HEMA) grown cells may be related to events that 
increase the migration of BA-treated cells. The actin morphology of 
noninvasive BA-pretreated Bl6a cells does not appear to be different 
from nonmigratory BA-pretreated cells. However, I have found by image 
analysis that there is an increase in actin 3, which represents·the 
highest level of actin organization. This information is further 
194 
evidence that higher levels of organization of actin is correlated with 
decreased migration. 
The Matrigel Invasion Assay 
The Matrigel assay can be modified to further understand the 
invasion process. In this dissertation, a chemoattractant from NIH 
fibroblasts was added to the lower chamber of the Transwell chamber. 
The advantage of this modification is that the time period for the 
invasion assay was shortened and that an inhibition of proliferation 
can be separated from an inhibition in invasion. The addition of the 
chemoattractant increased the invasion rate of untreated cells, but 
likewise increased the invasion rate of BA-pretreated cells. Other 
modifications of the Matrigel assay have been done. For example, 
additional amounts of collagen type IV have been added to the Matrigel 
(Wang and Stearns, 1988). They found that invasion of tumor cells 
decreased through the modified Matrigel as compared to the invasion 
through Matrigel alone. 
I have shown that cellular adhesion to Matrigel was enhanced by BA 
pretreatment. A major constituent of Matrigel is laminin. The 
interaction of tumor cells with laminin is important since BA has been 
shown to reduce the number of laminin receptors in a human pancreatic 
cell line (Bryant et al., 1986). However, laminin has also been shown 
to enhance the release of type IV collagenase (Turpeenniemi-Hujanen, 
1986). The Transwell system lends itself to manipulation to further 
elucidate the factors involved in cellular migration and invasion. The 
bottom surfaces of polycarbonate membranes may be coated with ·various 
basement membrane proteins for haptotactic assays or with chemotactic 
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peptides. Likewise, proteins may be added to the lower chamber to 
increase migration and invasion. 
A major concern about Matrigel for invasion assays is that it 
forms at varying concentrations a consistent uniform barrier. Scanning 
microscopy, transmission electron microscopy, and fluorescent diffusion 
studies have confirmed the integrity of the Matrigel barrier (Persky et 
al., 1990). Basement membrane products such as thrombospondin, which 
is not present in Matrigel is important to the invasion process 
(Roberts et al., 1987). Thrombospondin induced chemotactic and 
haptotactic responses in several human tumor cell lines (Roberts et 
al., 1987). A defined basement membrane product similiar to Matrigel, 
that is functionally analogous to the human amnion, which contains a 
basement membrane and a collagenous stroma, would be advantageous in 
tumor invasion studies. 
It is clear from this dissertation that vitro assays may not 
tell the whole story. My in vitro experiments evaluated two agents. 
Butyric acid increased the adhesion, migration and invasion of Bl6a 
cells. In contrast, the other agent, RA decreased migration and 
invasion. However, both agents inhibited experimental metastasis. The 
intricate nature of the metastatic cascade is not limited to tumor cell 
invasion or migration, but includes other complex interactions with the 
host. Liotta (1970) observed that only 0.1% of the cells injected into 
tail veins of mice produced metastatic foci. The tail vein protocol 
includes the steps of entrapment of cells in the lungs, extravasation, 
and growth of the foci, yet only a small number of cells survive. 
Since this time, the role of phenotypic selection of tumor cells in 
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metastasis has gained exceptance. Metastasis may be conceptually be 
thought of as a series of limiting steps or gates. These steps include 
lung entrapment, extravasation (which includes adhesion, invasion and 
migration), growth, and escape from the host defenses. Administration 
of BA may open the invasion gate, but close the proliferation gate 
allowing host defences to eradicate the tumor. Retinoic acid can have 
affect any point in the experimental metastatic assay, closing still 
tighter the various gates. In addition, various cell types including 
placental trophoblasts, which are neither tumorigenic nor metastatic, 
can migrate and invade through Matrigel (Librach et al., 1989). 
Although the Matrigel and migration assays are interesting reductionist 
model systems to study tumor cells, the importance of the 
metastasis assays (experimental and spontaneous) can not be 
overemphasized. 
vivo 
CHAPTER VIII 
SUMMARY 
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The affect of two potential antiturnor agents, butyric acid (BA) 
and all trans-retinoic acid (RA), on murine Bl6a melanoma cells was 
investigated in vitro and in vivo. Initial studies determined the 
cytostatic/cytotoxic concentrations of BA and RA by hemacytometer 
counts and by the trypan blue exclusion test. Cytostasis was confirmed 
by autoradiography and beta scintillation measurement of incorporation 
of either 3H-thymidine or 3H-Iodo-deoxyuridine. 
The in vitro studies included both migration and invasion assays. 
For the migration assays, cells were plated onto 3 and 5 um diameter 
pore polycarbonate membranes. For the invasion assays, cells were 
plated onto recombinant basment membrane coated 8 um pore polycarbonate 
membranes. Migration and invasion rates were quantified by scanning 
electron microscopy. Cells were treated with the cytostatic 
concentrations of BA and RA or untreated for 72 hrs before the 
migration and invasion assay. Butyric acid or RA was again added at 
the time of plating of cells onto the membranes. 
The cytoskeleton of untreated and drug-treated migratory and 
invasive cells was also investigated by transmission electron 
microscopy and fluorescent microscopy. Cytoskeletal changes were 
quantified by image analysis of F-actin that had been stained by Bodipy 
phallacidin. 
The vivo study used the experimental metastatic assay (tail 
vein inoculation). Butyric acid or RA containing pellets, as well as 
placebo pellets, were administered subcutaneously. 
The major findings were: 
1. The range of cytostatic/cytotoxic concentrations of RA were 1 
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7 -6 -5 X 10- - 1 X 10 / > 1 X 10 Mand of BA were .5 mM - 1.5 mM / 2.0 
mM. 
3. The chosen cytostatic concentration of BA (1.5 mM) decreased 
by 80% the incoporation of 3H-thymidine. 
4. The chosen cytostatic concentration of RA (1 X 10- 7 M) 
decreased by 72.3% the incorporation of 3H-IdUR. 
5. The cytostatic concentration of BA decreased incorporation of 
31-dUR within 24 hrs. 
7. Butyric acid increased migration and invasion of Bl6a cells. 
Pretreatment with BA further increased migration or invasion. 
9. Retinoic acid decreased migration and invasion of Bl6a cells. 
10. Administration of BA and RA by subcutaneous pellet 
significantly decreased the number of lung nodules. In addition, 
administration of BA by subcutaneous pellet also decreased the 
incidence of lung nodule formation. 
12. Both migratory and invasive cells formed pseudopods containing 
networks of cortical actin and parallel microtubules. 
13. Migratory untreated cells had significantly less filamentous 
F-actin than migratory BA-pretreated cells and migratory RA-pretreated 
cells. 
14. Invasive cells with or without drug treatment had similiar 
amounts of filamentous F-actin. 
15. Untreated and drug-treated invasive and migratory cells were 
capable in varying degrees of bundling actin. This finding is 
important since it has been reported that invasive cells contained only 
diffuse actin. 
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17. Untreated/drug treated noninvasive and nonmigratory cells have 
more actin 3 (the highest level of actin organization) than 
untreated/drug treated invasive and migratory cells. 
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APPENDIX I 
The appendix is titled "Discussion with Reviewers" and has been 
published in the paper "The Effects of Butyric Acid and Retinoic Acid 
on In Vitro Migration by Murine Bl6a Melanoma Cells: A Quantitative 
Scanning Electron Microscopy Study." Scanning Microscopy, 3 (2): 591 -
604. The appendix contains material pertinent to Chapter IV. 
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DISCUSSION WITH REVIEWERS 
R. Lotan: What is a diffusion chamber? 
Authors: The diffusion chamber is a modification of the Membrane 
Invasion Culture System (MIGS) chamber (Gehlsen et al., 1984; see 
References). Figure 13 is a 14 well MIGS chamber. The diffusion 
chamber is similar to the MIGS chamber except that the diffusion 
chamber has 45 wells. In the migration assays, complete medium with or 
without a drug is added to the lower wells. The polycarbonate membrane 
is placed between an upper and lower chamber, creating 45 separate 
upper and lower wells. Cells are then added in complete medium, with 
or without a drug, to the upper wells. 
Figure 13: MEMBRANE INVASION CULTURE SYSTEM 
(MIGS; Pat Pending 84-027-1) 
(A) Top Plate 
(B) Bottom Plate 
(C and E) Upper Wells 
(D and F) Lower Wells 
(G) Polycarbonate Membrane 
(H) Washer 
(I) Bolt 
Redrawn with permission from 
Hendrix et al. (1985). 
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M.J.C. Hendrix: It is very difficult to derive significant statistical 
information from Table 4 when less than seven cells are presented? 
Authors: As a purely statistical question, this is a valid criticism. 
Table 4 presents data obtained from 50 fields at 1700X. Data could 
have been presented at lower magnifications, e.g., 500X. At 500X, the 
exact same quantitated surface area would have provided 15 fields 
(1,700 divided by 500 = 3.4; 50 divided by 3.4 = 15). The mean number 
of cells for Table 4 would therefore be 3.4X greater. I chose to 
present the data at l,700X because we could positively distinguish 
individual cells at higher magnification. 
R.Lotan: It would have been interesting if a low metastatic variant 
had been used in the migration assay. 
Authors: This is true, but the objectives of this project are to 
evaluate the effect of two drugs on a highly metastatic cell line. 
This project is part of an overall investigation that will evaluate the 
effect of RA and BA on viability, proliferation, migration, invasion, 
and metastasis. Since the human amnionic basement membrane (HABM) 
assay of Liotta et al. (New method for preparing large surfaces of 
intact human basement membrane for tumor invasion studies. Cancer 
Letters, ·141-152, 1980) is being used as one of the invasion assays, 
and since the HABM assay is only valid for highly invasive cells 
(Welch, DR. 1986 Discussion of the suitability, availability and 
requirements for in and in vitro models of metastasis. In: Cancer 
Metastasis, Experimental and Clinical Strategies. (eds). DR. Welch, BK. 
Bhuyan, and LA. Liotta. Alan R. Liss, Inc., N.Y., p. 135). Low 
metastatic cells were not used. 
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M.J.C. Hendrix: Is the rapid rate of biological degradation of 
retinoic acid by tumor cells similar for butyric acid? If not, what 
bearing would this information have on the data generated in this 
study? 
Authors: To our knowledge the rate of biological degradation of BA by 
tumor cells has not been reported. The incorporation of tritiated RA 
by murine S91 melanoma cells has been reported to be rapid during the 
first 15 min. Tritiated RA is incorporated much more slowly after this 
initial 15 min time period (Lotan et al., Characterization of retinoic 
acid-induced alterations in the proliferation and differentiation of a 
murine and a human melanoma cell line in culture. Ann N.Y. Acad Sci 
359: 150-170, 1981). In addition, S91 and Bl6 melanoma cells, when 
-5 grown in 10 M RA for six days and then refed in RA-free medium, 
continued to proliferate at a reduced rate for 24-48 h. However, after 
3 days of incubation in RA-free medium, the growth rate of previously 
RA-treated cells returned to that of the control cells (Lotan et al., 
Characterization of the inhibitory effects of retinoids on the vitro 
growth of two malignant murine melanomas. JNGI 60: 1035 1041, 1980). 
This reversible inhibition of growth of various tumor cell lines has 
been reported by others using BA (Prasad and Sinha, Effect of sodium 
butyrate on mammalian cells in culture: a review. In Vitro 12:125-135, 
1976). I have observed reversible changes in morphology of RA and 
BA-treated Bl6a cells after removal of the drug from the medium. 
Therefore, despite a rapid incorporation and rapid degradation of RA 
(and possibly BA) these drugs remain effective in changing morphology 
and inhibiting growth beyond the 72 h experimental time period. 
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M.J.C. Hendrix: Was scanning electron microscopy the only technique 
used to quantitate the tumor cells on the polycarbonate membranes? If 
so, what precautions were taken to insure that the entire filter was 
examined with SEM? Weren't the samples quite large to handle? 
Our intial attempts to quantitate cells by light microscopy 
were unsuccessful because we were not able to distinguish cells above, 
in, and below the membrane. Radioisotope labelling of cells was also 
attempted, but difficulties were encountered in removing BA-treated 
cells from the polycarbonate membranes. Even a 20 min trypsin/EDTA 
incubation failed to completely remove the BA-treated cells from the 
membrane. The entire membrane was observed by SEM. Care was taken to 
select SO random fields to quanitate migration. Samples were not too 
large to handle. On the contrary the small size of the membranes 
permitted three complete Transwell membranes to be loaded at one time 
into the scanning scope. 
M.J.C. Hendrix: Do the authors propose that SEM offers a universal 
quantitation approach for tumor cell invasion that supersedes currently 
available technology? 
Authors: Scanning electron microscopy is an accurate and reproducible 
method for quantifying migration and invasion. SEM allows 
visualization of top and bottom membrane surfaces and permits 
observation of individual cells. SEM does not have the depth of field 
resolution problem that is associated with light microscopy. SEM is 
but one method to quantitate cell invasion and migration. 
Why is it probable that increasing the pore size from 3 um 
to 5 um allows "flattened" cells to migrate? 
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Authors: I have shown that the migration of early passage untreated 
Bl6a cells through 5 um diameter pore membranes is 66% greater than the 
migration through 3 um diameter pore membranes (Trials 1 and 3, Table 
4). I have observed that cells on the top surface of the 3 um diameter 
pore membrane are heterogeneous in shape and contain flattened cells. 
In contrast, the heterogeneous population of cells on top of 5 um 
diameter pore membranes have few flattened cells. It appears that the 
majority of cells on the bottom surface of the 5 um pore membrane are 
flat in shape. 
R. Lotan: It is possible to dehydrate tissues for SEM with alcohol 
instead of acetone that would have allowed you to critical point dry 
the specimens instead of air drying them. Also, the membranes can be 
cut out of the plastic well and processed separately. 
Authors: Despite the cracking produced by air drying, problems were 
not encountered in quantitating cells. The cracking produced by air 
drying the filters can be reduced by using hexamethyldisilazane (Nation 
et al. A new method using hexamethyldisilazane for preparation of soft 
insect tissues for scanning electron microscopy. Stain Tech. 
~:347-351, 1983). It is possible to dehydrate with alcohol instead of 
acetone before critical point drying. Our electron microscopy facility 
does not have a suitable drying agent, such as Freon 113, for critical 
point drying alcohol dehydrated specimens. The membranes were 
processed in Transwell chambers to facilitate ease of handling. 
Cutting out the membranes prior to alcohol dehydration causes the 
membranes to roll up. 
Reviewer #4: Is the rate of proliferation the same between cells grown 
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on polycarbonate membranes as cells grown on tissue culture treated 
plastic? 
Authors: Yes. I have previously determined that there is no 
significant difference between Bl6a cell proliferation rates for cells 
grown on plastic dishes versus polycarbonate membranes. I quantified 
proliferation by plating cells into Transwell chambers (50,000 
cells/well) and into a 24 well plate (Corning) (50,000 cells/well). 
Each experiment was done in triplicate and the number of cells 
determined after 72 h by hemacytometer count. 
Reviewer #4: Why did the authors use two different radioisotopes to 
determine proliferation rates? 
Authors: After completing the BA experiments with 3tt-thymidine, we 
changed radioisotopes to 3tt-IdUR. The irreversible binding property of 
3tt-IdUR makes it a better radiolabel than 3H-thymidine (Fidler, I. 
Metastasis: quantitative analysis of distribution and fate of tumor 
emboli labelled with 125 I-5-Iodo-2'-deoxyuridine. JNCI, 45:773-782, 
1971). Since BA had already been shown to produce a significant 
inhibition of 3H-thymidine incorporation, we thought it would not be 
necessary to repeat the BA experiments using 3tt-IdUR. 
Since the publication of this manuscript, the BA experiments were 
performed using 3HidUR. Butyric acid inhibited the incorporation of 
3HidUR by 76% after 18 h incubation (54 h preincubation with BA) and 
84% after 48 h incubation (24 h preincubation with BA). 
Reviewer #4: The methodology of choice for determining 
cytotoxic/cytotstatic effects of drugs is the double-label growth 
assay. Why did the authors not use this technique? 
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I agree that the double label growth assay is a preferred 
method to quantitate viablity and proliferation in drug studies. 
Although the trypan blue exclusion method is less sensitive, it did 
provide cytotoxic/cytostatic data that was statistically significant. 
APPENDIX II 
This appendix is titled "Transmission Electron Microscopy of the 
Cytoskeleton of Migratory and Invasive Cells" and has been published 
under the same name in the Journal of Electron Microscopy Technique, 
13(3): 272 - 273. This appendix describes the methodology used to 
evaluate the cytoskeleton of migratory and invasive cells by 
transmission electron microscopy. This methodology is pertinent to 
Chapter VI. 
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INTRODUCTION. The recent development of the Transwell cell culture 
chamber insert (Costar Co., Cambridge, MA) permits analysis of cellular 
migration and invasion. Transwell inserts contain a porous 
polycarbonate membrane and fit into 6 and 24 well cluster plates. 
Although cellular migration and invasion through polycarbonate 
membranes have been quantitated by routine LM, SEM and radiolabel 
techniques, few reports have focused on the cytoskeleton of cells in 
the process of moving through pores. This communication reports a 
simple methodology to evaluate the cytoskeleton of both migratory and 
invasive tumor cells within 5 um and 8 um diameter pore Transwell 
polycarbonate membranes. 
MATERIALS AND METHODS. Murine Bl6a melanoma cells were cultured in 
Eagle's medium (MEM) (Gibco, Grand Island, NY) containing Hank's salts 
and 1-glutamine supplemented with sodium pyruvate (Sigma, St. Louis, 
MO), 10% heat inactivated fetal calf serum (FCS) (Gibco), 1% penicillin 
G-streptomycin sulfate-amphotericin B (Fungizone) (Gibco), MEM non 
essential amino acids (Gibco), sodium bicarbonate (Sigma), and Hepes 
(Sigma). Cells were treated with sodium butyrate acid (BA) (JT Baker, 
Phillipsburg, NJ) for 3 days before plating onto the Transwell 
membranes. Transwell membranes were uncoated for migration assays 
(McGarvey and Persky, 1989) and coated with Matrigel (Collaborative 
Research, Cambridge, MA) for invasion assays (Repesh, 1989). 
Transmission electron microscopy (TEM) followed the method of 
McDonald (1984) in order to preserve microfilaments. Membranes were 
fixed for 30 min at 37°C with 2% glutaraldehyde in 50 mM cacodylate 
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buffer (pH 7.4) containing 5 mM Cacl 2 , rinsed in buffer (3X) for 5 min 
at 37°C and incubated for 30 min in buffer containing 0.8% K3Fe(CN) 6 . 
Membranes were then incubated for 30 min in buffer containing 0.5% Oso4 
and 0.8% K3Fe(CN) 6 , rinsed in buffer, rinsed in distilled water (3X), 
stained en bloc with 2% uranyl acetate (distilled water) for 60 to 120 
min, rinsed in distilled water (3X) and dehydrated in ethanol. 
Membranes were infiltrated into resin (Epon-Araldite), cut out of the 
Transwell inset, and polymerized in blocks at 60°C for 3 days. Thin 
sections were cut, stained in 1% uranyl acetate (in 70% methanol) and 
lead citrate, and viewed with an Hitachi H-600 microscope at 75 kV. 
RESULTS AND DISCUSSION. This investigation reports a simple method to 
prepare and analyze by TEM the cytoskeleton of migratory and invasive 
cells within a polycarbonate membrane. Figure 1 demonstrates a 
migratroy cell be seen extending two large pseudopods into two S um 
pores. Anchoring of the cell to the polycarbonate membrane appears to 
take place both within the pores as well as above and below the 
membrane (arrows). Higher magnification (Fig. 2) reveals an extensive 
parallel arrangement of the cytoskeleton within one of the large 
pseudopods. The cell border displays bundles of cortical actin. 
Cortical actin has been reported to have a major role in cell motility 
and migration (Hay, 1985). It is obvious that the actin preservation 
is excellent. 
Butyric acid (BA) was used in this study at a concentration of 1.5 
mM. This concentration has been shown to be noncytotoxic, to-
significantly increase cellular migration, and to induce changes in the 
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cytoskeleton of Bl6a cells (McGarvey and Persky, 1989). The 
arrangement of the cytoskeleton in the large pseudopod (Fig 2) may not 
only be indicitive of a migrating cell but also of BA treatment. 
The Transwell insert is an important new tool to analyze cellular 
migration and invasion. The polycarbonate membrane of the Transwell 
insert was uncoated for migration and coated with a reconstituted 
basement membrane, Matrigel, for invasion. Figure 3 depicts a 
BA-treated cell on top of the Matrigel. A portion of this cell and 
possibly another cell have extended into an 8 um pore by digesting the 
Matrigel (arrow). Higher magnification of this area (Fig. 4) reveals a 
cytoplasm without the extensive cortical actin and other cytoskeletal 
filaments seen in the migratory cell. Areas of contact with the 
Matrigel appear to contain actin (arrows). Kramer et al. (1989) have 
reported fibrosarcoma cells, which invaded Matrigel, to have (1) formed 
pseudopodia which contained organized microfilaments and (2) have 
cleared the matrix adjacent to the pseudopodia. While we did not 
observe bundles of microfilaments, matrix clearing (me) was evident 
around the pseudopodia. 
The ease of handling the Transwell insert is a major advantage for 
microscopy. Membranes can be processed for TEM in the Transwell 
inserts until embedding in the plastic. Together, the Transwell insert 
and Matrigel lend themselves to techiques such as immunogold to locate 
and identify cytoskeletal proteins and proteolytic enzymes in cells 
that are within the pores of the polycarbonate membrane. 
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FIGURE 1. 
A migrating BA-treated Bl6a cell cultured on a 5 um diameter pore 
polycarbonate membrane (pc). A large pseudopod extends the length of a 
pore with a smaller projection within a second pore (arrows). Bar= 2 
um. 
FIGURE 2. 
Higher magnification of the large pseudopod of Fig 1. Note the 
extensive actin (a) , intermediate filament () , and microtubule () 
system. Bar = 1 um. 
FIGURE 3. 
An invasive BA-treated Bl6a cell cultured on a Matrigel coated (m) 8 um 
diameter pore polycarbonate membrane (pc). A projection of this cell 
or possibly another cell (arrow) is found below the Matrigel barrier. 
Bar = 2 um. 
FIGURE 4. 
A higher magnification of the projection of Fig 3 with some cortical 
actin (a) as well as a clear Matrigel clear zone (me). Bar= 0.5 um. 
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